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 Porcine reproductive and respiratory syndrome virus causes PRRS which is one of the most 
economically significant diseases in the swine industry worldwide. PRRSV has the ability to 
suppress the type I interferon induction to facilitate its survival during infection, and the nsp1 
protein of PRRSV has been identified as the potent IFN antagonist. The nsp1β subunit of nsp1 
blocks the host mRNA nuclear export and this is one of the viral mechanisms to inhibit host 
antiviral protein translation. The functional motif for both IFN suppression and host mRNA 
nuclear retention were identified in nsp1β, and mutations in the motif results in the IFN-
suppression-negative and host-mRNA nuclear retention-negative. To examine the pathogenic 
consequence of these functions in the natural host animals, two mutant PRRS viruses (vL126A 
and vL135A) were generated using infectious clones. These mutant viruses retained the infectivity, 
and their phenotype was IFN suppression-negative and host mRNA nuclear retention-negative. 
Pigs infected with vL126A or vL135A exhibited milder severe clinical signs with lower viral titers 
and shorter duration of viremia when compared to those of WT-infected pigs. The levels of 
PRRSV-specific antibody remained comparable in all infected groups but the neutralizing 
antibody titers were high in vL126A-infected or vL135A-infected animals. The IFN-α 
concentration was also high in pigs infected with the mutant PRRSV.  
Subsequently, the nsp1β mediated inhibitory mechanism was investigated. Nsp1β was 
found to specifically interact with nucleoporin 62 (Nup62). Nup62 is one of the major components 
of the nuclear pore complex (NPC) that form channels spanning the double lipid bilayer of the 
nuclear envelope for nucleocytoplasmic transport of cellular molecules including host mRNAs. A 
region representing the C-terminal 328-522 residues of Nup62 was identified as the binding 
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domain to nsp1β. Mutational studies revealed that leucine 126 of nsp1β was the critical residue for 
Nup62 interaction. Nsp1β L126A did not bind to Nup62, and host mRNA nuclear export occurred 
normally. In nsp1β-overexpressing cells or siRNA-mediated Nup62 knock-down cells, viral 
growth was improved. This is likely attributed to nsp1β-mediated viral protein production 
enhancement and reduction of antiviral proteins in the cytoplasm. 
One of the mechanisms that PRRSV causes respiratory disease is the onset of inflammation 
at the site of infection. PRRSV activates NF-kB during infection, and the nucleocapsid (N) protein 
has been identified as the major NF-kB activator. The protein inhibitor of activated STAT1 
(PIAS1) was identified as a molecular partner of N. PIAS1 binds to RelA (p65) and prevents NF-
kB activation by interfering p65-DNA binding in the nucleus and thus functions as a negative 
regulator of NF-kB. The binding domain of PIAS1 was mapped to the N-terminal domain, and this 
domain was sufficient to bind to p65 and prevent its binding to the kB site, demonstrating the 
competitive binding between N-PIAS1 and NF-kB-PIAS1. For N, the region between 37 and 72 
amino acids was found to interact with PIAS1, and this region overlapped the nuclear localization 
signal (NLS) of N. A nuclear localization signal (NLS) knock-out mutant N did not activate NF-
κB, and this is likely due to the lack of its interaction with PIAS1 in the nucleus, demonstrating 
the positive correlation between the binding of N to PIAS1 and the NF-κB activation. 
In conclusion, the current study dissects the molecular basis of innate immune suppression 
and NF-kB activation of PRRSV and identifies the leucine 126 of nsp1β and NLS of N are essential 
residues. The innate immune modulation and NF-kB activation together delineate the pathogenic 
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CHAPTER 1: GENERAL INTRODUCTION 
 
1.1 INTRODUCTION 
Porcine reproductive and respiratory syndrome (PRRS) appeared in pigs in the US three 
decades ago and became endemic in most pig farming countries globally. Shortly after, two 
prototype viruses have been identified as etiological agents independently in the Netherlands and 
the US, and named Lelystad and VR-2332, respectively (Benfield et al., 1992; Wensvoort et al., 
1991). PRRSV forms the family Arteriviridae along with equine arteritis virus (EAV), lactate 
dehydrogenase elevating virus (LDV) of mice, and simian hemorrhagic fever virus (SHFV) 
(Snijder et al., 2013). Subsequent studies reveal that the genomic sequences of Lelystad and VR-
2332 share only approximately 60% identity and thus form the Europe genotype (genotype 1) and 
the North American genotype (genotype 2), respectively (Allende et al., 1999; Nelsen et al., 1999; 
Wensvoort et al., 1991). PRRSV has been evolving greatly since its emergence, and a variant of 
the genotype 2 in China shows much higher morbidity and mortality compared to previous isolates 
(Tian et al., 2007; Xiao et al., 2010). In contrast to the genetic variations of the virus, clinical signs 
of the disease are similar for both genotypes and exhibit the respiratory disease in young pigs and 
abortion in pregnant sows and gilts (Benfield et al., 1992; Chand et al., 2012; Magar et al., 1995; 
Nelsen et al., 1999). 1 
The genome of PRRSV is a single-stranded positive-sense RNA of approximately 15 Kb 
in length with the 5’-cap and 3’-polyadenylated tail (Meulenberg et al., 1993a; Nelsen et al., 1999; 
                                                
This chapter has partially appeared as an article in Veterinary Microbiology. The original citation 
is: Ke, H. and Yoo, D. 2017. The viral innate immune antagonism and an alternative vaccine design 
for PRRS virus. Veterinary Microbiology 209:75-89. The copyright owner, Elsevier B.V., 
permitted that author can included the article, in full or in part, in a thesis or dissertation, for a 
wide range of scholarly, non-commercial purposes. 
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Wootton et al., 2000). The PRRSV genome contains 11 open reading frames (ORFs): ORF1a, 
ORF1b, ORF2a, ORF2b, ORFs 3 through 7, plus the newly identified ORF5a and ORF2(TF) (Fang 
et al., 2012b; Firth, 2011; Johnson et al., 2011). ORF1a and ORF1b take up 75% of the genome in 
its 5’-proximimity and code for two large polyproteins, pp1a and pp1ab, of which the latter is 
produced by -1 ribosomal frame shifting in the overlapping region (Den Boon et al., 1991). Pp1a 
contains four viral proteases: two papain-like cysteine proteases PLP1α and PLP1β, poliovirus 3C-
like cysteine proteinase (CP), and serine proteinase (SP) residing in nonstructural protein (nsp) 1α, 
nsp1β, nsp2, and nsp4, respectively. The processing of pp1a and pp1ab for PRRSV nonstructural 
proteins is reviewed elsewhere (Fang and Snijder, 2010; Snijder et al., 2013). PLP1α, PLP1β, and 
PLP2 are responsible for cleaving nsp1α, nsp1β, and nsp2 off from pp1a, while the serine 
proteinase in nsp4 cleaves the remaining nsps. From the polyprotein processing, a total of 14 nsps 
are generated including the newly identified nsp2TF and nsp2N encoded by the newly identified 
ORF2(TF) within the nsp2 coding sequence, which is generated by -1/-2 ribosomal frame shifting 
(Fang et al., 2012b). The remaining quarter of the viral genome consists of structural genes coding 
for two major membrane proteins (GP5 and M), five minor membrane proteins (GP2a, GP3, GP4, 
GP5a, and E), and the nucleocapsid (N) protein.  
 
1.2 HOST RESPONSES TO PRRSV INFECTION 
PRRSV infection is comprised of three phases: acute infection, persistent infection, and 
extinction. During the acute phase, viremia appears as early as 6 to 12 h post-infection and the 
PRRSV replicates swiftly in alveolar macrophages and dendritic cells in the lungs and the upper 
respiratory tract. This phase usually lasts for 3 to 4 weeks until the clearance of viremia (Wills et 
al., 1997). PRRSV can also build a persistent infection (Allende et al., 2000). During this phase, 
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viral replication occurs only in the lymphoid tissues including tonsils and lymph nodes without 
viremia excluding the spleen (Beyer et al., 2000; Rowland et al., 2003a), and the persistence lasts 
for an extended period of up to 180 days. Since PRRSV can persist in the lymphoid tissues, the 
virus spreads easily from infected pigs to naive pigs. Such transmission makes hard to control 
PRRS in the field. The virus is eventually eliminated from infected hosts (Linhares et al., 2014; 
Torremorell et al., 2002), indicating that the pigs are able to develop immune responses that finally 
clear the infection. The response kinetics to eliminate PRRSV is slow and the overall response is 
delayed. The reason for this delay may be due to multi-phases of infection, poor induction of innate 
immune response, poor and delayed production of neutralizing antibodies, and/or delayed 
maturation and proliferation of cell-mediated immune responses (Lunney et al., 2016a; Sun et al., 
2012a).  
 
1.2.1 Innate immune response to PRRSV infection 
1.2.1.1 Type I IFN production and signaling 
The innate immune response is the first line of defense of a host in response to infection. 
Type I interferons such as IFNs-α/β are the most potent antiviral cytokines against invading viruses 
and trigger expressions of IFN-stimulated genes (ISGs) (Schneider et al., 2014b). Virtually all 
nucleated cells have the ability to produce IFNs-α/β, although plasmacytoid dendritic cells (pDC) 
are the most potent producers of type I IFNs (Liu, 2005). When an RNA virus enters the cell, a 
series of recognition mechanisms are triggered within the cell. The RNA genome of the virus is 
sensed by pattern recognition receptors (PRRs) which are consisted of two major categories; 
retinoic acid-inducible gene (RIG-I)-like receptors (RLRs) distributed in the cytoplasm and toll-
like receptors (TLRs) residing in the endosomal membrane. These receptor families work together 
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to maximally sense the “foreigners” despite of their locations (see (Wu and Chen, 2014) for innate 
immune sensing). The signaling cascades are then turned on by PRRs. RIG-I binds to viral RNA 
and undergoes a conformational change to expose its caspase activation and recruitment domain 
(CARD) at its N-terminus. The CARD domain then binds to the IFN promoter stimulator-1 (IPS-
1) (also known as Cardif, MAVS, or VISA) on the mitochondrial membrane through a CARD-
CARD interaction. IPS-1 is an adaptor which recruits the NEMO, TRAF3, and TANK proteins to 
form a complex, and the complex activates TBK1 and IKKε. They are the kinases responsible for 
activating IRF3 and IRF7 by phosphorylation. The phosphorylated IRF3 and IRF7 then form a 
homodimer or heterodimer and are subsequently translocated to the nucleus (Lin et al., 1998). The 
dimer in the nucleus is recruited by the CREB (cyclic AMP responsive element binding)-binding 
protein (CBP) to form an IFN enhanceosome (Panne et al., 2007). Inside the enhanceosome, 
activated IRF3- or IRF7-dimer binds to the positive regulatory domains (PRDs) I-III regions in the 
IFN promoters which drives IFNs gene transcription (Dragan et al., 2007; Honda et al., 2005; Sun 
et al., 2012a). Besides, IPS-1 may also trigger the activation of IKKα and IKKβ which 
phosphorylate IκB to allow degradation through a proteasom-dependent pathway. Degradation of 
IκB results in the release of NF-κB which is another transcription factor that binds to PRDs of IFN 
genes as well as genes coding for pro-inflammatory cytokines (Caamano and Hunter, 2002; Honda 
et al., 2005; Napetschnig and Wu, 2013). Other than activation of the RIG-I-mediated signaling 
cascades, TLR3 and TLR7 are also involved in sensing viral RNAs in the endosome (Karikó et 
al., 2004; Kawai and Akira, 2011). TLR3 binds to dsRNA. During the viral genome replication, 
dsRNA intermediates are produced, thus TLR3 can recruit the TRIF, NAP1 and TRAF3 adaptors, 
which leads to the activation of TBK1 and IKKε, like RIG-I does, and activates IRF3 and drives 
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IFN gene expression. Similarly, TLR3 can also activate the NF-κB pathway through the TRAF6, 
RIP1, TAK1, and IKK (both -α and -β) signaling (Honda et al., 2005; Wu and Chen, 2014). 
Once type I IFNs are produced, they are released from the cell and bind to their receptors 
(IFNAR1 and IFNAR2) on the same cell (autocrine) or neighbor cells (paracrine). The IFN binding 
to receptors triggers the Janus kinase 1 (JAK1) and tyrosine kinase 2 (Tyk2) activation, which 
results in phosphorylation and dimerization of signal transducers and activator of transcription-1 
(STAT1) and STAT2 to follow the formation of IFN-stimulated gene factor 3 (ISGF3) complex 
after recruitment of IRF9. ISGF3 then enters the nucleus and binds to IFN-stimulated regulatory 
response elements (ISRE) in the promoters of IFN-stimulated genes (ISGs). ISGs are the major 
executors of IFNs to establish an antiviral status of cells and/or to regulate other cellular functions 
(Ivashkiv and Donlin, 2014; Schneider et al., 2014b). 
1.2.1.2 Type I IFN response to PRRSV infection 
Porcine alveolar macrophages (PAMs) are the main target cells for PRRSV infection (Duan 
et al., 1997). Evidence is available to show that DCs are also susceptible for PRRSV replication 
(Loving et al., 2007). The IFN responses during PRRSV infection have been studied and reviewed 
previously (Han and Yoo, 2014; Sun et al., 2012a; Yoo et al., 2010). The IFN response is meager 
in PRRSV-infected pigs (Albina et al., 1998c), and remains low shortly after transient elevation 
below the detection level in the lungs of pigs where PRRSV actively replicates (Van Reeth et al., 
1999). Those studies show that the IFN response against PRRSV is poor, suggesting that the virus 
may actively suppress the IFN production in vivo. Similarly, the suppression of IFN has also been 
observed in vitro in PRRSV-infected MARC-145 cells and porcine alveolar macrophages (PAMs) 
(Albina et al., 1998c; Buddaert et al., 1998; Miller et al., 2004b). The poor induction of type I IFN 
response during infection suggests that PRRSV may have adopted various strategies to suppress 
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the induction and function of IFNs-α/β. Subsequent studies shows that the suppression of IFN 
production is a major strategy of PRRSV to modulate host antiviral defense. At least six viral 
proteins (nsp1α, nsp1β, nsp2, nsp4, nsp11, and N) have so far been identified as IFN antagonists, 
and their mechanisms of action are partially characterized (Han and Yoo, 2014; Lunney et al., 
2016a; Sun et al., 2012a; Yoo et al., 2010). Type I IFNs in swine are comprised of at least 39 
functional subtypes, which is more than double of humans, plus 16 pseudogenes in the type I IFN 
family (Groenen et al., 2012; Sang et al., 2010). For swine, 17 IFN-α subtypes are found and they 
contain anti-PRRSV activities (Sang et al., 2010). The second largest subtypes of swine type I 
IFNs is IFN-δ which contains 11 members, and this population of type I IFNs is growing and 
rapidly evolving (Dawson et al., 2013; Groenen et al., 2012; Sang et al., 2014a). The rest of swine 
type I IFNs includes seven subtypes of IFN-ω, and a sole type of IFN-β, IFN-ε, IFN-κ, and IFN-
α/ω (Groenen et al., 2012; Sang et al., 2014a; Sang et al., 2010). The antiviral effects of these 
subtypes are dependent on the cell types and invading viruses. It seems apparent that the type I 
IFN system in swine is more complicated than that of human, and many subtypes remain unclear 
in their antiviral actions for PRRSV, which warrants further studies on the interactions between 
PRRSV and these subtypes. The majority of mechanistic studies for type I IFN antagonism by 
PRRSV have focused on IFNs-α/β, largely due to their dominant role for antiviral activity.  
 
1.2.2 Dendritic cells (DCs) 
In addition to building an antiviral status by stimulating numerous ISG expressions, type I 
IFNs can also suppress viral infection indirectly by targeting NK cells, DCs, T cells, and B cell. 
The production of type I IFNs is in favor of a host to defend infection via three major actions: 
First, type I IFNs induce intrinsic antiviral activities through the JAK-STAT signaling pathway 
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and the expression of hundreds of antiviral proteins (Schneider et al., 2014b). Second, type I IFNs 
can also enhance antigen presentation in DCs and their migration to lymph nodes. The improved 
antigen presentation by DCs facilitates the maturation and proliferation of T cells. Third, type I 
IFNs activate and promote T cells and B cells directly by enhancing their antigen presentation, 
cytokine productions including IFN-γ, and chemokine production. The importance of type I IFNs 
in the development of adaptive immunity draws attentions and depicted in Fig. 1.1.  
1.2.2.1 Regulation of DC functions by type I IFNs 
Dendritic cell is the bridge between the innate and adaptive immunity. Type I IFNs regulate 
the function of DCs through an autocrine manner (Baranek et al., 2012) and activate the immature 
DCs to functional antigen-presenting cells (APCs) (Gessani et al., 2014). The MHC expression in 
DCs is elevated, so as in CD80 and CD86 which contribute to the DC activities to stimulate T cells 
from peripheral blood in humans or bone marrows in mice (Ito et al., 2001; Montoya et al., 2002). 
During vaccinia virus infection or lymphocytic choriomeningitis virus (LCMV) infection, type I 
IFNs promote the ability of DCs to cross-present antigens to T cells, as well as modulating the 
antigen survival and processing by T cells (Le Bon et al., 2003; Spadaro et al., 2012). Bringing 
viral antigens from the site of infection to lymph nodes and presenting them to T cells is how DCs 
perform their antigen presentation. Type I IFNs positively regulate the expression of MIP-3β, 
CCR-7, and Th1-type chemokines, and the DC migration is affected by these chemokines. Thus, 
it seems clear that type I IFNs promote mature DCs to migrate to lymph nodes, contributing to 
their antigen-presentation activities as shown in humans and mice for PBMCs (Parlato et al., 2001; 
Rouzaut et al., 2010). IL-12 is another cytokine that potently regulates NK cells, T cells secreting 
IFN-γ, and Th1 cells in response to viral infection (Gautier et al., 2005). Bone marrow-derived 
DCs produce IL-12 in humans or mice, and this activity is tightly regulated by type I IFNs (Gautier 
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et al., 2005). The importance of DCs in regulating normal function of adaptive immune cells is 
amplified by the fact that, in type I IFN receptor-deficient DCs, the norovirus persistence is 
increased even in the presence of enhanced adaptive immunity (Nice et al., 2016). In that study, 
type I IFNs primed DCs, and mature DCs were necessary for adaptive immune response. Not only 
on the positive regulation of DCs by type I IFNs, an attention needs to be paid on the negative 
modulation. Thus, depending on the circumstance, type I IFNs can suppress DC maturation or IL-
12 secretion (Cousens et al., 1997; Dauer et al., 2003). DCs are the major cell population 
expressing type I IFNs and connect the innate immunity to adaptive immunity, which makes DCs 
crucial for activation and maturation of adaptive immunity. Fine tuning on DCs by IFNs can 
enhance the role in the network important for the both innate and adaptive immune responses 
(Gommerman et al., 2014)).  
1.2.2.2 Porcine DC response to PRRSV infection 
Since PRRSV can infect DCs (Loving et al., 2007), the response of DCs to PRRSV 
infection is of interest. The production of type I IFNs by pDCs is severely suppressed during 
PRRSV infection (Baumann et al., 2013; Calzada-Nova et al., 2010). Furthermore, the pDCs 
activation, which is featured by the increase of CD80/86 expression and cell-type development, is 
not seen by PRRSV (Calzada-Nova et al., 2011). Since pDCs are not permissive for PRRSV 
(Calzada-Nova et al., 2011), the failure of pDC activation during PRRSV infection may be due to 
the lack of type I IFN production,  suggesting a role of type I IFN for priming the adaptive response 






1.2.3 NK cells 
1.2.3.1 Regulation of NK cell functions by type I IFNs 
Type I IFNs enhance the survival and function of NK cells directly or indirectly in murine 
models and human cells (Fig. 1.1) (Paolini et al., 2015). NK cells kill virus-infected cells directly, 
or secret IFN-γ and promote other antiviral functions indirectly. In influenza virus-infected or 
vaccinia virus-infected mice, a deficient production of type I IFNs results in the reduced activation 
of NK cells, reduced cytolytic effector expressions, and reduced IFN-γ secretion (Hwang et al., 
2012; Martinez et al., 2008). Such phenomena are also observed in LCMV-infected mice where 
type I IFN promotes IFN-γ secretion in NK cells through the STAT4-dependent pathway. 
Furthermore, anti-LCMV activity of NK cells is also enhanced (Mack et al., 2011). The decision 
to stimulate cytolytic effectors expression or IFN-γ secretion is dependent on the balance of 
STAT1 and STAT4 after IFN signaling activation (Hwang et al., 2012). These NK cell activities 
can also be regulated by IL-15, which is an ISG product after IFN binding to IFNARs on DCs in 
mouse models (Lucas et al., 2007). In the TLR-stimulated mice, increased accumulation of NK 
cells is seen in the local lymph nodes. This activity is mediated via IFN-primed DCs to increase 
the IL-15 production (Lucas et al., 2007). An independent study shows that both pDCs and 
monocytes (MOs) indirectly stimulate NK cell activation through IFN-α secretion during human 
herpes simplex virus-1 (HSV-1) infection of PBMC (Vogel et al., 2014). Indeed, type I IFNs can 
promote the NK cell expansion during murine cytomegalovirus (MCMV) infection (Madera et al., 
2016). A worth noting is that the IFN-induced intrinsic antiviral activity of NK cells is less of 
importance but NK cells respond to IFNs effectively. During MCMV infection, DCs respond to 
IFNs well by producing IL-15. While NK cells are less responsive to IFNs directly, these cells 
respond to IL-15 potently (Baranek et al., 2012). A long-term treatment of chronic hepatitis C 
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patients with IFN-α enhances the cytotoxicity of NK cells and results in the decrease of viral RNA 
in the serum of the patients (Hu et al., 2014). This indicates that IFN-α can fine-tune the NK cell 
activity through regulating the balance between activation and inhibition to suppress the chronic 
infection.  
1.2.3.2 Porcine NK cell response to PRRSV infection 
Nature killer (NK) cell is an additional arm important in the antiviral innate immune 
defense. NK cells nonspecifically target virus-infected cells by recognizing “altered-self antigen” 
characterized by reduced MHC-I expression (Gerner et al., 2009). The NK cell response to PRRSV 
infection has been reviewed elsewhere (Lunney et al., 2016a), and here we will only discuss the 
negative regulation of NK cell function by PRRSV. The cytotoxic function of NK cells is reduced 
in PRRSV-infected pigs and the reduced function begins from 2 days after infection and lasts for 
three to four weeks (Dwivedi et al., 2011a; Renukaradhya et al., 2010). This phenomenon is 
common for the field isolates and modified-live vaccine (MLV), and also for differently 
administrated routes of infection (Albina et al., 1998a; Dwivedi et al., 2011b; Renukaradhya et al., 
2010). Notably, experimentally infected pigs show low levels of IFN-α. Even though there is no 
clear correlation between the low level of type I IFNs and the reduced cytotoxic activity of NK 
cells, NK cell function is directly regulated by type I IFNs along with other cytokines such as 
interleukin (IL)-12 and IL-15 (Nguyen et al., 2002). 
 
1.2.4 T lymphocytes 
1.2.4.1 Regulation of T cell functions by type I IFNs 
In addition to modulating T cells through regulating DCs and cytokines release, type I IFNs 
can also regulate T cells directly through IFNARs on the surface of T cells. Type I IFNs modulate 
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the survival, proliferation, IFN-γ secretion, cytotoxic function, and memory development of T cells 
(Fig. 1.1). T cells are divided to CD4+ and CD8+ cells. CD4+ T cells include T-helper 1 (Th1), T-
helper 2 (Th2), follicular T-helper (Tfh), and regulatory T (Treg) cells. Each population has a 
distinct function in the adaptive immune system. All of these commitment of CD4+ T cells make 
up the crucial role of T cells in the adaptive immunity (Zhu and Paul, 2008). Type I IFNs stimulate 
CD4+ T cells undergoing clonal expansion during LCMV infection in mice (Havenar-Daughton 
et al., 2006). CD4+ T cells primed by type I IFNs increases the ability of T cells to help B cells to 
secrete antibodies (Le Bon et al., 2006b). IFN-α increases the ratio of Th1 cells secreting IFN-γ 
and inhibits the suppressive effect of IL-4 on IFN-γ production in those cells (Brinkmann et al., 
1993). After completing their roles, activated CD4+ T cells undergo either memory or apoptosis. 
In case of virus infection, IFNs-α/β maintains activated CD4+ T cells live longer and perform their 
antiviral functions (Marrack et al., 1999). In pigs infected with PRRSV, IL-4 is upregulated at 2 
days post-infection (Dwivedi et al., 2012). However, IL-4 does not promote the B cell development 
in PRRSV-infected pigs and instead suppresses the antibody and IL-6 secretion (Murtaugh et al., 
2009). It seems that porcine IL-13 takes over the role of IL-4 in pigs and drives the maturation of 
monocyte-derived DCs (Bautista et al., 2007). The role of porcine IL-13 in priming B cells is 
unknown for pigs. This observation leads to a cautious interpretation of immunological data for 
different animal species.  
Studies have focused on the interaction of CD8+ T cells and type I IFNs because these cells 
lyse virus-infected cells. Type I IFNs regulate CD8+ T cells for their survival, clonal expansion, 
cytotoxic activity, IFN-γ secretion, and memory cell differentiation (Fig. 1.1). The ability of type 
I IFNs to upregulate the survival and clonal expansion of CD8+ T cells has been studied for 
different viruses. During LCMV and vesicular stomatitis virus (VSV) infections in mice, type I 
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IFNs contribute to the activation and longer survival of CD8+ T cells and a larger number of clonal 
expansion (Aichele et al., 2006; Curtsinger et al., 2005; Keppler et al., 2012; Kolumam et al., 2005; 
Le Bon et al., 2006a; Le Bon et al., 2003; Marrack et al., 1999; Urban et al., 2016). For West Nile 
virus (WNV) infection, type I IFNs also promote the maturation of CD8+ T cells (Pinto et al., 
2011). Additional studies unveil that type I IFNs can enhance the cytotoxicity of CD8+ T cells in 
mice (Agarwal et al., 2009; Curtsinger et al., 2005; Jennings et al., 2014; Marshall et al., 2010). 
Interestingly, type I IFNs have both positive and negative effects on IFN-γ secretion by CD8+ T 
cells for different viruses (Cousens et al., 1999; Nguyen et al., 2000; Nguyen et al., 2002). Such 
differences are resulted from the balance between the levels of STAT1 and STAT4. Besides 
effector CD8+ T cells, memory CD8+ T cells are also regulated by type I IFNs. Type I IFNs 
promote the differentiation of memory CD8+ T cells via affecting the initial clonal expansion 
during virus infection (Kolumam et al., 2005; Ramos et al., 2009; Thompson et al., 2006). 
Reactivation of memory CD8+ T cells to effector CD8+ T cells is dependent on the presence of 
type I IFNs (Kohlmeier et al., 2010; Martinet et al., 2015; Soudja et al., 2012). Furthermore, type 
I IFNs can also protect T cells from killing by NK cell by expressing NCR1 (natural cytotoxicity 
triggering receptor 1; CD335) which is the negative signal for NK cells (Crouse et al., 2014; Xu 
et al., 2014).  
1.2.4.2 Porcine T cell response to PRRSV infection 
The T cell response in pigs to PRRSV is crucial for specific anti-PRRSV activities directly 
or indirectly. CD4+ T helper 1 (Th1) cells can become memory T cells or improve the killing 
efficacy of macrophages and the proliferation of CD8+ T cells by secreting IL-2 and IFN-γ. In 
contrast, CD4+ T helper 2 (Th2) cells can promote the maturation of B cells to plasma B cells and 
enhance the ability to secrete PRRSV-specific neutralizing antibodies. Alternatively, CD4+ Th2 
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cells can stimulate B cells to become memory B cells. Cytotoxic T lymphocytes (CTL) cause the 
death of infected cells specifically and directly. The T cell response of pigs during PRRSV 
infection is reviewed elsewhere (Loving et al., 2015). During infection, the number of CD4+ T 
cells decreases quickly in 3-7 days and then returns to normal by 7-14 day of infection (Nielsen 
and Bøtner, 1997; Shimizu et al., 1996). The number of CD4+ T cells is also limited in the lungs 
of infected pigs (Tingstedt and Nielsen, 2004). In addition, PRRSV-specific IFN-γ secreting T 
cells are low at all ages of pigs (Klinge et al., 2009). Such abnormal responses of CD4+ T cell in 
the host suggest that during PRRSV infection, the normal function of CD4+ T cells is interfered 
by the virus via indirect mechanisms. A large number of CD4+/CD8+ T cells are seen in pigs and 
these cells can be recruited to the sites of proliferation (Zuckermann and Husmann, 1996). The 
role of CD8+ T cells in clearing PRRSV persisting in the tonsils is unknown. In contrast to the 
crippled CD4+ T cell proliferation, regulatory T (Treg) cells which halt the activity of effector T 
cells (CD4+ T cells and CD8+ T cells) by producing TGF-β are significantly increased by PRRSV 
infection (Silva-Campa et al., 2012). The upregulation of IL-10 production by PRRSV also 
contributes to the Treg cell proliferation (Song et al., 2013b; Suradhat et al., 2003).  
 
1.2.5 B lymphocytes 
1.2.5.1 Regulation of B cell functions by type I IFNs 
The B cell-mediated antibody response is an important mechanism of host to eliminate 
invading viruses. Circulating neutralizing antibodies can potently clear the virus, and the antibody 
production by B cells is also modulated by type I IFNs (Fig. 1.1). During influenza virus infection 
of mice, IFNAR on B cells is necessary for B cell activation, suggesting the role of IFNs for B cell 
activation in response to influenza virus infection (Chang et al., 2007; Coro et al., 2006; Rau et al., 
2009). Type I IFNs also modulate the isotype switching from IgG1 to IgG2a/c in influenza-specific 
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B cells (Heer et al., 2007). Other reports also show the regulation of type I IFNs on B cell 
activation, antibody secretion, and isotype switching during viral infections, suggesting that type 
I IFNs regulate the B cells activity generally and deeply in mice (Bach et al., 2007; Fink et al., 
2006; Purtha et al., 2008).  
1.2.5.2 Porcine B cell response to PRRSV infection 
The poor and delayed B cell-mediated specific antibody response is one of the major 
obstacles to control PRRSV in pigs. Even though PRRSV-specific antibody appears at early times 
of 7-9 days post-infection, the efficacy of these antibodies is unclear. Neutralizing antibodies 
against PRRSV takes a longer time to develop and appears nearly 1 month after initial infection 
(Labarque et al., 2000b; Loving et al., 2015). The role of neutralizing antibodies for protection has 
been shown by serum transfer experiments, in which the pigs receiving passively transferred 
neutralizing antibodies are protected from PRRSV infection. However, the passive transfer of 
PRRSV-specific antibodies does not confer a full protection against homologous challenge, 
indicating the PRRSV-specific antibodies do not completely block the infection, and a higher dose 
of neutralizing antibodies is required for better protection (Lopez et al., 2007; Osorio et al., 2002). 
The antigenic heterogeneity of PRRSV is an additional challenge for neutralizing antibodies to 
elicit efficient protection since the neutralizing activity of these antibodies is restricted to the 
homologous virus (Vu et al., 2011; Zhou et al., 2012). 
 
1.3 PRRSV PROTEINS AND THEIR ROLES IN MODULATING TYPE I IFN RESPONSE  
Suppression of type I IFN production and signaling is one of the major characteristics of 
PRRSV, which is a tremendous benefit for the virus to survive in the host. PRRSV has evolved to 
take several strategies to gain such benefits, and the IFN suppression is polygenic, which is 
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executed by multiple viral proteins (Fig. 1.2). The viral proteins and their mechanisms of actions 
to suppress type I IFNs have been identified and reviewed elsewhere (Han and Yoo, 2014; Sun et 
al., 2012a; Yoo et al., 2010). Here, we briefly discuss the multiple ways that PRRSV modulates 
such functions. So far, five nonstructural proteins (nsp1α, nsp1β, nsp2, nsp4, and nsp11) and one 
structural protein (N) have been identified as IFN antagonists (Fig. 1.2) (Beura et al., 2010; Chen 
et al., 2010a; Chen et al., 2014; Chen et al., 2016; Han et al., 2013; Han and Yoo, 2014; Kim et 
al., 2010; Patel et al., 2010; Sagong and Lee, 2011; Song et al., 2010; Subramaniam et al., 2010b; 
Sun et al., 2012a; Sun et al., 2010; Sun et al., 2012b; Wang et al., 2013a; Yoo et al., 2010). 
 
1.3.1 Nsp1 as a negative regulator for type I IFN production 
1.3.1.1 Nsp1α 
Among the PRRSV proteins regulating type I IFN response, nsp1 (both nsp1α subunit and 
nsp1β subunit) is the most potent IFN antagonist. Nsp1 is the first viral protein synthesized and 
released from the polyprotein during infection. The PLP1α activity resides in the N-terminal 
portion of nsp1 and its catalytic resides are mapped to C76 and H146. This activity cleaves off the 
nsp1α subunit and releases it from pp1a (Fig. 1.2) (Den Boon et al., 1995). The cleavage site by 
PLP1α is mapped to M180/A181 and confirmed by two independent studies using peptide 
sequencing and  X-ray crystallographic study (Chen et al., 2010a; Sun et al., 2009). At the most 
N-terminal region of nsp1α, a zinc-finger motif (ZF1) of C8-C10-C25-C28 is identified, and this 
motif together with PLP1α determines the transactivation of viral subgenomic mRNA synthesis 
(Kroese et al., 2008; Tijms et al., 2007; Tijms and Snijder, 2003; Tijms et al., 2001). A second 
zinc-finger motif (ZF2) of C70-C76-H146-M180 has been identified in the C-terminal portion of 
nsp1α (Sun et al., 2009). The function of ZF2 remains unknown.  
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Studies have unveiled the nsp1α-mediated suppression of type I IFN response in cells 
(Beura et al., 2010; Chen et al., 2010a; Kim et al., 2010). Similar to EAV nsp1 (note: EAV nsp1 
remains uncleaved), PRRSV nsp1α is distributed in the both nucleus and cytoplasm (Tijms et al., 
2002; Yoo et al., 2010). Despite that PRRSV nsp1 is a nuclear cytoplasmic protein, no specific 
nuclear localization signal (NLS) is found in nsp1α, suggesting that it may enter the nucleus by 
binding to a cellular nuclear protein. The nuclear localization of nsp1α suggests that the nuclear 
form of nsp1α may play a regulatory role for host gene expression. Subsequently, nsp1α and nsp1β 
are found to inhibit type I IFN production and impair the IFN promoter activity when stimulated 
by a dsRNA analogues (polyinosinic:polycytidylic acid; poly I:C) (Chen et al., 2010a). The 
phosphorylation and nuclear translocation of IRF3 remain unchanged, indicating that nsp1α does 
not directly inhibit IRF3 function but inhibits the IFN production in the nucleus by blocking other 
components crucial for IRF3-mediated IFN expression. Subsequently, nsp1α has been found to 
trigger CBP degradation through the proteasome-dependent pathway (Fig. 1.3) (Han et al., 2013; 
Kim et al., 2010). The proteinase activity of PLP1α in nsp1α is no longer active, once is cleaved 
and released, due to the conformational change (Sun et al., 2009). Thus, the PLP1α activity does 
not seems to participate in the CBP degradation. The precise mechanism for CBP degradation by 
nsp1α is currently unknown. Recently, nsp1α of PRRSV has been reported to physically bind to 
CBP (Chen et al., 2016), which may explain a possible mechanism of nsp1α-mediated CBP 
degradation. In that study, a nuclear export signal (NES) has been identified in nsp1α and mapped 
to amino acids positions 29 to 49 (Fig. 1.2). The NES is crucial for nsp1α-mediated type I IFNs 
suppression. As discussed above, CBP-mediated enhanceosome formation is critical for both 
IRF3/7-mediated and NF-κB-mediated IFN productions (Panne et al., 2007). Without CBP, 
phosphorylated IRF3 in the nucleus does not stably activate IFN production. Interestingly, PRRSV 
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nsp1α triggers the swine leukocyte antigen class I (SLA-I) degradation in a ubiquitin-proteasome 
dependent manner and this action is mediated by direct binding of nsp1α with both chains of SLA-
I (Du et al., 2016). The fact that nsp1α binds to CBP and both chains of SLA-I and thus leading to 
degradation of CBP and SLA-1 provides new insights into a possibility that nsp1α may possess an 
ubiquitin E3 ligase-like activity. Such studies are under way. 
PRRSV nsp1α also suppresses the NF-κB activation when stimulated by either poly(I:C) 
or TNF-α (Song et al., 2010; Subramaniam et al., 2010b). This suppression is RIG-I dependent. In 
addition to PRD I/III in the IFN-β promoter for IRF3/7 binding, PRD II and PRD IV are specific 
for the binding of NF-κB and AP-1, respectively, to activate type I IFN production. The PRD II-
specific reporter activity is significantly suppressed by nsp1α upon stimulation (Han et al., 2013). 
The CBP degradation may also interfere the NF-κB function as a type I IFN inducer in the nucleus. 
Additionally, nsp1α blocks the phosphorylation and nuclear translocation of NF-κB, suggesting 
that the cytoplasmic form of nsp1α may regulate the host response (Kim et al., 2010). Thus, nsp1α 
is a multifunctional protein such that the nuclear form of nsp1α degrades CBP whereas the 
cytoplasmic form of nsp1α blocks the NF-κB nuclear translocation and activation, making nsp1α 
as the potent IFN antagonist.  
1.3.1.2 Nsp1β 
As with nsp1α, nsp1β also possesses a proteinase activity (PLP1β) and the catalytic 
residues for PLP1β have been mapped to C90-H159. The PLP1β activity is responsible for the 
cleavage of nsp1β from nsp2 (Fig. 1.2) (Den Boon et al., 1995; Snijder et al., 1992; Ziebuhr et al., 
2000). Thus, the release of nsp1β is dependent on the activities of PLP1α and PLP1β. PLP1α 
cleaves off nsp1α at M180/A181 of pp1a, and then PLP1β cleaves off nsp1β at Y382/G383 (Chen 
et al., 2010a). The cleavage sites for PLP1α and PLP1β are highly conserved among different 
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PRRSV isolates. PRRSV whose PLP1β active sites are mutated is non-viable, indicating that 
PLP1β is essential for virus replication (Kroese et al., 2008). The PLP1β activity in nsp1β also 
regulates the generation of nsp2TF via –1/2 ribosomal-frameshifting (Fang et al., 2012b; Li et al., 
2016). A nuclease motif has been identified at K18-E32 in the N-terminal region of nsp1β (Xue et 
al., 2010), but this motif is irrelevant to IFN suppression (Han et al., 2014).  
Although PLP1β loses its activity once cleaving and releasing nsp1β from nsp2 (Sun et al., 
2009), it still plays crucial roles in nsp2TF gene expression, type I IFNs suppression, and viral 
replication. The highly conserved motif in PLP1β plays a critical role in IFN suppression by nsp1β 
when stimulated with Sendai virus  (Li et al., 2013). PRRSV in which mutations are introduced in 
the conserved motif of PLP1β exhibits attenuated growth, and the suppression of type I IFNs is 
less potent (Li et al., 2016; Li et al., 2013). Several studies show that nsp1β suppresses type I IFN 
production (Chen et al., 2010a; Han and Yoo, 2014; Patel et al., 2010). The precise mechanism for 
nsp1β-mediated IFN suppression remains unclear. A study shows that modified nsp1β, of which 
26 amino acids derived from nsp1α are extended at its N-terminus impairs the IRF3 
phosphorylation and nuclear translocation (Beura et al., 2010). Whether these 26 amino acids 
derived from the C-terminus of nsp1α contribute to this activity is unclear. Like nsp1α, nsp1β is 
also distributed in the nucleus, indicating that nsp1β-mediated IFN suppression is a nuclear event. 
It is interesting to note that, although the PLP1β proteinase activity becomes inactive once nsp1β 
is cleaved, the conserved motif for PLP1β is still a major determinant for nsp1β-mediated IFN 
suppression. A worth noting is the nuclease activity of nsp1β. Considering the nuclease activity 
and nuclear distribution of nsp1β, it is presumed that nsp1β may digest the nucleic acids in the 
nucleus. In addition, nsp1β interrupts the phosphorylation of STAT1 and nuclear translocation of 
ISGF3, thus leading to the inhibition of JAK-STAT signaling pathway resulting in the inhibition 
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of ISG expressions (Chen et al., 2010a; Patel et al., 2010). Nsp1β blocks the ISGF3 nuclear 
translocation by degrading karyopherin-α1 (KPNA1) (Wang et al., 2013b), which is at least one 
possible mechanism for nsp1β-mediate ISGs inhibition (Fig. 1.3). The compensatory activities of 
nsp1α (for suppression of IFN production) and nsp1β (for suppression of IFN production and JAK-
STAT signaling) make the nsp1 protein the most potent type I IFN antagonist of PRRSV. Recent 
findings from our laboratory show that nsp1β suppresses the host mRNA export from the nucleus 
to the cytoplasm. The host mRNA nuclear retention is correlated with the IFN suppression of 
nsp1β. A SAP (SAF-A/B, Acinus, and PIAS) motif is found in nsp1β with the consensus sequence 
of 126-LQxxLxxxGL-135 residing in the PLP1β domain, and this motif is responsible for the host 
mRNA nuclear retention and IFN suppression (Han et al., 2017b). The SAP-negative mutant 
PRRSV is attenuated for viral replication in vitro and for virulence in vivo. These findings explicit 
a specific mechanism of IFN suppression by nsp1β and implies the importance of IFN suppression 
for viral pathogenesis.  
 
1.3.2 Nsp2  
Nsp2 is the largest protein of PRRSV and five major domains have been identified: 1) 
hyper-variable region 1 (HV1) at the N-terminal region, 2) papain-like cysteine protease 2 (PLP2) 
which belongs to the ovarian tumor (OTU) protease family at the N-terminal region, 3) very large 
hyper-variable region 2 (HV2) in the middle, 4) hydrophobic transmembrane region (TM) near the 
C-terminus, and 5) a cysteine-rich domain close to the end of  nsp2 (Fang et al., 2012b; Han et al., 
2007) (Fig. 1.2). The HV1 and HV2 regions in nsp2 account for the major genetic diversity of 
PRRSV (Music and Gagnon, 2010), and they are the key determinants for differentiation between 
genotypes 1 and 2 (Fang et al., 2004; Han et al., 2006). Mutations, insertions, and deletions are 
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frequent in HV1 and HV2, whereas other regions in nsp2 are relatively conserved (Fang et al., 
2004; Han et al., 2006; Music and Gagnon, 2010). The TM domain is involved in the membrane 
modification and the formation of a replication complex for PRRSV (Fang and Snijder, 2010). 
Thus, nsp2 plays an important role in the regulation of PRRSV replication (Wang et al., 2013a; 
Wang et al., 2012a). 
The PLP2 activity in nsp2 contributes to inhibiting the IRF3 phosphorylation and nuclear 
translocation and suppresses the type I IFN production (Li et al., 2010). The PLP2 domain belongs 
to the ovarian tumor (OTU) protease family which contains the de-ubiquitination (DUB) and de-
ISGylation activities (Frias-Staheli et al., 2007). Ubiquitination and ISGylation are important post-
translational modifications involved in the RIG-I and TLRs signaling pathways, and the OTU 
domain interferes them to antagonize type I IFN production. PRRSV nsp2 also inhibits the IκB 
phosphorylation and degradation when stimulated with TNF-α, resulting in the suppression of NF-
κB activation (Sun et al., 2010). In addition to de-ubiquitination, the OTU domain also plays a role 
to inhibit ISG15 production and ISG15-mediated ISGylation (Fig. 1.3) (Sun et al., 2012b). Thus, 
the ISGylation activity of nsp2 interferes with the IFN production and signaling pathways.  
 
1.3.3 Nsp4 
The nsp4 protein of PRRSV is the 3C-like serine proteinase (SP) responsible for cleaving 
the nonstructural proteins from pp1a and pp1ab, except nsp1α, nsp1β, nsp2 (Snijder et al., 1996). 
Structural studies unveil three domains in nsp4: domain I (aa 1-aa 69), domain II (aa 89-aa 153), 
and domain III (aa 157-aa 199) (Tian et al., 2009). The SP activity of nsp4 is located between 
domain I and domain II and the residues of S118, H39, and D64 constitute the canonical catalytic 
triad (Tian et al., 2009). Interestingly, a nuclear localization signal (NLS) site is found at positions 
21 
 
154-156 which also serves the hinge between domain II and domain III (Tian et al., 2009). Whether 
the NLS in nsp4 is functional or not is unclear but it may involve in inhibiting the IFN-β 
transcription because the residue at 155 (a middle amino acid of the three-residues for NLS) is 
crucial for nsp4 to suppress type I IFNs response when induced with poly(I:C) (Chen et al., 2014). 
The nsp4-mediated IFN-β inhibition is NF-κB dependent. The activation of NF-κB is significantly 
suppressed by nsp4 when stimulated by RIG-I, VISA, TRIF, as well as IKKβ, suggesting that nsp4 
interferes with the NF-κB signaling downstream of these molecules. The SP activity of nsp4 is 
responsible for suppressing IFN-β and NF-κB as shown by mutational studies in domains I and 
domain II which specifically knock-out the SP activity. Nsp4 appears to cleave NEMO at E349-
S350, which is a key regulator for NF-κB signaling (Huang et al., 2014b). In addition to the NF-
κB suppression and thus NF-κB-mediated IFN suppression, nsp4 also cleaves VISA which is an 
essential adaptor in the RLR-mediated IFN pathway (Huang et al., 2016).  
 
1.3.4 Nsp11 
Nsp11 of PRRSV has the endoribonuclease activity and is a component of the RNA-
dependent RNA polymerase (RdRp) complex for viral RNA synthesis (Fang and Snijder, 2010; 
Snijder et al., 2013). The endoribonuclease activity of nsp11 is conserved and unique for viruses 
in the order Nidovirales, designating this domain “NendoU” expanding from L126 to F204 (Fig. 
1.2). The NendoU domain is relative to the XendoU family of Xenopus laevis (Gorbalenya et al., 
2006; Ivanov et al., 2004; Laneve et al., 2003). As shown in Fig. 1.2, the NendoU domain resides 
near the C-terminus of nsp11 consisting of two subdomains; subdomain A and subdomain B 
(Posthuma et al., 2006; Shi et al., 2016). Subdomain A contains the nuclease activity of NendoU, 
and subdomain B serves as a conformational supporter (Shi et al., 2016). Similar to the coronavirus 
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NendoU residing in nsp15 (Bhardwaj et al., 2004; Ivanov et al., 2004), PRRSV NendoU in nsp11 
has the uridylate-specific RNA cleaving activity. Dissimilar to coronavirus nsp15, which forms a 
hexametric structure to achieve optimal enzyme activities (Xu et al., 2006), PRRSV nsp11 exists 
as a homodimer and elicits the nuclease activity (Shi et al., 2016). While two His residues form an 
“active site loop” and Val-Thr residues form a “supporting loop” in the NendoU, nsp11 NendoU 
of PRRSV and nsp15 NendoU of coronavirus are similar enough to be superimposed  (Bhardwaj 
et al., 2004; Ricagno et al., 2006; Snijder et al., 2003; Xu et al., 2006). The importance of NendoU 
activity in viral RNA synthesis and virus replication has been shown for EAV and SARS-CoV 
(Nedialkova et al., 2009; Posthuma et al., 2006). 
PRRSV nsp11 is an IFN antagonist and the endoribonuclease activity is critical for IFN 
suppression when stimulated by poly(I:C) (Shi et al., 2011). PRRSV nsp11 blocks the 
phosphorylation and nuclear translocation of IRF3, resulting in the inhibition of IRF3-mediated 
IFN production. PRRSV nsp11 also suppresses the phosphorylation of IκB, and thus activation of 
NF-κB is suppressed (Sun et al., 2016; Sun et al., 2014). Inhibition of the two pathways leads to 
IFN suppression (Sun et al., 2012a; Sun et al., 2016). Interestingly, PRRSV nsp11 appears to target 
MAVS (IPS-1) and degrades MARV mRNA (Sun et al., 2014). The IRF3 signaling pathway and 
NF-κB signaling pathway converge at MAVS, and thus MAVS is a crucial adaptor for both 
signaling pathways. The degradation of MAVS mRNA by PRRSV nsp11 results in the failure of 
activation of downstream pathways. The nsp11 mutants which specifically lose the NendoU 
activity do not suppress IFN production, further indicating that the NendoU activity of PRRSV 





1.3.5 Nucleocapsid (N) protein 
The nucleocapsid (N) protein of PRRSV is a relatively small protein encoded by ORF7 of 
the viral genome. N is consisted of 123 amino acids for genotype 2 and of 128 amino acids for 
genotype 1. In PRRSV-infected cells, N is abundantly expressed to benefit from the discontinuous 
transcription mechanism (Snijder et al., 2013). The N protein binds to the genomic RNA through 
its N-terminal region containing positively charged residues (Dokland, 2010). Binding to RNA is 
one of the major functions of N to form a viral capsid and to protect the viral genome. N is the 
only protein that forms the viral capsid. The N protein exists as a homodimer through covalent and 
non-covalent interactions using C23 (Fig. 1.2) (Wootton and Yoo, 2003). PRRSV of which C23 
is mutated loses its infectivity, indicating that the N protein homo-dimerization is critical for virus 
replication and infectivity (Lee et al., 2005). N is a phosphoprotein and the phosphorylation may 
be related to RNA binding and/or the dimerization of N even though its exact function remains 
unknown (Wootton et al., 2002). PRRSV replication occurs in the cytoplasm (Benfield et al., 1992; 
Mardassi et al., 1994), and thus the cytoplasmic distribution of N fulfills its function to support the 
particle assembly and replication. In addition it its cytoplasmic distribution, PRRSV N is also 
distributed in the nucleus and nucleolus in virus-infected PAMs and MARC-145 cells (Rowland 
et al., 1999). Two NLS sequences are found in the N-terminal half of the N protein and designated 
NLS-1 at residues 10-13 and NSL-2 at residues 41-47 (Fig. 1.2) (Rowland et al., 1999; Rowland 
et al., 2003b). NLS-1 seems non-essential for N protein nuclear translocation, whereas NSL2 is a 
functional motif. A single amino acid change in the conserved motif of 41-PGKKNKK-47 for NLS-
2 results in the blocking of N to nuclear translocation. (Rowland et al., 1999; Rowland et al., 2003b; 
Rowland and Yoo, 2003). Further studies have unveiled that importin-α and importin-β are the 
cellular proteins responsible for transporting N to the nucleus (Rowland et al., 2003b; Rowland 
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and Yoo, 2003). A NoLS sequence is mapped to residues 41-72 of N (Fig. 1.2) (Rowland et al., 
2003b; Yoo et al., 2003). The function of N in the nucleolus is not very clear thus far. Several 
cellular proteins appear to interact with N, including fibrillarin (Yoo et al., 2003), I-mfa domain 
containing protein (HIC) (Song et al., 2009a), protein inhibitor of activated STAT1 (PIAS1), 
nucleolin, B23, poly-A binding protein (Yoo et al., 2010), importin-α and -β, and exportin 
(Rowland et al., 2003b). Limited studies show that N protein delays the cell cycle progression and 
utilizes the cellular machinery for productive infection especially during the early stage of 
infection.  
The list of cellular proteins interacting with N suggests the modulation of host cell 
functions through their interactions. In studies using NLS-2 knock-out mutant PRRSV, pigs 
develop a significantly shorter duration of viremia and higher neutralizing antibodies than those 
of wild-type PRRSV-infected pigs (Lee et al., 2006). This observation suggests that the nuclear 
localization of N determines the PRRSV pathogenesis and NLS-2 is non-essential for PRRSV 
replication in vitro (Lee et al., 2006). Overall, NLS-2 is correlated to the virulence of PRRSV and 
the mutations in NLS-2 confer the attenuation of virus in pigs.   
Further studies show that PRRSV N suppresses the type I IFN production by inhibiting the 
IRF3 phosphorylation and nuclear translocation (Fig. 1.3) (Sagong and Lee, 2011). IL-10 functions 
as a negative regulator for host innate and adaptive responses (Couper et al., 2008), and PRRSV 
increases the IL-10 level in pigs (Suradhat and Thanawongnuwech, 2003; Suradhat et al., 2003; 
Thanawongnuwech and Thacker, 2003). The upregulation of IL-10 results in the suppression of 
the innate and adaptive immune responses in pigs. Subsequently, N has been identified as the 
protein upregulating IL-10 in PAMs (Wongyanin et al., 2012b). The upregulation of IL-10 by N 
suggests that N activates NF-κB signaling pathway which tightly regulates the production of IL-
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10 (Saraiva and O'Garra, 2010b). Indeed, the N protein has been shown to activate the NF-κB 
signaling and increases the expression of proinflammatory cytokines (Fu et al., 2012a; Luo et al., 
2008). The upregulation of proinflammatory cytokines are associated with PRRSV pathogenesis 
in pigs (Lunney et al., 2010; Van Reeth et al., 1999; Van Reeth et al., 2002b). Together, these 
findings indicate that PRRSV N, especially the nuclear form of N distributed in the nucleus, 
regulates the pathogenesis of PRRSV.  
 
1.4 NF-KB SIGNALING PATHWAY 
NF-κB is a family of transcription factors consisting of RelA (p65) and RelB for DNA 
binding and NF-κB1 (p50 and its precursor p105), NF-κB2 (p52 and its precursor p100), c-Rel for 
forming homo/heterodimers with RelA or RelB. NF-κB can be activated by proinflammatory 
cytokines such as TNF-α and IL-1. Upon stimulation, upstream kinases like IKKα and IKKβ are 
activated through phosphorylation. Then, IKKβ phosphorylates the inhibitor of κB (IκB), the latter 
then undergoes degradation through a proteasome-dependent pathway. IκB is the negative 
regulator of NF-κB through direct binding and inhibiting the activation of NF-κB in the cytoplasm. 
Once IκB is degraded, NF-κB is released and activated by phosphorylation. The activated NF-κB 
then translocates in the nucleus, followed by binding to κB sites which is the specific DNA locus 
for NF-κB (Chen and Greene, 2004). NF-κB regulates the expression of a variety of 
proinflammatory cytokine genes including IL-1β, IL-6, IL-8, IL-15, and TNF-α (Dinarello, 2000) 
and anti-inflammatory cytokine genes like IL-10 (Saraiva and O'Garra, 2010a). The 
proinflammatory cytokines like IL-1β and TNF-α will further activate NF-κB signaling through 
the autocrine manner (Kagoya et al., 2014). To keep the NF-κB signaling from over activation, 
there are negative feedback mechanisms regulating the NF-κB signaling pathway. For example, 
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IκB is a negative regulator of NF-κB in the cytoplasm and is promoted by the NF-κB-mediated 
gene expression (Chen and Greene, 2004). The protein inhibitor of activated STAT (PIAS)-1 
(PIAS1) is another NF-κB negative regulator in the nucleus. By specifically binding to p65 in the 
nucleus, PIAS1 prevents NF-κB dimers from docking to κB sites on the DNA (Liu et al., 2005). 
Thus, the NF-κB signaling is tightly controlled.  
 
1.5 ACTIVATION OF NF-KB SIGNALING BY PRRSV 
Many viruses utilize host NF-κB signaling pathways for their own good (Hiscott et al., 
2001; Rahman and McFadden, 2011; Santoro et al., 2003). The infection of PRRSV in pigs causes 
inflammation in the lungs featured by increasing the proinflammatory cytokines including IL-1β, 
IL-6, IL-8, and TNF-α, and increasing recruitment of monocytes and neutrophils to the lungs (Liu 
et al., 2010; Miguel et al., 2010; Van Reeth et al., 1999; Van Reeth and Nauwynck, 2000; Van 
Reeth et al., 2002a). The inflammation in the lungs and recruitment of neutrophils contribute to 
the pathogenesis of PRRS (Liu et al., 2015). In PRRSV infected cells, the elevated 
proinflammatory cytokines has been observed (Bi et al., 2014; Lee and Lee, 2012; Pineyro et al., 
2016; Xiao et al., 2015). Studies also have shown that NF-κB signaling pathway is activated by 
PRRSV in cells (Fu et al., 2012b; Lee and Kleiboeker, 2005; Song et al., 2013a; Yu et al., 2016; 
Zhang et al., 2013). Together, PRRSV activates NF-κB and causes NF-κB-mediated production 
of proinflammatory cytokines. This action is correlated with the pathogenesis of PRRS disease. 
Multiple studies demonstrated the PRRSV N protein as the NF-κB activator (Luo et al., 2011; 
Wongyanin et al., 2012b; Yu et al., 2016). Yet the mechanism remains unclear.  
The nucleocapsid (N) protein of PRRSV is a relatively small protein encoded by ORF7 
with 123 or 128 amino acids depending on the genotypes. N is the most abundant viral protein that 
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is expressed from the discontinuous transcription mechanism (Snijder et al., 2013). A nuclear 
localization signal (NLS) has been identified for N (Rowland et al., 2003b), and the N protein 
nuclear localization is NLS-dependent through binding to importin-α and importin-β (Rowland et 
al., 2003b). Though the exact function of N in the nucleus is unclear, the clinical role of the nuclear 
form of N protein has been studied using an NLS-null mutant PRRSV in pigs. The NLS-null virus-
infected pigs show milder clinical signs and shorter duration of viremia as well as higher titers of 
neutralizing antibodies (Lee et al., 2006a; Pei et al., 2008b). These studies show that the N protein 
nuclear localization plays an important role in the PRRSV pathogenesis during infection. Yet the 
mechanism is still unknown. Yeast 2-hybrid assays have been performed by our laboratory to 
identify cellular proteins interacting with N from the cDNA libraries from MARC-145 cells and 
PAMs. Several cellular proteins are identified as interaction partners of N, including fibrillarin 
(Yoo et al., 2003), I-mfa domain containing protein (HIC) (Song et al., 2009b), nucleolin, B23, 
(polyA)-binding protein (Yoo et al., 2010), plus importin-α and importin-β (Rowland et al., 
2003b). PIAS1 is also identified as a molecular partner of N, and this has also been reported by 
others (Wang et al., 2012b). As described above, taking the PIAS1 as a negative regulator of NF-
κB (Liu et al., 2005), N protein may activate NF-κB signaling via interaction with PIAS1. The fact 
that PRRSV N as a stimulator for IL-10 and IL-15 through the NF-κB signaling pathway support 
the hypothesis that PRRSV regulates the host inflammatory responses via its N protein (Fu et al., 
2012b; Song et al., 2013a), and it is reasonable to presume that PIAS1 is the target for N protein 





1.6 ALTERNATIVE APPROACHES TO PRRS VACCINES 
The current vaccines for PRRS elicit protective immunity to some extent but the protection 
works only against homologous infections and is partial for heterologous infections. Even though 
PRRSV-specific neutralizing antibodies can protect pigs from homologous challenges to a certain 
level, higher titers of antibodies are required for complete protection (Lopez et al., 2007). 
Additional problems associated with existing vaccines include viral persistence and possible 
reversion to virulence. Incomplete protection against field viruses (heterologous PRRSV) makes 
current vaccines less valuable in the field (Kimman et al., 2009). Aberrant and delayed cell-
mediated immune responses make hard to clear the virus persistently residing in the lymphoid 
tissues and even harder to control the transmission from persistently infected pigs to naive pigs. 
Thus, a vaccine that can improve the host anti-viral immune response including the innate 
immunity, CD4+ T cells, CTLs, and B cells will be of a significant benefit. Immunological 
hallmarks of PRRS are that the innate immunity (namely type I IFNs) is suppressed and the 
adaptive immunity is perturbed and delayed. Since type I IFNs prime the proliferation and 
maturation of adaptive immune responses, it is tempting to speculate that the disturbed and delayed 
adaptive immune responses against PRRSV is due to the suppression of type I IFNs response in 
host by PRRSV. A replication-competent recombinant PRRSV co-expressing various type I IFNs 
increases the IFN levels in pigs and elicits protection against PRRSV, but no significant PRRSV-
specific adaptive immune responses are observed in this study (Sang et al., 2014b; Sang et al., 
2012). Different observations have been made for an increased and prolonged adaptive immune 
response when using the porcine IFN-α expressing plasmid as an adjuvant for PRRSV vaccination 
(Meier et al., 2004). This suggests that the timing and routes to deliver IFNs and how long it will 
last in animals make a difference in priming the adaptive immune response against PRRSV 
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infection. Studies by (Brockmeier et al., 2009; Brockmeier et al., 2012)show the protective role of 
IFN-α in pigs. In these studies, IFN-α was expressed in vivo by adenovirus-mediated gene 
delivery. Following virulent challenges with PRRSV, the pigs showed delayed viremia and 
enhanced PRRSV-specific cell-mediated immune response. These results indicate that a higher 
level and sustained production of IFNs for an extended period is critical for the control of PRRSV 
in pigs. During PRRSV infection, a swift response of type I IFNs is observed which may reach a 
relatively high level of IFN (Albina et al., 1998a; Albina et al., 1998c)unpublished data from our 
laboratory). However, this response is only transient and the IFN levels drop quickly as the 
infection progresses. One of the reasons for this decrease may be due to the potent viral IFN 
antagonism. Other than exogenous administration of IFNs, promoting endogenous IFNs is also 
thought to function better to prime the adaptive immune responses. Indeed, the induction of IFN 
production in vivo has resulted in the increase of adaptive immune responses (Wang et al., 2013c).  
Nsp1β inhibits both type I IFN production and signaling potently (Beura et al., 2010; Chen 
et al., 2010a; Patel et al., 2010; Wang et al., 2013b). As discussed above, the conserved sequence 
motif of 123-GKYLQRRLQ-131 in PLP1β plays a critical role in the both IFN suppression and 
programming -2/-1 ribosomal frame shifting (Li et al., 2013). Single or double mutations in this 
motif (R128A, R129A, or RR128/129AA) impair the suppressive activity of nsp1β. Furthermore, 
PRRSV containing such mutations is attenuated for growth in cells. Pigs infected with the mutant 
PRRSV have shown lower levels of viremia, higher levels of IFN-α as well as ISGs comparing to 
pigs infected with wild-type PRRSV (Li et al., 2016). The NK cell function has also been 
increased, correlating with an increased level of IFN-α in the lungs of pigs infected with mutant 
virus. Furthermore, the IFN-γ level is also significantly higher in pigs infected with mutant virus 
(Li et al., 2016). This study nicely demonstrates the role of type I IFNs playing in priming adaptive 
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immune response and ultimate clearance of PRRSV in pigs. However, no direct evidence is 
available yet that such a mutant PRRSV can elicit protection from heterologous infection or 
reduced persistence. Such a study is cumbersome because of potential reversion to wild-type or 
compensatory mutations to restore the function during infection. This phenomenon has also been 
observed in our laboratory (unpublished data), suggesting the strong selective pressure on the viral 
IFN antagonism and the favor of IFN suppression for PRRSV replication in pigs. A recent study 
shows that the deficiency of type I IFN receptor in DCs makes the non-persistent murine norovirus 
(strain CW3) to systemically persist in mice (Nice et al., 2016). Surprisingly, during the persistent 
infection of the norovirus, CD8+ T cell function and antibody response are increased, suggesting 
that the deficiency of IFN responses is the determinant, leading to the virus to persistence in spite 
of the enhanced adaptive immunity (Nice et al., 2016). These finding correlate type I IFNs with 
viral persistence for the first time, further demonstrating the importance of type I IFNs for 
inhibition of virus infection either acutely or persistently. Thus, the removal of IFN antagonism 
from PRRSV seems a reasonable strategy to develop a novel vaccine candidate. Such strategy has 
been successful for some RNA viruses. Hepatitis C virus (HCV) infects humans and establishes 
persistence in the liver. During HCV infection, type I IFN response is downregulated, which is 
mediated by the NS3/4A protease which cleaves MAVS (Li et al., 2005). The suppression of IFN 
response may be one of the causes for HCV persistence, and the IFN treatment is most effective 
therapy to control the persistent HCV infection (Manns et al., 2001; Radkowski et al., 2005; 
Shiffman et al., 1999). In contrast, recent studies show that the LCMV persistence in mice is 
controlled or lost when type I IFN signaling is blocked, demonstrating the paradoxical role of type 
I IFNs in viral persistence (Teijaro et al., 2013; Wilson et al., 2013). In these studies, an IFN 
receptor-neutralizing antibody has been used in mice to block the IFN signaling pathway, and in 
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these animals, the activation of adaptive immunity is diminished and the mice regain the control 
of persistent infection (Teijaro et al., 2013; Wilson et al., 2013). These findings demonstrate the 
dual functions of type I IFNs in virus-host interactions depending on the type of viruses and the 
species of hosts (for a review, see (Snell and Brooks, 2015). Nevertheless, it is logical to 
hypothesize that a vaccine virus lacking the IFN suppressive function may be more immunogenic 
and provide improved protection against virulent challenge than the parental virus. Foot-and-
mouth disease virus (FMDV) is able to suppress type I IFN production in cattle, and may persist 
in the tonsils for up to 2 years. Npro is the major IFN antagonist of FMDV, and the mutation of Npro 
to knock-out the IFN suppression confers viral attenuation in both cells and animals. The IFN 
antagonism-negative FMDV elicits strong neutralizing antibody response in vaccinated animals, 
and these animals are completely protected from high doses of wild-type challenge as early as 2 
days post-challenge (Díaz-San Segundo et al., 2012b). For influenza virus, the NS1 protein is a 
viral IFN antagonist, and a similar approach has been applied to swine influenza virus (SIV). The 
IFN suppressive function has been removed from the NS1 gene, and by reverse genetics, mutant 
SIV has been generated such that the NS1 protein of mutant SIV is no longer able to suppress type 
I IFN production. This IFN antagonism-negative SIV appears to be attenuated in pigs and is able 
to stimulate the production of type I IFNs. The mutant SIV grows well in cells and pigs, and its 
attenuation in pigs is correlated with higher levels of IFNs in vivo (Solórzano et al., 2005). 
Furthermore, the pigs immunized with the IFN-antagonism-negative SIV are protected from both 
homologous and heterologous challenges. Induction of heterologous protection by IFN-
antagonism-negative virus has also been demonstrated for avian influenza (Marcus et al., 2010). 
A live attenuated influenza virus vaccine (LAIV) candidate has been isolated from a pool of NS1-
truncated mutants, and this virus is able to stimulate a higher level of IFN production than wild-
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type virus. The avian influenza virus containing a truncated NS1 gene is clinically attenuated and 
also able to elicit a higher level of IFNs and adaptive immunity (Jang et al., 2016; Marcus et al., 
2010; Ngunjiri et al., 2015). Such vaccine candidates induce a good level of protection from 
heterologous challenges in different species of animals (avian, mice, and pigs), making them 
alternative vaccine candidates. Equine arteritis virus (EAV) can persist in infected horses, and type 
I IFN production is suppressed during EAV infection. As discussed above, the nsp2 protein 
contains the deubiquitinase (DUB) activity in the PLP2 motif, which is responsible for the 
inhibition of innate immunity during infection. The DUB activity has been separated from PLP2 
by mutation, and DUB-negative mutant EAV has been generated. When horses are vaccinated 
with the DUB-negative EAV, the animals elicit higher levels of IFNs and adaptive immune 
responses. Upon virulent challenge of these horses, the DUB-negative EAV vaccinated animals 
are protected at a similar degree as its DUB-positive parental virus (van Kasteren et al., 2015). 
Therefore, such a strategy is worth trying for PRRSV as an alternative approach to developing a 
new vaccine. Despite the lack of solid experimental evidence for PRRSV at the present time 
whether an increased level of type I IFN production will improve the protection from heterologous 
infection as well as persistence, this is a logical approach to the control of PRRSV, and such studies 
are in progress by several research groups. Once proven, it will warrant the benefits to elicit 
effective and protective anti-PRRSV immune responses by vaccination. Such vaccines will be a 
promising alternative to existing vaccines for PRRSV.  
The hurdles in controlling PRRSV include viral suppression of innate immunity, delayed 
adaptive response of host, and antigenic heterogeneity of PRRSV. Poor innate immunity and slow 
developments of neutralizing antibodies and CTLs result in the failure of clearance of virus, 
leading to viral persistence in the lymphoid tissues (Zuniga et al., 2015). Type I IFNs are critical 
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components for development and maturation of adaptive immunity, and PRRSV has a potent 
ability to suppress the type I IFNs production and signaling directly, and to modulate the adaptive 
immunity indirectly. A key to the successful development of a future vaccine for PRRS is the 
removal of IFN suppression function from PRRSV such that a replication-competent and IFN 
antagonism-negative PRRSV can be generated by reverse genetics. Such virus is anticipated to be 
attenuated and warrants most effective protection not only from homologous infection but also 
from heterologous infection.  
 
1.7 HYPOTHESIS AND OBJECTIVES OF THE THESIS 
1.7.1 Introduction 
A virus life cycle is dependent on its host, and the virus-host interactions will determine 
the infection consequence to be virus elimination, viral persistence, or host disease. Usually the 
host is armed with a variety of immune surveillance mechanisms, from intrinsic to innate to 
adaptive immunity, to eliminate invading viruses. The virus, on the other hand, has evolved to 
disarm these mechanisms to facilitate its own survival. Innate immune response is the first line of 
defense for host to actively build anti-viral activities. These serial antiviral activities are triggered 
by recognition of pathogen-associated molecular patterns (PAMPs) by pattern recognition 
receptors (PRRs), followed by activation of type I interferons (IFNs) production. Thus, to 
modulate the innate immunity is critical for the survival of invading viruses and the infection 
outcome (for reviews, see Ke and Yoo, 2017; Wu and Chen, 2014).  
Porcine reproductive and respiratory syndrome (PRRS) is an emerging and re-emerging 
disease in swine and has become endemic throughout the pig farming countries worldwide with 
significant economic impact. PRRS is associated with reproductive failure in sows and severe 
34 
 
respiratory disease in nursing pigs (Albina, 1997). The etiologic agent, PRRS virus (PRRSV) was 
identified three decades ago in Europe (genotype I) and the US (genotype II) independently but 
almost simultaneously (Benfield et al., 1992; Wensvoort et al., 1991). Since then, extensive studies 
were carried out to develop effective vaccines and treatment strategies. There are several vaccines 
available for controlling PRRS. However, they are less effective in protection of heterogeneous 
infection and in clearance of persistent infection. PRRSV infection is featured by poor innate 
immune responses [low levels of type I interferons (IFNs) and interferon-stimulated genes (ISGs)] 
and delayed neutralizing antibodies (Albina et al., 1998a). Accumulating evidence suggest that 
PRRSV actively suppresses type I IFN production to facilitate virus survival and replication (for 
reviews, see Ke and Yoo, 2017; Yoo et al., 2010). Six viral proteins including nonstructural protein 
(nsp)1α, nsp1β, nsp2, nsp4, nsp11, and nucleocapsid (N) protein of PRRSV were identified as IFN 
antagonists (for reviews, see Ke and Yoo, 2017; Yoo et al., 2010). Among them, nsp1α and nsp1β 
are the two most potent IFN antagonists and nsp1β is of crucial importance for it regulates both 
type I IFN production and signaling pathways (Chen et al., 2010a; Han et al., 2017b; Patel et al., 
2010; Wang et al., 2013b). PRRSV disarms the host antiviral defense mechanisms to facilitate its 
own survival, and also triggers the onset of inflammatory responses at the sites of infection, which 
clearly contributes to the PRRSV-mediated disease. PRRSV infection causes fever, monocytes 
and neutrophils lung infiltration, and tissue damage, correlating with upregulated levels of 
proinflammatory cytokines including interleukin (IL)-1β, IL-6, IL-8, and tumor necrosis factor 
(TNF)-α (Albina, 1997; Liu et al., 2015; Loving et al., 2007; Van Reeth et al., 1999; Van Reeth 
and Nauwynck, 2000). Further studies unveiled that PRRSV activates nuclear factor (NF)-κB 
signaling pathway and nucleocapsid (N) protein was identified as the activator by other 
investigators and according to our own findings (Fu et al., 2012b; Lee and Kleiboeker, 2005; Luo 
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et al., 2011; Song et al., 2013a; Wongyanin et al., 2012b; Yu et al., 2016; Zhang et al., 2013). 
However, the molecular basis of action remains unknown. Overall, the dynamics of PRRSV-innate 
immune suppression and PRRSV-inflammation activation together contribute to the pathogenesis 
of the virus.  
In the present study, the molecular basis of PRRSV-mediated host innate immunity 
suppression and PRRSV-triggered inflammation will be unveiled. For innate immune suppression, 
the nsp1β protein will draw a special attention for its multiple roles in regulating type I IFN 
producing and signaling pathways. The mechanism of nsp1β-mediated IFN inhibition will be 
investigated and the functional motifs and crucial amino acids in nsp1β will be identified. Based 
on that, specific mutations will be introduced in both the nsp1β gene and PRRSV whole genome 
to alter the phenotype of PRRSV. The IFN-suppression negative mutant viruses will be studied in 
the natural hosts (pigs) to investigate the relationship between the PRRSV-mediated type I IFN 
suppression and PRRSV pathogenesis. For PRRSV-triggered inflammation, the molecular basis 
of PRRSV N protein-mediated activation of NF-κB signaling will be investigated. Functional 
motif will also be mapped. This study will delineate the molecular basis of PRRSV pathogenesis 
and provide novel strategies to develop an effective PRRSV vaccine.  
 
1.7.2 Principle hypothesis 
PRRSV suppresses the IFNs-α/β production and signaling pathways mostly by 
nonstructural proteins, which leads to disarming host innate immune antiviral activity. Since the 
type I IFN plays pleiotropic roles for regulation of adaptive immunity, the host adaptive immunity 
becomes weak and delayed, resulting in failure of virus clearance. Under such scenario, PRRSV 
survives longer and establishes persistent infection in pigs. The molecular basis of IFN suppression 
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by PRRSV will be identified, and IFN-suppression negative virus will be generated and examined 
in pigs in this study. Pigs infected with mutated PRRSV will mount higher IFNs-α/β and better 
adaptive immune responses. It is also expected that the mutated virus will be attenuated in 
replication and persistence. Meanwhile, PRRSV activates NF-κB and triggers inflammation. Over 
stimulation of inflammatory responses will recruit more monocytes, macrophages, and DCs to the 
sites of infection, which will provide more target cells for PRRSV to infect and will cause tissue 
damages. In turn, the inflammation contributes to the pathogenesis of the disease. The molecular 
basis of NF-κB activation will be identified. 
 
1.7.3 Specific aims 
Specific aim 1: Pathogenic consequence of type I IFN-suppression by PRRSV in vivo. 
Specific aim 2: Elucidation of the molecular mechanisms of nsp1β for type I IFN suppression. 







Fig. 1.1. The pleiothropic roles of type I IFNs for regulation of adaptive immunity. Type I 
IFNs stimulate dendritic cells (DC), CD4+ T cells, CD8+ T cells, B cells, and NK cells (indicated 
in solid arrow lines). Type I IFNs can also promote the cross-talk of DCs with NK cells and CD4+ 
T cells. The inter-connection of CD4+ T cells with CD8+ T cells and plasma B cells help the 
development of adaptive immunity (indicated in dotted arrow lines). Vertical arrows indicate 
positive regulation (↑) or negative regulation (↓) of cellular functions by type I IFNs.  Numbers in 
parenthesis indicate relevant references. ‘h’ associated with references denotes the information 






Fig. 1.2. Functional motifs and domains identified in the nsp1α, nsp1β, nsp2, nsp4, nsp11, 
and N proteins of PRRSV. Amino acids are presented in single letters. Numbers indicate amino 
acid positions.  ZF1, zinc finger domain of C8-C10-C25-C28; ZF2, zinc-finger domain of C70-
C76-H146-M180; PLP1α, papain-like protease domain of C76-H146; PLP1β, papain-like protease 
domain of C90-H159; HV, hyper-variable region; TM, transmembrane domain; Cr, cysteine-rich 
domain; NLS, nuclear localization signal; NoLS, nucleolar localization signal; NendoU, 
nidovirus-specific endoribonuclease; C23 of N, residue for  homodimerization; Vertical arrows 
indicate the cleavage sites specific for PLP1α of nsp1α, PLP1β of nsp1b, PLP2 of nsp2, and serine 





Fig. 1.3. Coding strategy of the PRRSV genome and type I IFN viral antagonists encoded by 
PRRSV. Viral IFN antagonists are indicated in magenta for nsp1α, red for nsp1b, light green for 
nsp2, yellow for nsp11, and purple for N. Vertical arrows indicate the specific cleavage sites for 
polyprotein processing. Colors are matched with respective proteases. IFN antagonistic functions 




CHAPTER 2: TYPE I INTERFERON SUPPRESSION-NEGATIVE AND HOST MRNA 
NUCLEAR RETENTION-NEGATIVE MUTATION IN NSP1-BETA CONFERS 
ATTENUATION OF PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME 
VIRUS IN PIGS 
 
2.1 ABSTRACT2 
Porcine reproductive and respiratory syndrome virus (PRRSV) has the ability to suppress 
the type I interferons (IFNs-α/β) induction to facilitate its survival during infection, and the nsp1 
protein of PRRSV has been identified as the potent IFN antagonist. The nsp1β subunit of nsp1 has 
also been shown to block the host mRNA nuclear export as one of the mechanisms to suppress 
host antiviral protein production. The SAP motif in nsp1β is the functional motif for both IFN 
suppression and host mRNA nuclear retention, and using infectious clones, two mutant viruses 
vL126A and vL135A have been generated. These mutants retain the infectivity, but the phenotype 
is negative for both IFN suppression and host mRNA nuclear retention due to the loss of the SAP 
motif. To examine the pathogenic role of IFN suppression in pigs, 40 piglets were allotted to four 
groups and each group was intramuscularly infected with vL126A, vL135A, wild-type (WT) 
PRRSV, and placebo. Pigs infected with vL126A or vL135A exhibited less severe clinical signs 
with lower viral titers and shorter duration of viremia when compared to those of WT-infected 
pigs. The levels of PRRSV-specific antibody remained comparable in all infected groups but the 
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neutralizing antibody titers were high in vL126A-infected or vL135A-infected pigs. The IFN-α 
concentration was also high in pigs infected with the SAP mutants. Reversion to WT sequence 
was observed in the SAP motif in some animals, and the revertants regained the function to 
suppress IFN production and host mRNA nuclear export, indicating strong selection pressure in 
the SAP motif of nsp1β. Together, our data demonstrate that the IFN antagonism and host mRNA 
nuclear retention mediated by nsp1β contributes to viral virulence, and loss of these functions 
confers PRRSV attenuation. 
 
2.2 INTRODUCTION 
Porcine reproductive and respiratory syndrome (PRRS) emerged in the United States in 
1987 and almost simultaneously but independently in Europe. PRRS has since become endemic 
in most pig producing countries with a significant economic impact. The etiologic agent is porcine 
reproductive and respiratory syndrome virus (PRRSV) of the family Arteriviridae in the order 
Nidovirales (https://talk.ictvonline.org/taxonomy). PRRSV genome is a single-strand positive-
sense RNA of 15 Kb in length with the 5’-cap and 3’-polyadenylated tail. According to their 
genomic similarity of approximately 60%, PRRSVs are grouped into two distinct species: PRRSV-
1 and PRRSV-2. Eleven functional open reading frames (ORFs) are found in the PRRSV genome. 
Among them, ORF1a and ORF1b take up three-quarters of the genome in the 5’-proximity. They 
are coding for two large polyproteins pp1a and pp1ab of which the latter is produced by the -1 
ribosomal frame-shifting mechanism. The polyproteins are further processed to generate 14 
nonstructural proteins (nsps). A -2/-1 ribosomal frame-shifting has been identified in the nsp2 gene 
for nsp2TF and nsp2N expression (Fang et al., 2012b). The remaining one-quarter in the 3’-
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proximity of the genome codes for eight structural proteins: E, GP2, GP3, GP4, GP5, ORF5a, M, 
and N proteins (Firth, 2011; Johnson et al., 2011; Nelsen et al., 1999; Wootton et al., 2000).  
Host-virus interactions determine the infection outcome, and the innate immunity is the 
first line of host defense against viral infection. Type I interferons (IFNs-α/β) are the most potent 
antiviral cytokines produced by hosts against invading viruses (Schneider et al., 2014b). Type I 
IFNs in pigs are comprised of at least 39 functional subtypes which are more than double of 
humans plus 16 pseudogenes (Groenen et al., 2012; Sang et al., 2010), suggesting that pigs have a 
more complicated IFN system than humans. Nevertheless, the induction of type I IFNs is unusually 
poor in PRRSV-infected cells and pigs (Albina et al., 1998b; Buddaert et al., 1998; Miller et al., 
2004a; Van Reeth et al., 1999), suggesting that PRRSV may actively modulate type I IFNs 
response during infection. Since type I IFNs also play pleiotropic roles in the regulation of adaptive 
immunity in addition to their antiviral activity, the adaptive responses of pigs to PRRSV are also 
perturbed. It seems that the suppression of type I IFN production is an important strategy of 
PRRSV to modulate host antiviral defense and to facilitate its own replication. So far, at least six 
PRRSV proteins (nsp1α, nsp1β, nsp2, nsp4, nsp11, and N) have been identified as IFN antagonists, 
and nsp1α and nsp1β are two potent proteins (Han and Yoo, 2014; Ke and Yoo, 2017). The 
mechanisms for PRRSV to suppress type I IFNs production vary. The PRRSV nsp1α protein 
travels to the nucleus and binds to the CREB (cyclic AMP-responsive element binding)-binding 
protein (CBP), leading to its degradation. Thus, the IFN enhanceosome is disrupted, and IFN 
production is suppressed (Chen et al., 2016; Han et al., 2013; Kim et al., 2010). The PRRSV nsp1β 
protein also suppresses type I IFNs production (Chen et al., 2010a; Han and Yoo, 2014; Patel et 
al., 2010).  
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The papain-like cysteine protease (PLP1β) domain in nsp1β is believed to play crucial roles 
for viral genome replication (Kroese et al., 2008), nsp2TF gene expression (Fang et al., 2012b), 
and type I IFN suppression (Li et al., 2016; Li et al., 2013). We have recently shown that the nsp1β 
protein blocks the host mRNAs export from the nucleus to the cytoplasm, which allows PRRSV 
to utilize the cellular translational machinery exclusively for viral protein synthesis and thus to 
promote progeny production (Han et al., 2017b). Furthermore, the nsp1β-mediated host mRNA 
nuclear retention is correlated with the nsp1β-mediated type I IFNs suppression, suggesting that 
the blocking of the host mRNA nuclear export is at least one mechanism for type I IFN 
suppression. We have identified a specific motif for SAP (SAF-A/B, Acinus, and PIAS) with the 
consensus sequence of 124-KxLQxxLxxxGL-135 in the PLP1β domain of nsp1β (Han et al., 2017b). 
Mutations in the SAP motif cause the loss of host mRNA nuclear retention and nsp1β-mediated 
type I IFNs suppression. Using reverse genetics, a series of SAP mutated PRRSV cDNA clones 
have been constructed, and two SAP mutants vL126A and vL135A have been successfully 
generated. These viruses are infectious, and their phenotypes are host mRNA nuclear retention-
negative and type I IFN suppression-negative (Han et al., 2017b).  
In this present study using the SAP mutant PRRSV, we investigated the roles of IFN 
suppression and host mRNA nuclear retention in the natural host animals. We showed that the IFN 
suppression-negative and host mRNA nuclear retention-negative PRRSV were clinically 
attenuated in the pigs. Pigs infected with the SAP mutant PRRSV exhibited attenuated clinical 
signs and lower titers and shorter durations of viremia compared to those of WT PRRSV-infected 
pigs. These pigs also produced high levels of neutralizing antibodies and IFN-α in the sera. Our 
study demonstrates that the IFN antagonism of PRRSV contributes to viral virulence, and the loss 
of function confers viral attenuation in pigs. 
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2.3 MATERIALS AND METHODS 
2.3.1 Cells, viruses, and antibodies 
HeLa cells (NIH AIDS Research and Reference Reagent Program, Germantown, MD) and 
MARC-145 cells were cultivated in Dulbecco’s modified Eagle’s medium (DMEM; Mediatech 
Inc., Manassas, VA) supplemented with 10% heat-inactivated fetal bovine serum (FBS; Gibco, 
Grand Island, NY) in a humidified incubator with 5% CO2 at 37 ºC NVSL 97-7895 is a North 
American (NA) type PRRSV, and FL12 is the infectious clone of the NVSL 97-7895 strain, and 
FL13 is a modified version of FL12 by adding cytomegalovirus (CMV) promoter in front of the 
viral genomic sequence for efficient transcription in mammalian cells. FL13-WT is the infectious 
virus reconstituted from the FL13 infectious clone. FL13-WT was propagated in MARC-145 cells. 
vL126A and vL135A were mutant viruses generated by introducing specific mutations in the SAP 
motif of the FL13 infectious clone as described elsewhere (Han et al., 2017b). Viral titers were 
determined by plaque assays in MARC-145 cells in duplicate using 6-well plates of 35 mm in 
diameter per well. Anti-swine IFN-α Ab (clone F17) was purchased from PBL Assay Science 
(Piscataway, NJ). Biotin-anti-swine IFN-α Ab (clone K9) was obtained from F. Zuckermann 
(University of Illinois, Urbana-Champaign, IL). Anti-FLAG mAb (mouse) (M2) was purchased 
from Agilent (Santa Clara, CA).  
 
2.3.2 Real time quantitative PCR (RT-qPCR) 
Total cellular RNA was extracted using the RNeasy mini kit according to manufacturer’s 
instruction (QIAGEN, Hilden, Germany). RT-qPCR was performed in the ABI sequence detector 
system (ABI Prism 7000 and software; Applied Biosystems, Life Technology) in a final volume 
of 25 µl containing 3 µl of cDNA synthesized from the reverse-transcription reaction, 12.5 µl of 
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SYBR Green Master Mix (Applied Biosystems), 2.5 µl primer pairs (1.25 µl each of sense and 
antisense primers (10 µM)), and 7 µl of distilled water. The β-actin gene was amplified using actin-
F (5’-GCGCGGCTACAGCTTCACCAC-3’) and actin-R (5’-
GGGCGCCAGGGCAGTAATCTC-3’) (Sun et al., 2016); The IFN-β gene was amplified using 
IFN-β-F (5’-GATTTATCTAGCACTGGCTGG-3’) and IFN-β-R (5’-
CTTCAGGTAATGCAGAATCC-3’) (Zhang et al., 2016); The ISG15 gene was amplified using 
ISG15-F (5’-CACCGTGTTCATGAATCTGC-3’) and ISG15-R (5’-
CTTTATTTCCGGCCCTTGAT-3’) (Zhang et al., 2016). The mRNA levels of indicated genes 
were calculated using the 2-ΔΔCT method by normalizing to that of β-actin mRNA. Each reaction 
was conducted in triplicate.  
 
2.3.3 Experimental infection of pigs 
The animal infection and necropsies were conducted at the Biosecurity Research Institute 
(BRI) on the Kansas State University Manhattan campus (Manhattan, KS). The study protocol was 
approved by the Institutional Animal Care and Use Committee (IACUC) of Kansas State 
University. A total of 40 piglets of 3 weeks of age were brought into the facility and were pre-
screened for the evidence of exposure to PRRSV and Mycoplasma hyopneumoniae. The animals 
were randomly allotted to four groups, 10 animals per each group, and were acclimatized for 4 
days in the isolation facility prior to infection. Animals within the same group were housed in the 
same room. Throughout the study, pigs were housed according to the IACUC protocols and were 
fed an age-appropriate non-medicated diet. Feed and water were provided ad libitum, and pigs in 
a group were allowed to freely mingle. On the day of infection, the PRRSV stocks were prepared 
to make 1×104 TCID50/ml, and each pig was infected with a total of 1×104 TCID50 by a single 
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intra-muscular administration with 2 ml of virus. After infection, an aliquot of each inoculum was 
titrated by plaque assay to confirm the dose of infection. Pigs were monitored daily and those 
exhibiting symptoms of illness were treated according to the recommendations of the veterinarian. 
Pigs that showed severe distress and were in danger of succumbing to infection were humanely 
euthanized. Clinical signs for general condition including rectal temperature, respiratory distress, 
coughing, and feces conditions were monitored. Blood samples were taken on 0, 3, 7, 11, 15, 21, 
and 27 days postinfection (dpi) for virus isolation and serology. Serum samples were aliquoted 
and stored immediately at -80 ºC until use. Pigs were weighed upon arrival at the site and at the 
days collecting the blood samples. Except one animal (No.137) that was euthanized before the end 
of study due to severe illness, all animals were euthanized at the end of the study. At necropsy, the 
lung sample from a representative lesion was taken and immersed in formalin for histopathological 
examination. Tonsil samples were collected for evaluation of viral RNA via RT-PCR. Sub-
mandibular lymph node samples were also collected for evaluation of viral RNA.  
 
2.3.4 Viremia, ELISA, and serum neutralization assays 
Viremia was measured by standard plaque assay in MARC-145 cells as described 
elsewhere (Lee et al., 2006; Pei et al., 2008). Briefly, cells were grown in the 6-well plate as 
monolayer and were infected with 0.1 ml of 10-fold serial dilutions of serum collected at indicated 
days. Virus-infected cells were overlaid with 0.8 % agarose in DMEM and incubated at 37 ºC. At 
3-4 dpi, plaques were stained with 5% crystal violet in 20% ethanol for 10 minutes and washed 
with water several times. The number of plaques was counted for each dilution and virus titers 
were calculated as PFU per ml of serum. Each sample was tested in duplicate.  
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Serum IFN-α concentration was measured by sandwich ELISA as described with minor 
modifications (Moraes et al., 2003). Briefly, 0.1 µg of MAb against porcine INF-α (clone F17; 
PBL Assay Science, Piscataway, NJ) in 50 µl 0.1 M carbonate buffer, pH 9.6, was used to coat 
one well of 96 well plate (Immulon 2HB, ThermoFisher Scientific, Rockford, IL) overnight at 4 
ºC. The plates were blocked with 200 µl of blocking solution (PBS containing 0.05% Tween 20 
and 5% non-fat skim milk for 2 h at 37 ºC and were washed 3 times with washing solution (PBS 
containing 0.05 % Tween 20). Fifty µl of 10-fold diluted serum samples in dilute solution (MEM 
containing 5% FBS) were added to the plates for 1.5 h at 37 ºC. The plates were washed 5 times, 
and 50 µl of biotinylated anti-porcine IFN-α (clone K9) diluted in PBST-1% BSA was added to 
the plates for 2 h at room temperature (R/T). The plates were washed 5 times and 50 µl of 
streptavidin-HRP (ThermoFisher Scientific, Rockford, IL) of 1:4000 dilution was added to the 
plates for 30 min at R/T. The plates were washed 6 times, and 50 µl of TMB 
(Tetramethylbenzidine) substrate (ThermoFisher Scientific, Rockford, IL) was added to the plates 
for 20 min at R/T. The reaction was stopped by adding 50 µl 0.2 M H2SO4. The plates were read 
at 450 nm using the SpectraMax Plus 384 Microplate Reader (Molecular Devices, Sunnyvale, CA). 
The porcine IFN-α concentrations were determined from a standard curve using recombinant 
porcine IFN-α in the same plate.  
PRRSV specific antibody was determined at the Veterinary Diagnostic Laboratory at the 
University of Illinois using the IDEXX ELISA kit according to manufacturer’s instruction 
(HerdCheck® PRRS ELISA kit). The S/P ratio value of 0.4 was set as cutoff for positive/negative. 
S/P ratios that greater than 0.4 were considered positive.  
Serum neutralization tests were performed in MARC-145 cells in the 96-well plates using 
wild-type PRRSV FL13-WT virus. Serum samples were inactivated by exposure to UV light 
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(Spectroline©, Westbury, NY) in petri dish for 10 min with shaking every minute, and was heated 
at 56 ºC for 30 min. Inactivated serum samples were diluted by 2-fold serial dilutions in DMEM. 
The FL13-WT virus stock was diluted in DMEM to make 100 PFU in 100 µl volume. The diluted 
virus was mixed with an equal volume of 2-fold dilutions of individual serum samples and the 
mixture was incubated for 1 h at 37 ºC. The mixture was added to the monolayers of MARC-145 
cells in the 96-well plates and incubated 24 h at 37 ºC. Cells were then fixed with 4% 
paraformaldehyde and permeabilized with 0.1% Triton X-100 for 15 min at room temperature 
(RT). After blocking with 1% BSA in PBS (blocking solution), cells were treated with the PRRSV 
N-specific monoclonal antibody MR-40 (1:1,000 dilution in blocking solution) for 2 h at RT, 
followed by staining with Alexa Fluor 488 conjugated goat anti-mouse IgG (Thermo Scientific, 
IL) (1:1,000 in blocking solution) for 1 h at RT. Fluorescent foci were examined by microscopy 
and counted. Virus neutralizing (VN) antibody titers were determined as the reciprocal of the 
highest serum dilution that reduced 90% or greater PRRSV foci relative to serum samples from 
placebo-infected pigs. The VN titer of serum sample which failed to inhibit fluorescent foci at 1:2 
dilution was counted as zero. Each sample was tested in triplicate.  
 
2.3.5 Viral RNA isolation 
Serum viral RNA was extracted using the QIAamp® Viral RNA mini kit according to 
manufacturer’s instruction (QIAGEN, Hilden, Germany). Tissue (tonsil and lymph node) viral 
RNA was extracted using TRIzol (Invitrogen, Carlsbad, CA). Tissue sample was cut into small 
pieces in 100 µl sterile PBS and was homogenized with the Biomasher II Tissue Grinder (Tokyo, 
Japan). One ml of TRIzol was added to the tissue for 5 min at R/T, and 0.2 ml of chloroform was 
added to the mixture, which was then shaken vigorously for 20 s and incubated for 3 min. The 
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mixture was centrifuged at 12,000 rpm in a microcentrifuge for 15 min at 4 ºC. The aqueous phase 
was transferred to a fresh tube, followed by addition of 0.6 ml isopropyl alcohol with shaking and 
centrifugation at 12,000 rpm for 10 min at 4 ºC. The RNA pellet was washed with 1 ml of 75% 
ethanol air dried, and dissolved in 30 µl of RNase-free water.   
 
2.3.6 Reverse transcription and gene cloning 
The viral sequence in the serum, tonsil, and lymph nodes was detected by RT-PCR for the 
nsp1β gene using M-MLV reverse transcriptase. The nsp1β gene were amplified using the nsp1β-
F (5’-CGGAATTCACCATGGATTACAAGGATGACGACGATAAGGCTACTGTCTATGAC 
ATTGGTC-3’) and nsp1β-R (5’-CCGCTCGAGCTAGCCGTACCACTTGTCAC-3’) primers. 
The PCR products were sequenced and the nsp1β gene from revertants were cloned in the pXJ41 
expressing vector using Eco RI and Xho I restriction enzymes.  
 
2.3.7 Luciferase reporter assay 
HeLa cells grown in 12-well plates were transfected with plasmids coding for viral 
proteins, luciferase reporter, and Renilla reporter pRL-TK at the ratio of 0.5 µg:0.5 µg:0.05 µg 
using the Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA). At 24 h post-transfection, cells 
were stimulated with 0.5 µg of poly(I:C) by transfection for 16 h and cell lysates were prepared 
for luciferase assays. For ISRE-luciferase assay, cells were treated with 1,000 units of human IFN-
β (bioWorld, Dublin, OH) for 16 h. Luciferase activity was measured using the Dual-luciferase 
assay system according to the manufacturer’s instruction (Promega, Madison, WI). Values for 
each sample were normalized using Renilla as an internal control and the results were expressed 




2.3.8 Oligo(dT) in situ hybridization (ISH) 
Oligo(dT) ISH was performed as described previously (Chakraborty et al., 2006; Han et 
al., 2017b). Briefly, HeLa cells at 24 h post-transfection were fixed with 4% paraformaldehyde, 
permeabilized with 0.5% Triton X-100, and incubated with primary antibodies for 2 h at R/T. The 
primary antibodies were diluted in PBS containing 0.2% Triton X-100, 1 mM DTT, and 200 U/ml 
RNasin (Promega, Madison, WI). The cells were fixed again with 4% paraformaldehyde and 
washed with PBS. In situ hybridization was then performed at 42 ºC overnight using biotinylated 
oligo(dT) as a probe (Promega, Madison, WI). The cells were washed twice with 0.5× SCC 
(ThermoFisher Scientific, Rockford, IL) at 42 ºC. Cells were incubated with cy3-streptavidin 
(Jackson Immuno Research, PA) and secondary antibodies for 1 h at R/T. Cells were stained with 
4',6-diamidino-2-phenylindole (DAPI) for nuclear staining, and the cover slips were mounted on 
glass slides. The cells were visualized and images were taken using the Nikon A1 confocal 
microscope (Dexter, MI).  
 
2.4 RESULTS 
2.4.1 Type I IFN suppression of SAP mutant PRRSV in cells 
PRRSV nsp1β protein contains a highly conserved sequence at residues 124-135 among 
strains of PRRSV, and this sequence of 124-KxLQxxLxxxGL-135 resembles the SAP (SAF-A/B, 
Acinus, and PIAS) consensus motif in the first α-helix, PLBxxHxxBxH, in which P, B, and H 
represent polar, bulky, and hydrophobic residues, respectively (Aravind and Koonin, 2000). The 
leucine residue at position 126 or 135 in nsp1β was mutated to alanine using the FL13 PRRSV 
infectious clone (Han et al., 2017a, 2017b). Two SAP mutant viruses were generated and 
51 
 
designated as vL126A and vL135A (Han et al., 2017b). We collected the passage 3 (P3) mutant 
viruses and stored them in -80 ºC until further experiments.  
Since the SAP motif was responsible for nsp1β-mediated type I IFN suppression (Han et 
al., 2017b), the IFN phenotype of the mutant viruses was examined in cells. MARC-145 cells were 
infected with FL13-WT, vL126A, or vL135A, and stimulated with poly(I:C) (Fig. 2.1C) or 
recombinant IFN-β (Fig. 2.1D). Total RNA was isolated and RT-qPCR was conducted to 
determine the IFN-β and ISG15 expressions. As shown in Fig. 2.1C, poly(I:C) stimulation 
increased the IFN-β transcription by more than 10 times in mock-infected cells, whereas in FL13-
WT-infected cells, the IFN-β transcription was not increased even after stimulation, suggesting 
that FL13-WT actively suppressed the IFN-β gene expression. In contrast, both vL126A and 
vL135A were able to elicit higher level expression of IFN-β even without poly(I:C) stimulation, 
and the expression levels were even higher when stimulated (Fig. 2.1C). Interenstingly, vL126A 
induced a higher level of IFN-β expression than vL135A. This suggests that the SAP mutant 
PRRSV lost the ability of IFN suppression, at least partially. The PRRSV nsp1β protein is also 
known to modulate the JAK-STAT signaling pathway (Chen et al., 2010a; Patel et al., 2010) and 
thus, we examined whether the SAP mutant PRRSV still retained the suppressive function for 
JAK-STAT signaling. To do this, cells were stimulated with recombinant IFN-β to bypass the IFN 
production pathway, and ISG15 transcription was examined by RT-qPCR. As shown in Fig. 2.1D, 
recombinant IFN-β triggered the ISG15 transcription by more than 25 times in mock-infected cells. 
FL13-WT triggered the suppression of ISG15 when stimulated with recombinant IFN-β. The SAP 
mutant vL126A stimulated higher levels of ISG15 transcription even without IFN-β stimulation. 
Similarly, vL135A also stimulated ISG15 transcription without IFN-β stimulation to a lesser extent 
compared to vL126A. These results indicate that SAP mutant PRRSV lost the suppression function 
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for the JAK-STAT signaling. They may rather elicit IFN production. We noted that vL126A and 
vL135A induced different levels of IFN modulation: vL126A elicited higher levels of IFN-β and 
ISG15 expression than vL135A. Together, these data demonstrate that vL126A and vL135A lost 
the ability of type I IFN antagonism, and their phenotype became IFN suppression-negative. Their 
phenotype for host mRNA nuclear retention was negative and is described elsewhere (Han et al., 
2017b). 
 
2.4.2 Virulence of SAP mutant PRRSV in pigs 
To examine the immunogenic and pathogenic profiles of the IFN suppression-negative 
PRRSV in the natural host, 40 piglets were randomly allotted to four groups, 10 animals per group, 
and infected intramuscularly with 2×104 TCID50 of mutant PRRSV. An aliquot of each inoculum 
was titrated to confirm the dose. The pigs were maintained for 4 weeks and their serum samples 
were periodically taken as indicated. One pig (No. 137; Table 2.1) in the FL13-WT group was 
euthanized at 23 days postinfection (dpi) due to illness. Clinical signs including rectal 
temperatures, respiratory difficulties, coughing, and fecal conditions were monitored daily and 
summarized in Table 2.1. During the course of study, only three of 10 pigs in vL126A-infected 
pigs showed rectal temperatures higher than 103.5F, and the average duration of fever was 1.4 
days. In vL135A- or FL13-WT-infected pigs however, seven pigs showed rectal temperatures 
higher than 103.5 F with a mean duration of 3.6 and 3.4 days, respectively. For respiratory 
difficulties, only two and three pigs in vL135A- and vL126A-infected groups exhibited difficulty 
breathing with average scores of 0.8 and 2.6, respectively. Five animals in FL13-WT-infected 
group showed respiratory difficulty with a mean score of 1.7. Only one animal in vL126A-infected 
group showed coughing for one day, whereas two animals in vL135A-infected group showed 
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coughing for 3 days. In FL13-WT-infected groups however, five pigs showed coughing with the 
duration of 1 day to 6 days. For fecal conditions, seven of 10 animals in vL126A-infected group 
showed fecal staining or diarrhea with an average score of 3.9, and nine of 10 animals in vL135A-
infected group showed such fecal conditions with an average score of 9.8. In FL13-WT-infected 
group, seven animals showed such conditions with an average score of 5.7. The average daily 
weight gains of all infected groups seemed to be lower than that of the placebo group, but the 
differences were negligible among the FL13-WT, vL126A, and vL135A groups (data not shown). 
In summary, SAP mutant virus (vL126A and vL135A)-infected animals showed mild clinical 
signs, short durations of high rectal temperatures and coughing, low scores of respiratory difficulty 
and fecal conditions, as well as low numbers of animals that developed such clinical signs when 
compared to FL13-WT-infected pigs. vL126A-infected pigs appeared to behave slightly better 
than vL135A-infected pigs, suggesting a difference between two SAP mutants.  
Pigs in the placebo group remained PRRSV-negative throughout the study, while pigs in 
FL13-WT group became viremic at 3 dpi with the mean titer of 3.5 log PFU/ml. Most pigs in 
vL126A and vL135A groups also developed viremia by 3 dpi (Fig. 2.2). In vL126A group, eight 
out of 10 pigs became viremic at 3 dpi with the mean titer of 2.0 log PFU/ml. Two pigs in this 
group remained negative at this time. Similarly, in vL135A group, eight out of 10 pigs became 
viremic at 3 dpi with the mean virus titer of 1.8 log PFU/ml. The viral titers in vL126A and vL135A 
groups were lower than the titers in FL13-WT group. The viremia peaked at 7 dpi with a titer of 4 
log PFU/ml for FL13-WT group. For vL126A and vL135A groups, all 10 pigs in each group 
became viremic at 7 dpi, and the mean titers increased moderately to 2.2 log PFU/ml for vL126A 
group and 2.5 log PFU/ml for vL135A group. Both groups still showed lower titers of viremia than 
FL13-WT group. The viral titers of all three groups decreased gradually from 7 dpi, while the 
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mean titer of FL13-WT group remained high until 11 dpi. The duration of viremia for FL13-WT 
group was also longer than that in other groups. Only one pig was weakly viremic at 15 dpi in 
vL126A group, and all pigs in vL135A group became viremia-negative, whereas five pigs were 
still viremic in FL13-WT group. The viremia disappeared at 21 dpi in vL126A and vL135A 
groups, but in FL13-WT group, viremia disappeared only at 27 dpi. In summary, the pigs infected 
with SAP mutant PRRSV (vL126A and vL135A) developed lower titers and shorter duration of 
viremia, and together with clinical observations, we concluded that the IFN suppression-negative 
mutant PRRSV was attenuated in pigs.  
 
2.4.3 Serum IFN-α level of pigs 
The SAP motif by nsp1β protein was critical for IFN suppression, and the phenotype of 
SAP mutant PRRSV (vL126A and vL135A) was IFN suppression-negative in cells. Thus, we 
examined the IFN-α concentrations in the sera of SAP mutant PRRSV-infected pigs by the 
sandwich ELISA assays. As shown in Fig. 2.3, the basal level of IFN-α was approximately 150 
pg/ml for all animals. While the IFN-α level remained consistent throughout the study in the 
placebo group, virus-infected pigs elicited the IFN-α production. At 3 dpi, approximately 450 
pg/ml of IFN-α was seen for vL126A group, and 400 pg/ml was detected for FL13-WT group. The 
IFN-α concentration of vL135A group was approximately 260 pg/ml, which was lower than those 
of the FL13-WT and vL126A groups. The IFN-α levels decreased by 7 dpi for all three groups to 
different extents. The IFN-α concentration dropped to 220 pg/ml, 160 pg/ml, and less than 100 
pg/ml in vL126A, vL135A, and FL13-WT groups, respectively. It was noteworthy that the IFN-α 
levels of vL126A and vL135A groups were higher than that of FL13-WT group. The IFN-α levels 
of all three virus-infected groups decreased gradually until the end of the study and reached the 
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basal level. Even though the mean concentrations of IFN-α in vL126A and vL135A groups were 
higher than that of FL13-WT, the differences among groups were marginal. Nevertheless, these 
data suggest that vL126A was able to elicit high levels of IFN-α during infection of pigs, whereas 
vL135A elicited IFN-α to intermediate levels. 
 
2.4.4 PRRSV-specific antibody response and serum neutralizing antibodies 
The antibody response to the IFN suppression-negative SAP mutant PRRSV was also 
examined (Fig. 2.4). The positive/negative cut-off line was set to 0.4 according to the 
manufacturer’s instructions. The control pigs in the placebo group remained seronegative 
throughout the study, indicating no cross-infection between groups. In vL126A group, two pigs 
out of 10 seroconverted at 7 dpi, and eight pigs remained seronegative. In vL135A group, four 
pigs out of 10 seroconverted and six pigs remained seronegative. FL13-WT group showed the 
highest rate of seroconversion as six out of 10 pigs become seropositive, and only four remained 
seronegative. However, only marginal differences were observed between the average titers (S/P 
ratio) of antibodies in all three groups. All pigs in the infected groups seroconverted by 15 dpi and 
remained seropositive throughout the study. At 21 dpi, FL13-WT groups showed lower titer 
antibodies than those of vL126A and vL135A group, and the differences were statistically 
significant (asterisks in Fig. 2.4A).  
Since neutralizing antibodies contribute to the protection of pigs from PRRS to some extent 
(Lopez et al., 2007; Osorio et al., 2002), neutralizing antibodies were determined in SAP mutant 
and FL13-WT PRRSV-infected pigs. Pigs, but not all of them, developed neutralizing antibodies 
by 21 dpi with comparable titers (Fig. 2.4B). By 27 dpi, both vL126A and vL135A groups 
developed higher titers of neutralizing antibodies than FL13-WT. vL126A in particular induced 
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the highest titers, approaching to a mean titer of 7.3 by 27 dpi. In contrast, FL13-WT induced the 
lowest titers of neutralizing antibodies with a mean titer of 3.8 by 27 dpi. The pigs in vL135A 
group induced intermediate levels of serum neutralizing antibody responses with a mean titer of 
5.9 at 27 dpi. This data together demonstrated that the serum neutralizing antibody induced in 
vL126A and vL135A groups was higher than that in FL13-WT group, despite the PRRSV-specific 
total antibodies being similar. 
 
2.4.5 Genetic stability of SAP mutants in vivo and reversion in tonsil and submandibular 
lymph node tissues 
The IFN-α kinetics of vL126A and vL135A groups was complicated (Fig. 2.3), and we 
reasoned that sequence reversion or compensatory mutations might have occurred in the SAP 
mutant viruses. To examine this possibility, we isolated viral RNAs from the sera and conducted 
RT-PCR and sequencing of the nsp1β gene. The sequencing results showed that mutation occurred 
in the sera at 7 dpi of both vL126A and vL135A groups. No reversion was identified at 3 dpi. For 
vL126A group, the GCA codon for Ala126 was mutated to GTA for Val in all pigs. For vL135A 
group, GCC for Ala135 was mutated to GTC for Val in eight pigs out of 10, whereas two pigs 
remained unchanged. These data indicated that the SAP motif was under strong selection pressure. 
Similar to Ala, Val is a hydrophobic amino acid and the Ala to Val mutation may possibly regain 
the SAP function. This result further showed the essential role of SAP motif in the PRRSV 
pathogenesis.  
One of the hallmarks of PRRSV infection in pigs is viral persistence for a prolonged period 
in the lymphoid tissues especially in the tonsils (Allende et al., 2000; Wills et al., 1997). We 
examined the presence of virus in the lymphoid tissues. Total RNA was isolated from the tonsils 
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and lymph nodes, and RT-PCR and sequencing were conducted. As summarized in Table 2.2, the 
tonsils of pigs in FL13-WT and vL126A groups were all positive, and in vL135A group, nine pigs 
out of 10 were positive. No mutation was found in the nsp1β gene of PRRSV in FL13-WT pigs. 
In contrast, seven pigs out of 10 in vL126A group showed a single nucleotide mutation from GCA 
(Ala) to GTA (Val). Three pigs showed double mutations from GCA (Ala) to TTA (Leu) indicating 
the complete reversion to wild-type amino acid sequence. In vL135A group, the tonsils of seven 
pigs out of nine were positive for a single mutation from Ala to Val. One pig had two nucleotide 
mutations from Ala135/Arg136 to Ala135/Leu136, and one pig remained unchanged. For 
submandibular lymph nodes, six pigs out of nine in FL13-WT group showed viral sequence-
positive without any mutation. Seven pigs out of 10 in vL126A group showed viral sequence-
positive, and among those, 5 pigs had mutations from Ala to Val, and the remaining two pigs had 
mutations from Ala to Leu. In vL135A group, only five pigs showed viral sequence-positive in the 
lymph nodes, and 4 pigs of the 5 viral sequence-positives pigs showed mutation from Ala to Val, 
while one pig was undetermined. However, the time of tissue collection at 27 dpi may be too early 
to determine the persistence since this time period can be considered an acute phase during 
PRRSV-infection (Charpin et al., 2012). The mutations in the SAP domain of vL126A and 
vL135A viruses residing in the lymph nodes confirm the strong selection pressure on the IFN-
suppression function.  
 
2.4.6 IFN suppression is regained by revertants 
Since mutations were found in the SAP motif in the serum and lymph nodes of pigs infected 
with SAP mutant PRRSV, it was of particular interest to assess whether the revertants regained 
the function of type I IFN suppression and inhibition of host mRNA nuclear export. We cloned 
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nsp1β genes from revertants isolated from the tonsils and expressed the genes in cells. To facilitate 
the immunofluorescence, the FLAG tag was added at the 5’-terminus of each clone. Three nsp1β 
revertants were chosen and designated L126V, L135V, and AR135/136AL. To determine the type 
I IFN suppression of the revertants, luciferase assays were performed using the IFN-β and ISRE 
luciferase constructs in HeLa cells. As shown in Figs. 2.5A and 2.5B, poly(I:C) induced IFN-β 
luciferase significantly when co-transfected with the empty vector, whereas wild-type nsp1β (L126 
or L135) suppressed IFN-β luciferase significantly. The SAP mutant PRRSV (L126A or L135A) 
was IFN suppression-negative as anticipated. However, the revertants L126V, L135V, and 
AR135/136AL suppressed the IFN-β-luciferase activity significantly, suggesting the revertants 
regained the function of IFN-β suppression. The ISRE-luciferase assays also showed that wild-
type nsp1β suppressed the ISRE-luciferase activity when stimulated with recombinant IFN-β, 
whereas the SAP mutants L126A and L135A mutants did not (Fig. 2.5B). However, the SAP 
revertants L126V, L135V, and AR135/136AL regained the ISRE suppression function 
dramatically. Since PRRSV nsp1β could block the host mRNA nuclear export and this ability was 
correlated with the SAP motif (Han et al., 2017b), we also examined the ability of the revertants 
for the host mRNA nuclear retention. The in situ hybridization (ISH) assays using oligo(dT) as a 
probe in cells expressing wild-type nsp1β (126L/135L), SAP mutant nsp1β (L126A and L135A), 
or SAP revertants (L126V, L135V, and AR135/136AL) (Fig. 2.5C). In pXJ41 empty vector-
transfected cells, the host mRNAs were evenly distributed in the nucleus and cytoplasm, whereas 
in cells expressing wild-type nsp1β, the host mRNAs accumulated in the nucleus. Neither of 
L126A nor L135A triggered the host mRNA nuclear retention. In contrast, the host mRNAs 
accumulated in the nucleus in cells expressing each of the revertants L126V, L135V, or 
AR135/136AL, indicating that the revertants regained the function and blocked the host mRNA 
59 
 
nuclear export. These data demonstrated that the SAP revertants regained the ability of nsp1β-
mediated type I IFN suppression and the JAK-STAT signaling suppression. Furthermore, these 
revertants also regained the function to inhibit the host mRNA nuclear export, further 
demonstrating the correlation between IFN suppression, host mRNA nuclear retention, and the 
virulence of PRRSV. 
 
2.5 DISCUSSION 
The SAP motif has been identified mostly in nuclear proteins, including the scaffold 
attachment factors A and B (SAF-A and -B), the protein inhibitor of activated STAT-1 (PIAS) 
family, and myocardia, and is usually involved in the transcriptional control-mediated protein-
protein interactions between activators and repressors (Aravind and Koonin, 2000; Okubo et al., 
2004). The SAP motif is critical for binding to A/T-rich DNA sequences present in scaffold-
attachment region/matrix-attachment region (SAR/MAR) (Aravind and Koonin, 2000). For PIAS, 
the unique motif of LxxLL in the N-terminal region of SAP enables PIAS1 to inhibit STAT1-
dependent transcription, whereas the SAP mutant of PIAS1 does not inhibit type I IFN signaling 
pathway (Kubota et al., 2011; Liu et al., 2001). Besides cellular proteins, the SAP motif has also 
been found in viral protein. The leader proteinase (Lpro) of foot-and-mouse disease virus (FMDV) 
contains a SAP motif, and this motif is critical for the subcellular localization and IFN-suppression 
function of Lpro (De Los Santos et al., 2009a). The SAP mutant FMDV is attenuated in pigs with 
no clinical signs, no viremia, and no shedding. Furthermore, animals inoculated with the SAP 
mutant FMDV develop high titers of neutralizing antibodies, and this response is strong enough to 
protect the animals from virulent FMDV challenge (Díaz-San Segundo et al., 2012a). In the 
previous study, we have identified a SAP motif in the PRRSV nsp1β protein with a consensus 
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sequence of 124-KxLQxxLxxxGL-135, whose sequence meets the SAP consensus motif identified 
in the cellular proteins (Fig. 2.1; (Han et al., 2017b). Two SAP mutant viruses, vL126A and 
vL135A do not suppress the IFN production and signaling and are able to trigger IFN-β induction 
even without poly(I:C) stimulation. The SAP mutant PRRSV still contains a partial activity for 
IFN suppression, although it is not as potent as FL13-WT, and this residual activity is probably 
due to the fact that PRRSV contains multiple IFN antagonists (nsp1α, nsp2, nsp4, nsp11, and N) 
and nsp1β is only one (but perhaps the most potent) of these antagonists. A previous study showed 
that a highly conserved sequence of 123-GKYLQRRLQ-131 in nsp1β, which partially overlapped 
SAP motif, was critical for innate immune suppression function of PRRSV (Li et al., 2013). Single 
amino acid mutation of R128A or R129A, and double mutations of K124A/R128A or RR129AA 
abolished the nsp1β-mediated IFN suppression of PRRSV.  
Acute infection by PRRSV causes viremia as early as 2 dpi, and the viremia lasts up to 23 
days in pigs (Allende et al., 2000). In the current study, the viremia is detectable at 3 dpi in all pigs 
of the FL13-WT group and in some animals of the SAP mutant groups. By 21 dpi, all pigs in the 
SAP mutant groups and 9 pigs out of 10 in the FL13-WT group become negative, while one pig 
in the FL13-WT group is still viremic. The viral titers in the SAP mutant groups are consistently 
lower than that of pigs in FL13-WT group (Fig. 2.2). The results together with the clinical signs 
indicate that SAP mutant PRRSV is attenuated in pigs. It is unclear however whether the 
attenuation is due to the slow growth of the virus or due to the strong immune response elicited by 
these mutants. Type I IFNs are the most potent antiviral cytokines against invading pathogens and 
also play pleiotropic roles in adaptive immunity by priming and maturation of immune cells (Ke 
and Yoo, 2017; Schneider et al., 2014b). Indeed, the IFN-α concentration in the SAP mutant 
PRRSV-infected pigs, especially pigs in vL126A group, is higher than FL13-WT infected pigs 
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during the first week of infection (Fig. 2.3). The loss of IFN-suppression function of the SAP 
mutants resulted in the higher concentrations of IFN-α in pigs during infection. Then, the IFN-α 
may enhance anti-viral activities and inhibit virus replication. PRRSV-infected pigs produce 
detectable levels of IgG at 7 to 14 dpi (Labarque et al., 2000a; Rossow et al., 1994; Yoon et al., 
1995), and we have also detected PRRSV-specific antibodies from 7 dpi. The PRRSV-specific 
antibody titers remain comparable in all three groups throughout the study. The role of PRRSV-
specific antibodies in protection is uncertain since the passive transfer of PRRSV-specific 
antibodies does not confer a full protection against homologous challenge (Lopez et al., 2007; 
Osorio et al., 2002). Instead, neutralizing antibodies in serum can induce better protection, 
although this requires a longer time to develop and multiple exposures to reach high titers (Lopez 
et al., 2007; Loving et al., 2015; Osorio et al., 2002). In our study, pigs in vL126A develop the 
highest titer of neutralizing antibodies with 7.3 at the end of the study, while pigs in FL13-WT 
group develop the lowest titer and the vL135A group show the medium level titer of neutralizing 
antibodies (Fig. 2.4B). Taking into consideration of the pleiotropic roles of type I IFNs for adaptive 
immunity, the higher titers of neutralizing antibodies in the SAP mutant virus-infected pigs may 
be correlated with the higher amounts of IFNs, which is shown in Fig. 2.3. The protective role of 
type I IFNs during PRRSV infection has been described additionally. A replication-competent 
recombinant PRRSV expressing IFNs were delivered in cells and pigs, and the infected animals 
were protected from PRRSV (Sang et al., 2014b; Sang et al., 2012). In another study, the IFN-α 
and/or IL-12 expressing plasmid was used as an adjuvant for vaccination, and the elevated levels 
of IFN-α augmented the T helper (Th) 1 type response, which positively influenced the cell-
mediated response in pigs to PRRSV (Meier et al., 2004) even though a correlation between IFN-
α levels and reduction of viremia was not found. Adenovirus expressing IFN-α was also used for 
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immunization of pigs and the levels of IFN-α concentration was correlated with delayed viremia 
and enhanced cell-mediated responses after PRRSV challenge (Brockmeier et al., 2009; 
Brockmeier et al., 2012). Such studies suggest that higher levels of type I IFNs can elicit protection 
from PRRSV infection. The route of administration and the duration of IFN production seem to 
be essential for the control of PRRSV. The SAP mutant PRRSV is IFN-suppression negative and 
thus elicits IFN induction, and in the SAP mutant PRRSV group, higher levels of type I IFNs are 
mounted (Figs. 2.1, 2.3). Thus, it is tempting to anticipate better protection when immunized pigs 
with the SAP mutant PRRSV.  
PRRSV can undergo persistence. During persistence, limited viral replication occurs 
without viremia only in the lymphoid tissues including tonsils and lymph nodes (Beyer et al., 2000; 
Rowland et al., 2003a). The mechanism of PRRSV persistence is unknown. In the present study, 
all pigs in FL13-WT and vL126A groups and 9 pigs out of 10 in the vL135A group are viral-
sequence positive in the tonsils. Sequencing data show that reverse mutations have occurred in the 
SAP motif of the majority of pigs except for a pig in vL135A group (Table. 2). The reversion has 
occurred as early as 7 dpi in the SAP mutant groups. Further studies of vL126A group unveil the 
nucleotide mutations from GCA (Ala) to GTA (Val) at 7 dpi in the serum and from GCA (Ala) to 
TTA (Leu) in the tonsils at the end of the study. Both Val and Leu are hydrophobic residues and 
thus Val mutation meets the consensus sequence for the SAP motif. This finding shows that the 
SAP motif is under strong selection pressure, and PRRSV cannot afford to lose the SAP function 
to reside in the tonsils. It is noteworthy that one pig (No. 18) in the vL135A group is viral sequence-
positive in the tonsils but no reversion occurs in the SAP locus (Table 2.2). In this particular case, 
other compensatory mutations may have occurred in the viral genome. Our results also show that 
the virus prefers to reside in the tonsils rather than other lymph nodes since the percentage of viral 
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sequence-positive in the submandibular lymph nodes are lower than that of the tonsils. The 
revertants regain the function by mutations for the IFN suppression and the host mRNA nuclear 
retention.  
In conclusion, our study demonstrates the role of the SAP motif of the nsp1β protein for 
virulence and pathogenesis in the natural host animals using the IFN suppression-negative and 
host mRNA nuclear retention-negative PRRSV. SAP mutations mediate the loss of IFN 
suppression function and render viral attenuation in pigs. The pigs infected with the SAP mutant 
PRRSV elicit higher levels of IFN-α in the circulation and develop stronger neutralizing antibody 
responses. We noticed that vL126A consistently performed better than vL135A, suggesting that 
there might be an unknown function associated with the mutated residues of SAP. In turn, the SAP 
revertants regain the function of IFN suppression as well as the host mRNA nuclear retention. Our 
study highlights the correlation between viral pathogenesis and type I IFN suppression and 
demonstrates proof that the modification of IFN antagonism can be an alternative approach to 











Fig. 2.1 (cont.). (A), The SAP motif conserved in the nsp1β protein of various arteriviruses and 
the mutation of SAP to generate L126A and L135A. Red boxes indicate crucial amino acids at 
positions 126 and 135. (B), Electrophoregram of the mutated sequence. Leucine (Leu) at position 
126 was mutated to alanine (Ala) by changing CTA to GCA, and Leu at 135 was mutated to Ala 
by changing CTC to GCC. SAP mutant viruses were generated by the reverse genetics using the 
FL13 PRRSV infectious clones. (C) and (D), RT-qPCR for mRNAs for IFN-β gene expression 
(C) and ISG15 gene expression (D). MARC-145 cells were mock-infected, or infected with FL13-
WT, vL126A, or vL135A at a multiplicity of infection (MOI) of 5 for 24 h, followed by poly(I:C) 
stimulation (black bars in panel C) or recombinant IFN-β treatment (black bars in panel D) for 12 
h. A total RNA was isolated, and RT-qPCR was performed to detect the transcripts for IFN-β or 
ISG15. Relative fold increases were compared to mock-infected or untreated groups, and mRNA 
levels were normalized using β-actin mRNA. NT, non-treated; PIC, poly(I:C)-treated. A statistical 
analysis was carried out by comparing the FL13-WT, vL126A, or vL135A groups with the mock-
infection group, respectively. Statistical significance (P-value) was calculated by two-tailed 







Fig. 2.2. Viral titers in the sera of pigs in the placebo, FL13-WT, vL125A, and vL135A 
groups. Standard plaque assays were conducted in duplicate using MARC-145 cells, and the viral 
titers was calculated as log10 PFU/ml of serum. Each dot represents an individual pig. Different 





Fig. 2.3. Serum IFN-α concentration in pigs in the placebo, FL13-WT, vL125A, and vL135A 
groups. Porcine IFN-α was determined by sandwich ELISA using anti-swine IFN-α antibody 
(clone F17) as the capture antibody and biotinylated anti-swine IFN-α antibody (clone K9) as the 
detecting antibody. Each assay was conducted in triplicate. Concentrations were determined using 










Fig. 2.4 (cont.). PRRSV-specific antibody responses in pigs in the placebo, FL13-WT, 
vL125A, and vL135A groups. (A), PRRSV-specific antibody was determined using the IDEXX 
PRRSV ELISA kit. S/P ratio=0.4 was set as the cutoff value (dotted line) for positive/negative. 
S/P ratios greater than 0.4 were considered positive. Each dot represents an individual pig, and 
different shapes of symbols in different colors represent pigs in different groups. (B), Plaque 
reduction neutralizing assay was performed in MARC-145 cells to determine neutralizing titers 
using 200 PFU of FL13-WT. Virus neutralizing titers were determined in triplicate as the 
reciprocal of the highest serum dilution that reduced 90% or greater PRRSV foci relative to serum 




















Fig. 2.5 (cont.). Regain of suppression for IFN production, JAK-STAT signaling, and host 
mRNA nuclear export by SAP revertants. (A) and (B), The nsp1β gene from revertants was 
cloned from tonsils of pigs and expressed in cells to determine the IFN-β and ISRE luciferase 
activities. The nsp1β gene from revertants were cotransfected with the IFN-β or ISRE luciferase 
reporter construct, along with the RL-TK Renilla plasmid in 1:1:0.1 ratios to HeLa cells for 24 h. 
The cells were either not- treated (NT; white bars) or stimulated with poly(I:C) (black bars in panel 
A), or stimulated with IFN-β (black bars in panel B) for another 16 h, and luciferase activities were 
measured using the Dual-luciferase assay system (Promega). Values for each sample were 
normalized using Renilla activity and the results were expressed as relative luciferase activities in 
fold changes. All assays were determined in triplicate. Statistical analyses were conducted by 
comparing to the pXJ41 empty vector group with stimulation. P values were calculated by 
Student’s two-tailed t-test. ***, P<0.0001. (C), In situ hybridization of poly(A)+ RNA in cells. 
The nsp1β gene from revertants were expressed in HeLa cells and poly(A)+ RNA (red) was 





Table 2.1. Health status evaluations of pigs. 
















101 0 0 0 7 
102 2 0 0 2 
103 0 2 0 5 
104 0 0 0 26 
105 4 14 1 18 
106 2 0 3 5 
107 1 0 0 3 
108 1 0 1 0 
109 0 0 0 0 
110 1 0 0 4 
Positivee 6/10 2/10 3/10 8/10 






111 3 1 0 14 
112 5 0 0 3 
113 3 0 3 3 
114 0 0 0 0 
115 7 0 0 12 
116 0 0 0 6 
117 4 0 3 12 
118 9 0 0 28 
119 5 7 0 15 
120 0 0 0 5 
Positivee 7/10 2/10 2/10 9/10 






121 0 2 0 4 
122 0 0 0 0 
123 0 0 0 1 
124 5 11 0 4 
125 6 13 0 5 
126 0 0 0 4 
127 0 0 0 15 
128 3 0 0 0 
129 0 0 0 6 
130 0 0 1 0 
Positivee 3/10 3/10 1/10 7/10 







131 0 0 0 0 
132 0 0 0 3 
133 6 2 6 21 
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134 6 4 1 8 
135 0 0 0 0 
136 10 5 3 3 
137f 5 0 0 5 
138 1 0 1 0 
139 2 2 1 4 
140 4 4 0 13 
Positivee 7/10 5/10 5/10 7/10 
Mean±SEM 3.4±3.37 1.7±2.00 1.2±1.93 5.7±6.73 
Table 2.1 (cont.). 
 
a: In this column, number of days that pigs showed rectal temperatures higher than 103.5F are 
counted.  
b: Respiratory difficulty for each pig. The criteria for scores: 0 = no difficulty, 1 = mild difficulty 
after handling, 2 = mild difficulty when resting, 3 = moderate difficulty after handling, 4 = 
moderate difficulty when resting, 5 = severe difficulty after handling, 6 = severe difficulty when 
resting. Accumulated scores represent the sum of scores that pig showed throughout the study. 
c: Number of days that pigs exhibited coughing. 
d: Conditions of feces (fecal staining and diarrhea) was observed daily and scored for each pig. 
The criteria for scores: 0 = no feces observed, 1 = normal feces, 2 = soft feces, 3 = runny feces 
with much particulate matter, 4 = liquid feces with some particulate matter, 5 = liquid feces with 
no particulate matter. Accumulated score represents the sum of scores that pig had throughout the 
study. 
e: ‘Positive’ represents the ratio of pigs that were observed positive symptoms in that group. 




Table 2.2. Reversion of the SAP motif of the PRRSV nsp1β sequence in tonsils and lymph 




















101 Neg n/a n/a Neg n/a n/a 
102 Neg n/a n/a Neg n/a n/a 
103 Neg n/a n/a Neg n/a n/a 
104 Neg n/a n/a Neg n/a n/a 
105 Neg n/a n/a Neg n/a n/a 
106 Neg n/a n/a Neg n/a n/a 
107 Neg n/a n/a Neg n/a n/a 
108 Neg n/a n/a Neg n/a n/a 
109 Neg n/a n/a Neg n/a n/a 





111 Pos A-V Yes Pos A-V Yes 
112 Pos AR135/136AL Yes Neg n/a n/a 
113 Pos A-V Yes Pos A-V Yes 
114 Pos A-V Yes Pos A-V Yes 
115 Pos A-V Yes Pos A-V Yes 
116 Neg n/a n/a Neg n/a n/a 
117 Pos A-V Yes Neg n/a n/a 
118 Pos No mutation No Pos ND ND 
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Table 2.2 (cont.). 
  
119 Pos A-V Yes Pos A-V Yes 





121 Pos A-V Yes Neg n/a n/a 
122 Pos A-V Yes Pos A-V Yes 
123 Pos A-V Yes Pos A-V Yes 
124 Pos A-L Yes Pos A-L Yes 
125 Pos A-L Yes Pos A-L Yes 
126 Pos A-V Yes Neg n/a n/a 
127 Pos A-V Yes Pos A-V Yes 
128 Pos A-L Yes Neg n/a n/a 
129 Pos A-V Yes Pos A-V Yes 

















134 Pos No mutation Yes Neg n/a n/a 




136 Pos No mutation Yes Neg n/a n/a 
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Table 2.2 (cont.). 
 
A-V, Alanine to Valine mutation; A-L, Alanine to Lysine mutation  
n/a, not applicable 
ND, not determined due to sequence fail or early euthanasia 
Neg, negative; Pos, positive 
  
 
137 Euthanized n/a n/a n/a n/a n/a 
138 Pos No mutation Yes Neg n/a n/a 










CHAPTER 3: PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS 
NSP1-BETA INTERACTION WITH THE NUCLEOPORIN 62 (NUP62) TO PROMOTE 
VIRAL REPLICATION AND IMMUNE EVASION 
 
3.1 ABSTRACT3 
Porcine reproductive and respiratory syndrome virus (PRRSV) blocks host mRNA nuclear 
export to the cytoplasm, and nonstructural protein (nsp) 1-beta of PRRSV has been identified as 
the protein disintegrating nuclear pore complex. In the present study, the molecular basis for 
inhibition of host mRNA nuclear export was investigated. Nucleoporin 62 (Nup62) was identified 
to specifically bind nsp1-beta, and the region representing the C-terminal 328-522 residues of 
Nup62 was determined as the binding domain to nsp1-beta. The nsp1-beta mutant L126A did not 
bind to Nup62, and in L126A-expressing cells, host mRNA nuclear export occurred normally and 
was not inhibited. The vL126A mutant PRRSV was generated by reverse genetics and this mutant 
virus replicated at a slower rate and the titer was lower than wild-type virus. In nsp1-beta 
overexpressing cells or siRNA-mediated Nup62 knock-down cells, viral protein synthesis was 
increased, and antiviral protein expression was decreased, resulting in the growth compensation of 
vL126A mutant to the level of wild-type. These findings are attributed to preferred viral protein 
synthesis in the cytoplasm to cellular protein translation including antiviral protein due to the NPC 
disintegration. Our study reveals a new strategy of PRRSV for immune evasion and enhanced 
replication during infection.  
                                                
This chapter has generated a manuscript: Ke, H., Han, M., Kim, J., and Yoo, D., 2019. Porcine 
reproductive and respiratory syndrome virus nsp1-beta protein interacts with nucleoporin 62 
(Nup62) to promote viral replication and immune evasion. This manuscript has been accepted in 




Porcine reproductive and respiratory syndrome virus (PRRSV) is an RNA virus belonging 
to the family Arteriviridae in the order Nidovirales (https://talk.ictvonline.org/taxonomy). The 
genome of PRRSV is single-stranded positive-sense RNA of approximately 15 Kb in length with 
the 5’-cap and 3’-polyadenylated tail, and is translated directly in the cytoplasm (Meulenberg et 
al., 1993b; Nelsen et al., 1999; Wootton et al., 2000). The PRRSV genome contains 10 open 
reading frames: ORF1a, ORF1b, ORF2a, ORF2b, ORFs 3 through 7, and ORF5a (Fang et al., 
2012b; Firth, 2011; Johnson et al., 2011). ORF1a and ORF1b generate two large polyproteins 
(pp1a and pp1ab), and remaining ORFs produce eight structural proteins; E, GP2, GP3, GP4, GP5, 
ORF5a, M, and N. Pp1a and pp1ab are further processed to 14 nonstructural proteins (nsps).  
While the structural proteins assemble the viral particles, the nsps facilitate virus survival 
and replication by modulating a wide range of cellular functions. One of such actions is to regulate 
host innate immune responses. An immunological hallmark of PRRSV infection is the poor 
induction of type I interferons (IFNs) (reviewed in Han and Yoo, 2014; Ke and Yoo, 2017; Sun et 
al., 2012a). So far, five PRRSV nsps (nsp1α, nsp1β, nsp2, nsp4, nsp11) and nucleocapsid (N) have 
been identified as IFN antagonists (reviewed in Ke and Yoo, 2017). Nsp1α and nsp1β are among 
the most potent IFN antagonists (Chen et al., 2010a; Chen et al., 2016; Han et al., 2013; Kim et 
al., 2010; Patel et al., 2010) and reviewed in (Han and Yoo, 2014; Ke and Yoo, 2017)). PRRSV 
nsp1α travels to the nucleus and triggers the degradation of CREB (cyclic AMP-responsive 
element binding)-binding protein (CBP), and this action eventually results in the subversion of 
IFN production (Chen et al., 2016; Han et al., 2013; Kim et al., 2010). PRRSV nsp1β is a 
multifunctional protein and plays roles in viral genome replication (Kroese et al., 2008), nsp2TF 
translational frame-shifting  (Fang et al., 2012b), and type I IFN suppression (Chen et al., 2010a; 
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Li et al., 2016; Li et al., 2013; Patel et al., 2010). We have previously shown that nsp1β blocks the 
nuclear export of host mRNAs to the cytoplasm, resulting in the shutdown of host protein 
translation and thus inhibition of host innate immunity (Han et al., 2017b). A SAP (SAF-A/B, 
Acinus, and PIAS) motif has been identified in the papain-like cysteine protease (PLP)-1β (PLP1β) 
domain of nsp1β  and this motif has been shown to be critical for nsp1β-mediated host mRNA 
nuclear retention (Han et al., 2017b). Mutations in the SAP domain (L126A and L135A) impaired 
the inhibition of host mRNA export, and the respective mutant viruses were clinically attenuated 
in pigs (Han et al., 2017b; Ke et al., 2018), suggesting the inhibition of nsp1β-mediated host 
mRNA nuclear export contributes to viral pathogenesis.  
The nucleocytoplasmic trafficking of proteins and RNAs is critical for many cellular 
functions including gene expression, cell cycle, stress response, and virus infection responses, and 
the nuclear pore complex (NPC) is the fine-tuned gateway for this process (reviewed in (Mattaj 
and Englmeier, 1998; Reichelt et al., 1990; Wente and Rout, 2010)). The NPC is a macromolecular 
proteinaceous structure that forms channels spanning the lipid bilayer of the nuclear envelope and 
is assembled with more than 30 different nucleoporin proteins (Nups) (reviewed in (Cronshaw et 
al., 2002; Rout et al., 2000; Wente and Rout, 2010)). Among those Nups, ~40% have unfolded 
domains which are rich in phenylalanine and glycine (FG) to serve as a docking site for transport 
receptors (Cronshaw et al., 2002; Rout et al., 2000; Yarbrough et al., 2014). Nup62 is one of the 
major nucleoporins located at the core of NPC and forms a complex with Nup45, Nup54, and 
Nup58 (Carmo-Fonseca et al., 1991; Guan et al., 1995; Hu et al., 1996). Nup62 is 522 amino acids 
in size consisting of two distinct functional domains. As with other Nups, the N-terminal domain 
of 1-327 is rich in FG repeats and functions as a docking site for nuclear transport factor 2 (NTF2) 
which plays a role for protein transport (Clarkson et al., 1996; Guan et al., 1995) and for nuclear 
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RNA export factor 1 (NXF1) which is important for RNA export (Lévesque et al., 2006), driving 
the translocation of receptor-cargo complexes through the NPC. The C-terminal domain of 328-
522 interacts with nuclear transport receptors for nucleocytoplasmic transport or with other Nups 
such as Nup45, Nup54, and Nup58 to facilitate the anchoring of Nup62 to NPC via its coiled-coil 
structure (Alber et al., 2007; Buss et al., 1994; Devos et al., 2006; Frey and Görlich, 2007; Melčák 
et al., 2007; Percipalle et al., 1997; Van Impe et al., 2008).  
The structural complexity of NPC and tightly controlled nucleocytoplasmic trafficking 
through NPC make this process a valuable target for viruses to facilitate their replication. 
Mediators including transport receptors and Nups within this process are cleaved, degraded, 
phosphorylated, and redistributed by different viruses (Kuss et al., 2013; Yarbrough et al., 2014). 
Vesicular stomatitis virus (VSV) matrix (M) protein interacts with Nup98 and RAE1 and blocks 
the nucleocytoplasmic transport (Enninga et al., 2002; Faria et al., 2005; Ferran and Lucas-Lenard, 
1997; Petersen et al., 2000; Quan et al., 2014; Von Kobbe et al., 2000), whereas influenza virus 
NS1 targets the mRNA export machinery through its  interaction with TAP/NXF1, p15/NXT, 
Rae1/Mrnp41, E1B-AP5, and Nup98, resulting in the formation of inhibitory complexes and 
degradation of Nup98 (Satterly et al., 2007). Member viruses in the order Picornavirales cleave 
Nup62, Nup98, Nup153 through their 2A and 3C proteases, and the Leader protein induces 
nucleoporin phosphorylation (Castelló et al., 2009; Ghildyal et al., 2009; Gustin and Sarnow, 2002; 
Park et al., 2008; Park et al., 2015; Park et al., 2010; Porter et al., 2010; Porter and Palmenberg, 
2009; Walker et al., 2013; Watters et al., 2017; Watters and Palmenberg, 2011). Herpes simplex 
virus ICP27 interacts with Nup62 and inhibits the nucleocytoplasmic transport pathway(Malik et 
al., 2012). The mechanisms for different viruses may vary, but the outcome is similar leading to 
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the suppression of host antiviral defense and the increase of viral replication which relies on the 
host translation machinery for viral mRNA translation and viral protein synthesis.  
For PRRSV, inhibition of host mRNA nuclear export and protein translation has been 
reported (Han et al., 2017b; Ke et al., 2018), and in the present study, we investigated the 
mechanism for this inhibition. Our results showed that this inhibition was resulted from the direct 
binding of nsp1β to Nup62. Leucine at position 126 of nsp1β was identified as the critical amino 
acid for the nsp1β-Nup62 interaction. The mutation of leucine at 126 to alanine using an infectious 
clone was possible to rescue an infectious PRRSV, and using L126A mutant PRRSV, we 
demonstrated that the Nup62-nsp1β binding enhanced PRRSV replication.  
 
3.3 MATERIALS AND METHODS 
3.3.1 Cells and viruses 
HeLa (NIH AIDS Research and Reference Reagent Program, Germantown, MD), MARC-
145, and Vero (ATCC CCL-81) cells were cultivated in Dulbecco’s modified Eagle’s medium 
(DMEM; Mediatech Inc., Manassas, VA), supplemented with 10% heat-inactivated fetal bovine 
serum (FBS; Gibco, Grand Island, NY), 3D4/21 (ATCC CRL-2843) cells were cultivated in 
RPMI-1640 Medium (Mediatech Inc., Manassas, VA) supplemented with 10% heat-inactivated 
fetal bovine serum (FBS; Gibco, Grand Island, NY), in a humidified incubator with 5% CO2 at 37 
ºC. 
PRRSV NVSL 97-7895 is a type 2 strain (North American genotype), and FL12 is the 
infectious clone of the NVSL 97-7895 strain. FL13 is a modified version of FL12 by adding the 
cytomegalovirus (CMV) promoter in front of the vial genome for transcription in mammalian cells. 
FL13-WT is the infectious virus reconstituted from the FL13 infectious clone and was propagated 
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in MARC-145 cells. vL126A is a mutant PRRS virus generated by substituting Leu at position 126 
of nsp1β with Ala of the FL13 infectious clone (Han et al., 2017a; Han et al., 2017b). Lelystad 
virus (LV) is a prototype virus of the European genotype and was propagated in MARC-145 cells. 
For infection, MARC-145 cells were grown to approximately 70% confluency and infected with 
PRRSV at a multiplicity of infection (moi) of 0.1-5 for different experiments. Viral titers were 
determined by plaque assays in MARC-145 cells using 6-well plates of 35 mm in diameter per 
well as described previously (Ke et al., 2018). The Colorado strain of PEDV (USA/Colorado/2013; 
Genbank accession no. KF272920) was obtained from the Agricultural Research Service, U.S. 
Department of Agriculture (Ames, IA). PEDV was propagated in Vero cells with FBS-free DMEM 
supplemented with 0.3% tryptose phosphate broth (Sigma, St. Louis, MO), 0.02% yeast extract 
(Teknova, Hollister, CA) and 5 µg/ml trypsin, and titrated according to the 50% tissue culture 
infective dose (TCID50) protocol on the same cells (Zhang et al., 2018). The PEDV titers were 
calculated by using the Spearman-Karber equation (Kärber, 1931; Spearman, 1908). For PEDV 
infection in MARC-145 cells, FBS-free DMEM supplemented with 0.3% tryptose phosphate broth 
(Sigma, St. Louis, MO), 0.02% yeast extract (Teknova, Hollister, CA) and 2 µg/ml trypsin were 
used (Zhang et al., 2016).  
 
3.3.2 Antibodies and chemicals 
Antibodies and chemicals used in the present study are listed as follow: Anti (α)-PRRSV-
nsp1β rabbit pAb specific for NA-PRRSV nsp1β was produced at the Immunological Research 
Center, University of Illinois at Urbana-Champaign (Urbana, IL). α-IRF3 PAb (rabbit) (FL-425, 
sc-90821), α-p65 PAb (rabbit) (H-286, sc-7151), α-STAT1 PAb (rabbit) (M-22, sc-592), α-STAT2 
PAb (rabbit) (C-20, sc-476), α-Aly MAb (mouse) (11G5, sc-32311), α-Nxf1 MAb (mouse) (D-9, 
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sc-365576), α-Nup62 MAb (mouse) (G-8, sc-16680) and α-β-actin MAb (mouse) (C4, sc-47778) 
were purchased from Santa Cruz biotechnologies Inc. (Santa Cruz, CA). α-FLAG PAb (rabbit) 
was purchased from Rockland Inc. (Gilbertsville, PA). α-FLAG mAb (rat) (M2) was purchased 
from Agilent (Santa Clara, CA). α-HA MAb (mouse), and Alexa-Flour 488-conjugated and Alexa-
Flour 568-conjugated secondary antibodies were purchased from ThermoFisher (Rockford, IL). 
α-HA MAb (rabbit) (C29F4), human Tumor Necrosis Factor-α (TNF-α) (8902) were purchased 
from Cell Signaling (Danvers, MA). The peroxidase-conjugated Affinipure goat anti-mouse IgG 
and peroxidase-conjugated Affinipure goat anti-rabbit IgG were purchased from Jackson Immuno 
Research (West Grove, PA). Isopropyl β-D-1-thiogalactopyranoside (IPTG), polyinosinic: 
polycytidylic [poly (I:C)] and DAPI (4’, 6’-diamidino-2-phenylindol) were purchased from Sigma 
(St. Louis, MO). Human recombinant IFN-β was purchased from Calbiochem (San Diego, CA).  
 
3.3.3 Genes and plasmids 
The HA-Nup62, HA-Nup62-N (1-327), HA-Nup62-C (328-522), pVP16-Nup62, pVP16-
Nup62-N (1-327), and pVP16-Nup62-C (328-522) genes were subcloned from the plasmid 
pAcGFPNup62WT, which was kindly provided by Dr. Kurt Gustin (University of Arizona) (Park 
et al., 2010), into the pXJ41 expression vector using the Hind III- and Xho I-recognition sequences 
and the pVP16 expressing vector (Clontech) downstream of the activation domain of the herpes 
simplex virus VP16 transactivator using the Sal I- and Hind III-recognition sequences. FLAG-
nsp1α, FLAG-nsp1β, and FLAG-N of PRRSV, LDV, and SHFV were cloned into pXJ41 
expressing vectors as described previously (Han et al., 2017b). FLAG-nsp1 of EAV and FLAG-
nsp1γ of SHFV were also cloned n to pXV41. The nsp1β gene and its mutant plasmids pM-K124A 
and pM-L126A were constructed by subcloning into pM expression vector (Clontech) downstream 
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of the yeast GAL4 DNA binding domain using the EcoR I- and Hind III-recognition sequences. 
The pGEX-4T3-nsp1β and its mutant plasmids pGEX-4T3-K124A and pGEX-4T3-L126A were 
constructed into the pGEX-4T3 (Amersham Pharmacia) expression vector using EcoR I- and Xho 
I-recognition sequences. The reporter constructs p5xGal4SV40-luc and p5xGal4tk-luc contain the 
luciferase gene and five copies of the GAL4 DNA binding sequence upstream of the simian virus 
40 (SV40) promoter or herpes simplex virus (HSV) thymidine kinase (tk) promoter, and they were 
described previously (Yoo et al., 2003). The pRL-TK Renilla luciferase reporter plasmid was 
purchased form Promega (Madison, WI). DNA transfection was performed using Lipofectamine 
2000 (Invitrogen, Carlsbad, CA) according to the manufacturer’s instructions. E. coli strain DH5α 
was used for transformation. 
 
3.3.4 Reverse transcription-quantitative PCR (RT-qPCR) 
For total RNA extraction, the RNeasy mini kit was used according to the manufacturer’s 
instructions (QIAGEN, Hilden, Germany). For the nuclear and cytoplasmic RNA fractionations, 
the SureprepTM cytoplasmic and nuclear RNA purification kit was used according to the 
manufacturer’s instructions (Fisher BioReagents, PA). RT-qPCR was performed in the ABI 
sequence detector system (ABI Prism 7000, Applied Biosystems, Life Technologies) in a final 
volume of 25 µl containing 3 µl of cDNA (diluted to ~100 ng/ µl) from RT reaction, 12.5 µl of 
SYBR Green Master mix (Applied Biosystems), 2.5 µl of primer pairs (1.25 µl each of sense and 
antisense primers [10 µM]), and 7 µl of water. Primers for swine (s)-β-actin, sIFN-α, sIFN-β, 
sIRF3, sPKR, sOAS, sMx1, sISG15, sIFIT1, and sIFIT2 were described elsewhere (Lee et al.) 
(Lee and Lee, 2012), primers for β-actin, GAPDH, DEPTOR, NOL6, SH2 genes were described 
elsewhere (Han et al., 2017b) and primers for IFN-α, and IFN-β genes were described previously 
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(Zhang et al., 2016). The mRNAs were quantified using the 2-ΔΔCT method (Livak and Schmittgen, 
2001) and normalized to that of GAPDH mRNA. Cytoplasmic and nuclear mRNAs were 
normalized to total GAPDH mRNA (cytoplasmic and nuclear fractions combined). Two 
independent experiments were conducted each in triplicate.  
 
3.3.5 Immunofluorescence analysis (IFA) 
HeLa or MARC-145 cells were grown on microscope coverslips and fixed with 4% 
paraformaldehyde in PBS for 1 h at room temperature (RT) followed by three washes with PBS. 
Cells were permeabilized with 0.1% Triton X-100 for 15 min at RT, followed by three washes. 
After incubation with 1% BSA in PBS for 1 h at RT, cells were incubated with a primary antibody 
(1:200) in the blocking buffer for 2 h, followed by three washes with PBS and incubation with a 
secondary antibody (1:200) for 1 h at RT. Cells were stained with DAPI (1:5000) for 5 min, and 
after final wash with PBS, the coverslips were mounted on microscope slides using the 
Fluoromount-G mounting medium (Southern Biotech, Birmingham, AL). Cells were examined 
using the Nikon A1R confocal microscope.  
 
3.3.6 Mammalian two-hybrid luciferase assay 
HeLa cells were grown in 12-well plates, and in each well of the plate, 0.5 µg of 
p5xGal4SV40-luc or p5xGal4tk-luc, 0.05 µg of pRL-TK, 0.5 µg of pM and 0.5 µg of pVP16 
plasmids were cotransfected. After 48 h post-transfection, cell lysates were prepared using the 
passive lysis buffer (Promega). Supernatants were collected and luciferase activities were 
determined in the Dual luciferase reporter assay system (Promega). Signals were obtained with the 
luminometer (Wallac 1420 VICTOR multi-label counter, Perkin Elmer, Waltham, MA). Values 
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for firefly luciferase reporter activities were normalized using the Renilla internal control, and 
results were expressed as relative luciferase activities. The assay was repeated two times, each 
assay in triplicate. 
 
3.3.7 GST pull-down assay 
pGEX-4T3-nsp1β and its mutants pGEX-4T3-K124A and pGEX-4T3-L126A were 
expressed in E. coli strain BL21(DE3) as described previously (Yoo et al., 2003). Briefly, Bacteria 
transformed with each plasmid were grown to an optical density of 0.6 at 600 nm and were 
stimulated with IPTG (1 mM) for 3 h. The bacteria were collected and resuspended in cold PBS 
and sonicated on ice three times for 30 s each time with 2 s intervals (Soniprep 150, Gallenkamp). 
The proteins were solubilized by 1% of triton X-100 and the supernatants were incubated with 
glutathione SepharoseTM 4B beads (GE Healthcare). The beads were collected and washed with 
PBS and final resuspend in binding buffer (20 mM Tris-HCl, 100 mM KCl, 2 mM CaCls, 2 mM 
MgCl2, 5 mM dithiothreitol, 0.5% NP-40, 1 mM PMSF, 5% glycerol). For GST pull-down assay, 
whole cell lysates were prepared and incubated with GST fusion proteins in binding buffer at 4 ºC 
overnight. The beads were washed three times with binding buffer and boiled at 95 ºC for 10 min 
in SDS-PAGE sample buffer. Supernatants were collected by centrifugation at a full-speed in a 
microcentrifuge at 4 ºC for 5 min and proteins were resolved by 10% SDS-PAGE. The gels were 
subjected to Western blot assays. 
 
3.3.8 Co-immunoprecipitation and Western blot 
Cell lysates were incubated with 2 µg α-FLAG mAb (rat) (M2) (Agilent, Santa Clara, CA) 
overnight at 4 ºC with gentle agitation. 30 µl of protein G agarose beads (EMD Millipore, 
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Temecula, CA) were added and the mix was further incubated for at least 2 h at 4 ºC. Beads were 
washed three times with lysis buffer, and precipitates were eluted in 30 µl of M-PER mammalian 
protein extraction reagent (Thermo, Rockford, IL) and 6X loading buffer by boiling at 95 ºC for 5 
min. The beads were spun down in a microcentrifuge at full-speed at 4 ºC for 5 min, and the 
supernatants were subjected to 10% SDS-PAGE. Resolved proteins were transferred to 
Immobilon-P PVDF membrane (Millipore), and the membranes were incubated with the TBST 
blocking buffer (10 mM Tris-HCl, 150 mM NaCl, 0.05% Tween-20 containing with 5% skim milk 
powder) for 1 h at RT followed by further incubation with primary antibody at 4 ºC overnight. The 
membranes were washed five times with TBST and incubated with peroxidase-conjugated 
secondary antibody in TBST blocking buffer for 1 h at RT. The membranes were washed five 
times, and proteins were visualized using the ECL detection system (Thermo, Rockford, IL). 
 
3.3.9 Oligo(dT) in situ hybridization (ISH) 
Oligo(dT) ISH was performed as described previously(Chakraborty et al., 2006). HeLa 
cells 24 h post-transfection were fixed with 4% paraformaldehyde, permeabilized with 0.5% Triton 
X-100, and incubated with primary antibodies for 2 h at RT. The primary antibodies were diluted 
in PBS containing 0.2% Triton X-100, 1 mM DTT, and 200 U/ml RNasin (Promega, Madison, 
WI). The cells were fixed again with 4% paraformaldehyde and washed with PBS. In situ 
hybridization was then performed at 42 ºC overnight using biotinylated oligo(dT) as a probe 
(Promega, Madison, WI) in a humidified chamber. The cells were washed twice with 0.5× SCC 
(ThermoFisher Scientific, Rockford, IL) at 42 ºC. Cells were further incubated with cy3-
streptavidin (Jackson Immuno Research, PA) and secondary antibody for 1 h at RT. Cells were 
finally stained with 4',6-diamidino-2-phenylindole (DAPI), and the cover slips were mounted on 
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glass slides using the Fluoromount-G mounting medium (Southern Biotech, Birmingham, AL). 
The cells were visualized and images were taken using the Nikon A1 confocal microscope. 
 
3.3.10 siRNA-mediated Nup62 knockdown in MARC-145 cells 
To knockdown the Nup62 gene in MARC-145 cells, a siGENOME Human Nup62 siRNA-
SMART Pool (M-012468-01-0005) was purchased from DharmaconTM (Lafayette, CO). This is a 
pooled siRNAs with 4 individual siRNAs that are all targeting Nup62. The sequences targeting 
Nup62 were as follows: siRNA D-012468-01, Nup62: 5’-GAACAGCGACUCUUGCUUC-3’; 
siRNA D-012468-03, Nup62: 5’-GCACUGGAGGGUUUAAUUU-3’; siRNA D-012468-04, 
Nup62: 5’-GGACACAGGGCUUCAGCUU-3’; siRNA D-012468-17, Nup62: 5’-
GAGCGCAGCUUCCGGAUCA-3’. A siGENOME Non-Targeting siRNA Pool (D-001206-13-
05) was also purchased and used as controls with no specific gene-targeting. Their sequences were 
as follows: 5’-UAGCGACUAAACACAUCAA-3’; 5’-UAAGGCUAUGAAGAGAUAC-3’; 5’-
AUGUAUUGGCCUGUAUUAG-3’; 5’-AUGAACGUGAAUUGCUCAA-3’. MARC-145 cells 
were grown to 50% confluency in 6-well plates, and 100 pmol per well of siRNA were transfected 
using lipofectamine 2000 according to the manufacturer’s instruction (Invitrogen, Carlsbad, CA). 
Cell lysates were collected at 24 h or 48 h post-transfection and analyzed by Western blot to 
determine the knockdown efficiencies.  
 
3.3.11 Statistical analysis 
Statistical significance was determined by two-tailed Student’s t-test with a value of 





3.4.1 Colocalization of PRRSV nsp1β with nucleoporin 62 (Nup62) 
The nucleocytoplasmic trafficking of RNA and protein is a highly complex and regulated 
(reviewed in (Köhler and Hurt, 2007; Kuss et al., 2013; Okamura et al., 2015; Yarbrough et al., 
2014)). To identify the target process by nsp1β, we chose to examine three representative 
pathways. Aly is the export adaptor involved in nuclear export of spliced and unspliced mRNA 
and transferring mRNA to NXF1-NXT1 heterodimer for export. NXF1 is the major mRNA 
receptor delivering mRNAs to NPCs, and Nup62 is the core protein of NPC and serves as docking 
sites for mRNA receptors including NXF11 (reviewed in (Köhler and Hurt, 2007; Kuss et al., 
2013; Okamura et al., 2015; Yarbrough et al., 2014)). We firstly examined ALY and NXF1 for 
their colocalization with nsp1β by IFA using anti-ALY and anti-NXF1 antibodies. No changes in 
distribution, degradation, or colocalization was observed for ALY and NXF1 in nsp1β-expressing 
cells (Figs. 3.1A & 3.1B). We then examined Nup62. In this experiment, we cloned the Nup62 
gene with an HA-tag at its N-terminus to facilitate the detection. Nup62 forms nuclear rim 
surrounding the nuclear envelop, and in pXJ41-, nsp1α-, and nucleocapsid (N) protein-expressing 
cells, Nup62 staining was evident (Fig. 3.1C). In nsp1β expressing cells, however, the integrity of 
the nuclear rim was disrupted, and its disintegration was striking. Nup62 was distributed as 
discontinuous punctuates along with the nuclear periphery (Fig. 3.1C). Further examination 
showed that nsp1β was co-localized with Nup62 (Fig. 3.1C, arrows), suggesting the interaction of 
nsp1β with Nup62. To examine this interaction in the context of viral infection, MARC-145 cells 
were infected with PRRSV and stained with anti-nsp1β and anti-Nup62 antibodies. In mock-
infected cell, Nup62 formed an integrated nuclear rim (Fig. 3.1D). In PRRSV-infected cells 
however, the nuclear rim was disintegrated and nsp1β colocalized with Nup62, similar to 
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observation in nsp1β gene-transfected cells (Fig. 3.1D). Our results showed that PRRSV nsp1β 
specifically colocalized with Nup62 and disrupted the integrity of Nup62-associated nuclear rim, 
suggesting that the interaction between Nup62 and nsp1β may be the mechanism for inhibition of 
nucleocytoplasmic trafficking inhibition.  
 
3.4.2 Direct binding of nsp1β to Nup62 
To determine if nsp1β binds to Nup62 as suggested by colocalization, we performed  a 
mammalian two-hybrid assay (Song et al., 2009a; Wootton and Yoo, 2003). Since PRRSV N 
protein forms homodimers (Wootton and Yoo, 2003) , it was included as a positive control. Cells 
were transfected with respective genes along with p5XGal4tk-luciferase as a reporter and pRL-TK 
Renilla plasmid as an internal control. Similar to co-expression of pM-N and pVP16-N with 
increased luciferase activity (Fig. 3.2A), co-expression of pM-nsp1β and pVP16-Nup62 also 
increased the luciferase activity, which was suggestive of the interaction between nsp1β and 
Nup62 (Fig. 3.2A). Similar observations were obtained when using p5XGal4SV40-luciferase as 
an alternative promoter (Fig. 3.2B), further confirming their interaction. To determine if nsp1β 
directly binds to Nup62, a GST-pull down assay was conducted. Nsp1β was expressed as the GST-
nsp1β fusion protein in E. coli (Fig. 3.2B), and the protein was immobilized to glutathione 
SepharoseTM 4B beads. The beads were incubated with the whole cell lysates and the bound 
proteins was subjected to Western-blot using anti-Nup62 antibody. GST-nsp1β pulled down 






3.4.3 Identification of nsp1β-binding region in Nup62 
Nup62 contains two domains which are functionally and structurally distinct from each 
other. To further characterize their interactions with nsp1β, the N-terminal 1-327 amino acids 
(Nup62-N) representing the FG rich region and Thr-rich linker and the C-terminal 328-522 amino 
acids (Nup62-C) representing coiled-coil domain were examined for their binding to nsp1β (Fig. 
3.3A). The Nup62-N and Nup62-C domains were first examined in the mammalian two-hybrid 
assay (Fig. 3.3B). When co-expressed with pM-nsp1β, pVP16-Nup62-C, but not pVP16-Nup62-
N increased the luciferase activity significantly (P=0.000813) (Fig. 3.3B). The signal was even 
higher than that of pM-nsp1β and pVP16-Nup62, indicating that the C-terminal domain of Nup62 
was sufficient for nsp1β binding. To further confirm this interaction, Nup62-N and Nup62-C were 
individually expressed as a fusion protein with an HA-tag at the N-terminus, and co-
immunoprecipitation was conducted using anti-FLAG MAb for immunoprecipitation and anti-HA 
MAb for Western-blot. Both HA-Nup62-N and HA-Nup62-C were properly expressed in HeLa 
cells (Fig. 3.3C), and as anticipated, the full-length HA-Nup62 and HA-Nup62-C were precipitated 
by nsp1β (Fig. 3.3C, top panel, lanes 3, 5). In contrast, HA-Nup62-N was not precipitated by nsp1β 
(Fig. 3.3C, top panel, lane 4). These data demonstrate that the C-terminal 328-522 amino acids of 
Nup62 was the domain sufficient for nsp1β binding.  
 
3.4.4 Correlation between nsp1β-Nup62 interaction and nsp1β-mediated host mRNA nuclear 
retention 
Previously, we identified a SAP domain in the nsp1β PLP1β region and leucine 126 (L126) 
within this domain was critical for the host mRNA nuclear retention (Han et al., 2017b). Thus, we 
examined if this residue was involved in the nsp1β binding to Nup62 using the L126A mutant. 
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Since K124 was nonessential for nsp1β function, K124A was made and included as an additional 
control (Fig. 3.4A). The cellular distribution of host mRNAs by K124A and L126A was first 
examined by in situ hybridization (ISH) using oligo (dT) as a probe (Fig. 3.4B). In pXJ41-empty 
vector transfected cells, mRNAs were distributed in the both nucleus and cytoplasm (Fig. 3.4B). 
Wild-type nsp1β and K124A nsp1β confined host mRNA in the nucleus, while L126A nsp1β 
failed, which was consistent with our previous finding to (Fig. 3.4B). Of note, the cellular 
distribution of L126A nsp1β were also changed in comparison with WT nsp1β and K124A. The 
Nup62 binding of these mutants were then investigated. By IFA, the nuclear rim was disintegrated 
by wild-type nsp1β and K124A nsp1β, and they also colocalized with Nup62 (Fig. 3.4C). L126A 
nsp1β, however, did not disrupt the nuclear rim nor colocalized with Nup62 (Fig. 3.4C, bottom 
panel) To confirm this, L126A was subjected to mammalian two-hybrid assay. Both pM-nsp1β 
and pM-K124A increased the reporter activity whereas pM-L126A did not (Fig. 3.4D), further 
demonstrating the loss of Nup62 binding with L126A nsp1β. The GST-pull down assay also 
confirmed the direct binding of GST-K124A and Nup62, whereas L126A nsp1β did not bind 
Nup62 (Figs. 3.4E & 3.4F). These data showed that leucine 126 of nsp1β was the critical residue 
for both host mRNA nuclear accumulation and Nup62 binding and that the interaction of nsp1β 
with Nup62 was the basis for nsp1β-triggered host mRNA nuclear retention. 
 
3.4.5 Biological consequences of nsp1β-Nup62 interaction 
Since PRRSV transcription occurs in the cytoplasm of the cell, inhibition of host mRNA 
nuclear export to the cytoplasm will help the virus to gain benefits by three folds; 1) exclusive 
utilization of translational machinery in the cytoplasm for viral mRNA translation, 2) suppression 
of host antiviral response, 3) enhanced viral growth. To examine this hypothesis, we conducted 
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three experiments in nsp1β-overexpressing cells to measure; 1) host antiviral mRNAs in the 
cytoplasm, 2) viral protein synthesis in the cytoplasm, 3) viral titers and growth curves. 3D4/21 
cells, which are immortalized porcine alveolar macrophages (Weingartl et al., 2002), were 
transfected with nsp1β gene for 24 h and stimulated with poly(I:C) for 12 h. Total cytoplasmic 
RNAs were isolated, and RT-qPCR was conducted to quantify the amounts of nine antiviral 
mRNAs. Two type I IFNs (sIFN-α and sIFN-β), one positive regulator (sIRF3), and six antiviral 
effectors (sPKR, sOAS, sMx1, sISG15, sIFIT1, sIFIT2) were chosen to determine as described 
(Schneider et al., 2014a). Poly(I:C) stimulation increased the amounts of the sIFN-α and sIFN-β 
mRNAs in pXJ41-transfected cells as expected, whereas the respective mRNAs were significantly 
reduced in nsp1β-expressing cells (Fig. 3.5A), indicating the inhibition of host mRNA nuclear 
export by nsp1β. The mutant L126A did not inhibit host mRNA nuclear export (Figs. 3.4B, 3.4C), 
and in consistent with that finding, the amounts of the sIFN-α and sIFN-β mRNAs increased in the 
cytoplasm by stimulation (Fig. 3.5A). For sIRF3, its mRNA in the cytoplasm of nsp1β-expressing 
cells was lower (Fig. 3.5A), and similarly, the mRNA levels for other antiviral effectors sPKR, 
sOAS, sMx1, sISG15, sIFIT1, and sIFIT2 were lower in the cytoplasm of nsp1β-expressing cells 
(Fig. 3.5A). Collectively, these results demonstrate that nsp1β reduced the amounts of antiviral 
mRNAs, suggesting the antiviral host response is suppressed by PRRSV. 
Next, we examined the viral proteins in the cytoplasm. MARC-145 cells were transfected 
with nsp1β gene for 24 h and infected with PRRSV for 48 h. Cell lysates were prepared and 
subjected to Western blot using anti-PRRSV antiserum. The amount of viral nucleocapsid (N) 
protein was more abundant in nsp1β-overexpressing cells than in pXJ41- or L126A-expressing 
cells (Fig. 3.5B). The absolute gray intensity of N was measured as 11395 in nsp1β-overexpressing 
cells and corrected to relative intensity to that of β-actin of 0.30. In pXJ41- and L126A- transfected 
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cells, however, the amounts of N were less with the absolute gray intensity of 9678 and 6968 and 
relative intensity of 0.23 and 0.24, respectively (Fig. 3.5B). This result demonstrates the enhanced 
viral protein translation in nsp1β expressing cells which is likely due to the enhanced translation 
of viral mRNA.  
The enhanced synthesis of viral proteins and suppression of antiviral proteins may result 
in an enhanced viral replication. Thus, to examine their biological consequences, we determined 
the virus titers and growth kinetics in nsp1β-overexpressing cells. MARC-145 cells were 
transfected with nsp1β gene for 24 h and infected with PRRSV for indicated times. For this 
infection study, we constructed an infectious L126A mutant PRRSV (vL126A) to use it as a 
control. The vL126A mutant was Nup62-interaction negative (Fig. 3.6A). Supernatants were 
harvested at indicated times and viral titers were determined by plaque assays (Fig. 3.6B-3.6E). 
The viral titer of wild-type PRRSV was detectable as early as 6 hpi in nsp1β-expressing cells (Fig. 
3.6B), and the peak titer was higher than in L126A-expressing cells or pXJ41-transfected cells 
(Fig. 3.6B). The vL126A mutant virus grew less efficiently by <1 log than wild-type in MARC-
145 cells. However, vL126A replication was rescued in nsp1β-expressing cells, and its titers 
increased by an average of 1 log throughout the infection periods up to 96 h (Fig. 3.6C), indicating 
the positive role of nsp1β for viral growth. The nsp1β overexpression also promoted Lelystad virus 
(LV) replication, a prototype of type I (European) genotype of PRRSV (Fig. 3.6D). Since the 
molecular function of nsp1β may be applicable to other cytoplasmic RNA viruses, we examined 
replication of other RNA virus in nsp1β-overexpressing cells. We chose porcine epidemic diarrhea 
virus (PEDV) as a coronavirus in the same order as PRRSV and because PEDV readily infects 
MARC-145 cells (Zhang et al., 2016). Interestingly, the PEDV growth was also enhanced in 
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nsp1β-expressing MARC-145 cells (Fig. 3.6E), indicating that the inhibition of nucleocytoplasmic 
trafficking by nsp1β broadly exerts benefits for other cytoplasmic RNA virus.  
The effects of nsp1β-Nup62 binding on PRRSV growth was also examined by gene 
silencing of Nup62 expression. Nup62-specfic siRNA (siNup62) treatment reduced Nup62 
expression down to 37% and 43% at 24 h and 48 h post-transfection, respectively, whereas control 
siRNA (siControl) did not affect Nup62 expression (Fig. 3.6F). In siControl-treated cells, vL126A 
grew poorly with a peak titer of 2.8 log PFU/ml (Fig. 3.6G). In siNup62-treated cells, however, 
the vL126A titer increased up to 4.0 log PFU/ml (Fig. 3.6G), indicating the rescue of vL126A 
growth by Nup62-knock-down. For wild-type PRRSV, the siNup62-treatment also increased the 
vial titer but only slightly at 48 hpi (Fig. 3.6G). These results confirm the dysfunction of Nup62 is 
beneficial for viral growth.  
 
3.4.6 Nup62-nsp1 interaction for other arteriviruses 
Two member viruses in the Arterivirus family, lactate dehydrogenase-elevating virus 
(LDV) of mice and simian hemorrhagic fever virus (SHFV) exhibited the host mRNA nuclear 
retention, while equine arteritis virus (EAV) did not possess this function (Han et al., 2017b). It 
was of interest to examine whether nsp1 of LDV and SHFV contained the similar binding to 
Nup62. IFA staining was performed in cells co-expressing HA-Nup62 and nsp1 of other 
arteriviruses (Fig. 3.7A). The nsp1β subunit of PRRSV, LDV, and SHFV colocalized with Nup62, 
and the nuclear rim structure was disrupted (Fig. 3.7A). However, none of PRRSV-nsp1α, LDV-
nsp1α, EAV-nsp1, SHFV-nsp1α, and SHFV-nsp1γ caused disintegration of the nuclear rim nor 
colocalized with Nup62. Note that EAV-nsp1 is uncleaved contrasting to other arterivirus nsp1 
which is cleaved to nsp1α and nsp1β. The binding of these proteins to Nup62 was further 
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confirmed by co-IP assays. Among arterivirus nsp1 subunits, only PRRSV-, LDV-, and SHFV-
nsp1β coprecipitated HA-Nup62 (Fig. 3.7B). Our data demonstrate a correlation between the 
Nup62-binding of nsp1β and host mRNA nuclear retention, further showing the interaction of 
Nup62 as a general strategy adopted by arteriviruses. 
 
3.5 DISCUSSION 
Nucleocytoplasmic trafficking is an important process for cells to respond properly against 
viral infection, and viruses have evolved to modulate this process for their own benefits. Like many 
other positive-sense RNA viruses, PRRSV replication occurs in the cytoplasm and the viral 
genome is translated in the cytoplasm to initiate infection (Meulenberg et al., 1993b; Nelsen et al., 
1999; Wootton et al., 2000). PRRSV has been found to block the host mRNA nuclear export, and 
its nsp1β protein has been identified as the responsible viral factor (Han et al., 2017b). In the 
present study, we have uncovered the underlying mechanism for PRRSV nsp1β-mediated host 
mRNA nuclear retention. Nsp1β functions the most effective on inducible genes, intermediate on 
regular genes, and neglectable on housekeeping genes (Fig. 3.8). In nsp1β-expressing HeLa cells, 
the IFN-α and IFN-β genes have the highest nuclear/cytoplasmic ratios after stimulation, 
suggesting that the majority of inducible genes are imprisoned in the nucleus, while other genes 
including DEPTOR, NOL6, SH2 and β-actin have lower nuclear/cytoplasmic ratios. This finding 
implicates an important biological meaning during viral infection. By blocking mRNA nuclear 
export, host innate immune genes will not be translated, and so viruses may replicate better. 
Indeed, the host mRNA nuclear accumulation correlates with nsp1β-mediated type I IFN inhibition 
(Han et al., 2017b). It is also noteworthy that the host mRNA export process is not completely 
blocked by nsp1β, and some of the functions may still be retained. Similar observations have been 
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made in poliovirus-infected cells whose Nup62 is cleaved and degradated (Gustin and Sarnow, 
2001) and in Saccharomyces cerevisiae and Xenopous laevis whose NPC FG repeats are removed 
but the Nup62 function still retained at certain levels (Strawn et al., 2004; Walther et al., 2002; 
Zeitler and Weis, 2004). We have also noticed that the total mRNAs for IFN-α and IFN-β are 
decreased by nsp1β when stimulated with poly (I:C) (Fig. 3.8). This is probably due to the fact 
that nsp1β impairs the IFN production by inhibiting the IRF3 activation and nuclear translocation 
(Fig. 3.9 and (Beura et al., 2010)). This observation leads us to investigate whether nsp1β can 
block the nuclear translocation of transcription factors involved in different signaling pathways. 
Indeed, nsp1β blocks the IRF3, p65, STAT1, STAT2 nuclear translocation for the interferon 
production, NF-kB signaling, and interferon signaling pathways, respectively (Figs. 3.9), 
suggesting that nsp1β plays a universal mechanism blocking nucleocytoplasmic trafficking. 
NPCs are the gateways for nucleocytoplasmic trafficking of cellular molecules, and in turn 
are likely the target of PRRSV. We find no interactions of PRRSV nsp1β with Aly and Nxf1 which 
both are important mediators for mRNA export (reviewed in (Köhler and Hurt, 2007; Kuss et al., 
2013; Okamura et al., 2015; Yarbrough et al., 2014)). Instead, we have found the disintegration of 
nuclear rims in PRRSV-infected cells and nsp1β gene-transfected cells, indicating the disruption 
of NPCs. NPC is the massive proteinaceous structure consisting of approximately 30 different 
Nups (reviewed in (Cronshaw et al., 2002; Rout et al., 2000; Wente and Rout, 2010)), making it 
vulnerable that a damage on any of its components may lead to disruption of the NPC structure. 
We have investigated Nup98, Nup153, and Nup62 for nsp1β binding. The nuclear rim is 
consistently disrupted by nsp1β, and Nup62 is the only Nup colocalized with nsp1β (Fig. 3.1; 
Nup98 and Nup153 staining results are not shown), suggesting the specific interaction between 
nsp1β and Nup62. The interaction has been confirmed by mammalian two-hybrid luciferase assay, 
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GST-pull down assay, and co-IP (Figs. 3.2 & 3.3). Further studies show that the C-terminal 328-
522 residues of Nup62 is the binding domain to nsp1β (Fig. 3.3). Because this region functions to 
anchor to NPC through its coiled-coil structure (Alber et al., 2007; Buss et al., 1994; Devos et al., 
2006; Frey and Görlich, 2007; Melčák et al., 2007; Percipalle et al., 1997; Van Impe et al., 2008), 
it is possible that the nsp1β binding to Nup62 disrupts the NPC structure (Fig. 3.1). Even though 
nsp1β contains the PLP1β domain, we find no cleavage or degradation of Nup62 by nsp1β in 
nsp1β-transfected cells and PRRSV-infected cells (data not shown). A highly conserved domain 
has previously been identified within the PLP1β region (Han et al., 2017b; Li et al., 2016) and 
leucine 126 is one of the most critical residues that support the nsp1β function (Fig. 3.4B and (Han 
et al., 2017b)). Further investigation unveils that L126A mutation is unable to induce mRNA 
nuclear retention and also abolishes the nsp1β-binding to Nup62, demonstrating the correlation 
between mRNA nuclear retention and nsp1β-Nup62 binding. Leucine is a hydrophobic amino acid 
and L126 of nsp1β is the residue supporting the tertiary structure of nsp1β (Xue et al., 2010). Thus, 
it is not surprising that a mutation at L126 changes the Nup62 binding. A similar observation has 
been made for VSV M protein whose methionine at 51 is highly conserved and contributes to M-
Nup98-Rae1 complex formation (Quan et al., 2014). The nsp1β subunit of other arteriviruses LDV 
and SHFV also contains the similar function of mRNA nuclear retention (Han et al., 2017b) and 
their binding to Nup62 (Fig. 3.7). It is noteworthy that nsp1β of PRRSV, LDV, SHFV, and FMDV 
Lpro share a high similarity in the PCPβ domain (Xue et al., 2010), which may explain their binding 
to Nup62. Interestingly, a SAP motif in PRRSV nsp1β is also found in FMDV Lpro (de los Santos 
et al., 2009b), implying that FMDV Lpro may contain a similar function to block the host 
nucleocytoplasmic trafficking. The binding of LDV nsp1β and SHFV nsp1β to Nup62 further 
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demonstrates a common mechanism for host mRNA nuclear retention mediated by different 
arteriviruses with an exception of EAV. 
The biological consequence of the nsp1β-Nup62 interaction has also been investigated and 
appears to be significant. By the reverse genetics, L126A mutation has been introduced to the 
PRRSV FL13 infectious clone, and an infectious PRRSV mutant (vL126A) has been rescued (Han 
et al., 2017b). The L126A mutation abolishes the nsp1β-Nup62 binding, nsp1β-mediated mRNA 
nuclear retention, and nsp1β-mediated type I IFN suppression. The vL126A mutant virus is 
attenuated in its growth in MARC-145 cells, and its clinical signs in pigs is also attenuated (Han 
et al., 2017b; Ke et al., 2018). The growth attenuation of vL126A can be rescued in cells 
overexpressing nsp1β (Fig. 3.6C), demonstrating the blocking of the nucleocytoplasmic trafficking 
by nsp1β is beneficial for PRRSV growth. This mechanism exerts the benefit to both North 
American genotype PRRSV, European genotype PRRSV, and another cytoplasmic RNA virus 
PEDV coronavirus (Figs. 3.6B, 3.6D, and 3.6E). Nup62 gene silencing using siRNAs also confers 
the rescue of vL126A growth by 1 log (Figs. 3.6F & 3.6G), further demonstrating the inhibition 
of the nucleocytoplasmic trafficking is beneficial for virus replication. Our data also showed that 
the host antiviral mRNAs are fewer in the cytoplasm and the viral protein synthesis is enhanced in 
nsp1β-overexpressing cells (Fig. 3.5). This is due to the inhibition of nucleocytoplasmic 
trafficking. The enhanced viral protein synthesis may be attributed to exclusive utilization of the 
translation machinery available in the cytoplasm, and the reduced amounts of antiviral mRNAs in 
the cytoplasm are probably due to the inhibition of host mRNA nuclear transport (Fig. 3.10). In 
summary, our study has identified the interaction of PRRSV nsp1β with Nup62 as the basis for 
nsp1β-mediated host mRNA nuclear retention. The host mRNA nuclear retention is beneficial for 
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virus growth. L126 in the SAP domain of nsp1β plays a critical role for Nup62 interaction, and the 






Fig. 3.1. Colocalization of PRRSV nsp1β and Nup62. (A) and (B), HeLa cells were transfected 
with FLAG-nsp1β plasmid and stained with anti-FLAG (F) PAb (rabbit) (red) and anti-Aly MAb 
(green) (A) or anti-NXF1 MAb (green) (B). (C), HeLa cells were cotransfected with HA-Nup62 
gene together with the pXJ41, F-nsp1α, F-nsp1β, or F-N plasmid and were stained with anti-FLAG 
MAb (green) and anti-HA MAb (red). Arrows indicate colocalization of F-nsp1β and HA-Nup62. 
(D), MARC-145 cells were infected with PRRSV strain FL13 and stained with anti-PRRSV-nsp1β 
PAb (red) and α-Nup62 MAb (green). Nuclei were stained with DAPI (blue). Arrows indicate 






Fig. 3.2. Direct interaction of PRRSV nsp1β and Nup62. (A) and (B), Mammalian two-hybrid 
luciferase reporter assay using pM-nsp1β and pVP16-Nup62. HeLa cells were cotransfected with 
(A) p5XGal4tk-Luciferase plasmid or (B) p5XGal4SV40-luciferase plasmid together with pRL-
TK, pM-nsp1β, and pVP16-Nup62 at 1:0.1:1:1 ratios for 48 h. Cell lysates were prepared in 
passive lysis buffer (Promega) and relative luciferase activities were obtained by normalizing the 
firefly luciferase to Renilla luciferase activities. Error bars, mean ± standard deviation (s.d.). (n=3). 
***, P<0.001. (C), Expression of GST-nsp1β fusion protein in E. coli BL21(DE3). Cells were 
transformed with pGEX-4T3 or pGEX-4T3-nsp1β and were grown to optical density (OD 600nm) 
0.6, followed by induction with 1 mM IPTG for 3 h in 37 ºC. Cell lysates were prepared and 
resolved by SDS-10% PAGE, followed by staining with Coomassie Blue R250. Arrows indicate 
GST and GST-nsp1β. (D), GST-pull down assay for Nup62 using GST-nsp1β. The GST or GST-
nsp1β protein was immobilized to glutathione SepharoseTM 4B beads and incubated with whole 





Fig. 3.3. Nup62 C-terminal coiled-coil domain is sufficient for interaction with PRRSV 
nsp1β. (A), Schematic representation of N-terminal and C-terminal regions of Nup62. Numbers 
indicate amino acid positions. (B), Mammalian two-hybrid luciferase assay using pM-nsp1β along 
with pVP16-Nup62, pVP16-Nup62-N, or pVP16-Nup62-C. HeLa cells were cotransfected with 
p5XGal4SV40-luciferase and pRL-TK along with indicated plasmids at 1:0.1:1:1 ratios for 48 h. 
Cell lysates were prepared in the passive lysis buffer (Promega) and relative luciferase activities 
were obtained by normalizing the firefly luciferase to Renilla luciferase activities. Error bars, mean 
± standard deviation (s.d.). (n=3). ***, P<0.001. (C), Coimmunoprecipitation of F-nsp1β with HA-
Nup62, HA-Nup62-N, or HA-Nup62-C. HeLa cells were transfected with 2 µg of indicated 
plasmids and incubated for 30 h. Cell lysates were precipitated with anti-FLAG MAb followed by 
Western blot using anti-HA MAb (top panel). Whole cell lysates (WCL) were probed with anti-











Fig. 3.4 (cont.). PRRSV nsp1β-mediated host mRNA nuclear retention is determined by 
Nup62 binding. (A), Schematic representation of nsp1β mutations. PLP1β: papain-like proteinase 
domain1β. (B), Oligo(dT) in situ hybridization (ISH) of cells expressing nsp1β or its mutants. 
HeLa cells were transfected with indicated plasmids and were subjected to ISH as described in 
Materials and Methods. Nuclei were stained with DAPI. Arrows indicate nsp1β-expressing cell. 
(C), Cellular redistributions of HA-Nup62 by nsp1β and its mutants. HeLa cells were cotransfected 
with HA-Nup62 and nsp1β or its mutants and were stained with α-FLAG MAb (green) and α-HA 
MAb (red). Nuclei were stained with DAPI. Arrows indicate colocalization of nsp1β and Nup62. 
Images were taken by confocal microscopy (Nikon A1R). (D), Mammalian two-hybrid luciferase 
assay for pVP16-Nup62 and pM-nsp1β or its mutants. HeLa cells were cotransfected with 
p5XGal4SV40-luciferase plasmid, pRL-TK, and indicated plasmids at 1:0.1:1:1 ratios for 48 h. 
Cell lysates were prepared in passive lysis buffer and relative luciferase activities were obtained 
by normalizing the firefly luciferase to Renilla luciferase activities. Error bars, mean ± standard 
deviation (s.d.). (n=3). ***, P<0.001. (E), Expression of GST-nsp1β and its mutant proteins in E. 
coli BL21(DE3). Bacteria were transformed with the pGEX-4T3, pGEX-nsp1β, pGEX-K124A, or 
pGEX-L126A plasmid and were grown to optical density (600nm) 0.6 followed by induction with 
1 mM IPTG for 3 h in 37 ºC. Cell lysates were prepared and resolved in SDS-10% PAGE and 
stained with Coomassie Blue R250. Dots indicate the GST, GST-nsp1β, or mutants. (F), GST pull-
down assay for Nup62. GST, GST-nsp1β or its mutant proteins were coupled with glutathione 
SepharoseTM 4B beads and incubated with HeLa cell lysates. The precipitates were subjected to 













Fig. 3.5 (cont.). Reduction of antiviral mRNA and enhanced production of viral nucleocapsid 
protein in the cytoplasm of nsp1β-expressing cells. (A), 3D4/21 cells were transfected with 2 
µg of pXJ41, nsp1β or nsp1β-L126A plasmid for 24 h and stimulated with poly (I:C) (PIC) by 
transfection. Cytoplasmic RNAs were isolated for RT-qPCR analysis. Relative amounts of RNA 
were calculated using the 2-ΔΔCT method and by normalizing the values to that of β-actin as 
described in Materials and Methods. Fold changes were compared to the amounts of pXJ41-
transfected cells. Error bars, mean ± standard deviation (s.d.). (n=3). *: P<0.05, **: P<0.01. (B), 
MARC-145 cells were transfected with 2 µg of pXJ41, nsp1β or nsp1β-L126A plasmid for 24 h 
and infected with wild-type PRRSV FL13 at 5 moi for 48 h. Cell lysates were prepared and 
subjected to Western blot analysis. The membrane was reacted with FL13-infected swine serum. 
β-actin serves as the loading control. The lysates were also probed with α-FLAG PAb (rabbit) to 








Fig. 3.6 (cont.). Enhanced replication of PRRSV in nsp1β-expressing cells. (A), MARC-145 
cells were infected with PRRSV FL13 or vL126A, and cells were stained with anti-PRRSV-nsp1β 
PAb (rabbit) (red) and anti-Nup62 (mouse) MAb (green). Nuclei were stained with DAPI (blue). 
Arrows indicate colocalization. Images were taken by confocal microscopy (Nikon A1R). (B)-(E), 
MARC-145 cells were transfected with the nsp1β or nsp1β-L126A plasmid for 24 h and infected 
with wild-type PRRSV FL13 at 0.1 moi (B), PRRSV vL126A mutant at 0.1 moi (C), PRRSV 
Lelystad (LV) at 0.1 moi (D), or porcine epidemic diarrhea virus (PEDV) Colorado strain at 0.01 
moi (E). Supernatants were harvested at 0, 6, 12, 24, 48, 72, 96 hpi for PRRSV (B-D) or at 0, 6, 
12, 24, 36, 48, 60, 72 hpi for PEDV (E). The viral titers were determined by plaque assay for 
PRRSV (B-D) or TCID50 for PEDV (E) as described in Materials and Methods. The viral titers 
were expressed as Log10 PFU/ml in (B-D) and Log10 TCID50/ml in e. The error bars represent 
mean ± s.d. (n=2). At each time point, mean titers indicated with different lowercase letters (a, b) 
indicate statistical significance (P<0.05). (F), siRNA-mediated gene silencing of Nup62. MARC-
145 cells were transfected with siControl or siNup62, and relative amounts of protein were 
determined at 24 h or 48 h posttransfection. β-actin serves as a loading control. Intensities of Nup62 
were quantified with the FluroChem R system, normalized to that of β-actin, and compared to the 
nontreated (NT) control (Lane 1). Percentages below the top panel indicate relative changes. (G), 
MARC-145 cells were treated with siRNA for 48 h and infected with wild-type PRRSV FL13 
(FL13-WT) at 0.1 moi or PRRSV vL126A mutant at 0.1 moi. Supernatants were harvested at 0, 6, 
12, 24, 48, 72, 96 hpi, and viral titers were determined by plaque assay as described in Materials 
and Methods. The viral titers were expressed as Log10 PFU/ml. The error bars represent mean ± 
s.d. (n=2). At each time point, mean titers indicated by lower-case letters (a, b, or c) showed 










Fig. 3.7 (cont.). Nup62 binding by nsp1 subunits of different arteriviruses and nuclear rim 
disintegration. (A), HeLa cells were cotransfected with HA-Nup62 gene together with indicated 
plasmids for 24 h and stained with anti-FLAG MAb (green) and anti-HA MAb (red). Images were 
taken by confocal microscopy (Nikon A1R). (B), Co-IP of Nup62 using F-nsp1 subunits from 
different arteriviruses.   HeLa cells were co-transfected with HA-Nup62 together with indicated 
plasmids, and cells lysates were precipitated with anti-FLAG MAb followed by Western blot using 
anti-HA MAb. The whole cell lysates (WCL) were probed to indicate the expression of each 







Fig. 3.8. PRRSV nsp1β-mediated host mRNA nuclear accumulation by RT-qPCR. (A), RT-
qPCR for various cellular genes in nsp1β-expressing cells. HeLa cells were transfected with 2 µg 
of nsp1β gene and stimulated with poly(I:C) (PIC) (0.5 µg/ml). Total cellular RNA was isolated 
for qPCR analysis, and relative amounts of RNA were calculated using the 2-ΔΔCT method by 
normalizing the values to that of total GAPDH as described in Materials and Methods. Fold 
changes were compared to the amounts of pXJ41-transfected cells. Error bars, mean ± standard 
deviation (s.d.). (n=3). *: P<0.05. (B), mRNA ratios between nuclear and cytoplasmic fractions. 
HeLa cells were transfected with 2 µg of nsp1β gene and stimulated with poly(I:C) (PIC) (0.5 
µg/ml). Nuclear and cytoplasmic RNA were isolated separately and relative amounts of respective 
mRNA were calculated using the 2-ΔΔCT method by normalizing the values to that of total GAPDH. 
The ratios were calculated by comparing the nuclear mRNA to cytoplasmic mRNA for each gene. 











Fig. 3.9 (cont.). PRRSV nsp1β-mediated transcription factors nuclear import inhibition. 
HeLa cells were transfected with pXJ41, F-nsp1α, F-nsp1β, or F- nsp1β-L126A plasmids and 
stimulated with poly (I:C) (0.5 µg/ml) (A), TNF-α (20 ng/ml) (B), or IFN-β (1000 U/ml) (C) and 
(D). Cells were stained with anti-FLAG MAb (mouse) (green) and α-IRF3 (A), p65 (B), STAT1 
(C), or STAT2 (D) PAb (rabbit) (red). Nuclei were stained with DAPI (blue). Images were taken 







Fig. 3.10. Proposed mechanism of PRRSV nsp1β-mediated virus replication enhancement. 
PRRSV replicates and completes its life cycle in the cytoplasm. However, the host cell will initiate 
antiviral mechanisms by activating transcription factors (TFs). The activated TFs then translocate 
to the nucleus to induce the production of antiviral genes. Then the antiviral mRNAs travel out of 
the nucleus to the cytoplasm and translated into antiviral effectors. The PRRSV nsp1β specifically 
interact with Nup62 lead to the shutting down of nucleocytoplasmic trafficking and this action 
exerts two benefits for the virus: 1. the host cell translation machinery will be exclusively utilized 
for viral mRNA translation and thus maximize progeny production, 2. the host cell antiviral 
effectors will be reduced due to the mRNA nuclear export inhibition. Together, the virus 




CHAPTER 4: INTERACTION OF PIAS1 WITH PORCINE REPRODUCTIVE AND 
RESPIRATORY SYNDROME VIRUS NUCLEOCAPSID PROTEIN MEDIATES NF-KB 
ACTIVATION AND TRIGGERS PROINFLAMMATORY MEDIATORS 
 
4.1 ABSTRACT4 
Porcine reproductive and respiratory syndrome virus (PRRSV) activates NF-κB during 
infection. We examined the ability of all 22 PRRSV genes for NF-κB regulation and determined 
the nucleocapsid (N) protein as the NF-κB activator. Protein inhibitor of activated STAT1 (signal 
transducer and activator of transcription 1) (PIAS1) was identified as a cellular protein binding to 
N. PIAS1 is known to bind to p65 (RelA) in the nucleus and blocks its DNA binding, thus functions 
as a repressor of NF-κB. Binding of N to PIAS1 released p65 for NF-κB activation. The N-terminal 
half of PIAS1 was mapped as the N binding domain, and this region overlapped its p65-binding 
domain. For N, the region between 37 and 72 aa was identified as the binding domain to PIAS1, 
and this domain alone was able to activate NF-κB. A nuclear localization signal (NLS) knock-out 
mutant N did not activate NF-κB, and this is likely due to the lack of its interaction with PIAS1 in 
the nucleus, demonstrating the positive correlation between the binding of N to PIAS1 and the NF-
κB activation. Our study reveals a role of N in the nucleus for NF-κB activation and 
proinflammatory cytokine production during infection. 
 
 
                                                
This chapter has generated a manuscript: Ke, H., Lee, S., Kim, J., Liu, HC., and Yoo, D., 2019. 
Interaction of PIAS1 with PRRSV nucleocapsid protein mediates NF-κB activation and triggers 
proinflammatory mediators during PRRSV infection. This manuscript has been submitted to 




Many viruses utilize NF-κB signaling pathway for their own benefit (Hiscott et al., 2001; 
Rahman and McFadden, 2011; Santoro et al., 2003). Porcine reproductive and respiratory 
syndrome virus (PRRSV) is a single-stranded positive-sense RNA virus that infects domestic and 
wild pigs and causes PRRS which is one of the most economically important diseases in the swine 
industry worldwide (Albina, 1997; Lunney et al., 2016b). The disease is characterized by severe 
respiratory stress in nursing pigs and reproductive failure in sows and gilts (Albina, 1997). PRRSV 
primarily infects pulmonary alveolar macrophages (PAMs) and dendritic cells (DCs) in the tonsils, 
upper respiratory tract, and lungs (Duan et al., 1997; Loving et al., 2007). PRRSV infection of pigs 
induces inflammation in the lungs, which is characterized by the increase of proinflammatory 
cytokines including IL-1β, IL-6, IL-8, and TNF-α and by the recruitment of monocytes and 
neutrophils to affected sites (Liu et al., 2010; Miguel et al., 2010; Van Reeth et al., 1999; Van 
Reeth and Nauwynck, 2000). The recruitment of fresh neutrophils and monocytes to affected sites 
provides more target cells for PRRSV to replicate and contributes to pathogenesis (Liu et al., 2015; 
Van Reeth et al., 1999). Since proinflammatory cytokines are elevated (Bi et al., 2014; Lee and 
Lee, 2012; Pineyro et al., 2016; Xiao et al., 2015), and NF-κB signaling is activated in PRRSV-
infected cells (Fu et al., 2012b; Lee and Kleiboeker, 2005; Song et al., 2013a; Yu et al., 2016; 
Zhang et al., 2013), it seems evident that PRRSV activates NF-κB and causes the NF-κB-mediated 
production of proinflammatory cytokines, which is correlated with PRRSV pathogenesis. Despite 
the potential role of NF-κB for viral pathogenesis, the underlying mechanism for NF-κB activation 
by PRRSV remains unknown.  
NF-κB is a family of transcription factors consisting of RelA (p65), RelB, NF-κB1 (p50 
and its precursor p105), NF-κB2 (p52 and its precursor p100), and c-Rel for homo/heterodimers 
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with RelA or RelB (Chen and Greene, 2004). NF-κB can be activated by proinflammatory 
cytokines such as tumor necrosis factor-α (TNF-α) and interleukin-1 (IL-1). Upon stimulation, NF-
κB becomes phosphorylated and translocated to the nucleus where it binds to κB sites, which are 
the specific DNA loci for NF-κB. NF-κB regulates the expression of a variety of proinflammatory 
cytokine genes including IL-1β, IL-6, IL-8, and TNF-α (Dinarello, 2000) and anti-inflammatory 
cytokines such as IL-10 (Saraiva and O'Garra, 2010a). The proinflammatory cytokines will further 
activate NF-κB signaling in the autocrine manner (Kagoya et al., 2014). Dysregulation of NF-κB 
may result in disease, and thus maintaining the homeostasis of NF-κB is crucial for the health of a 
host (Chen and Greene, 2004; Karin and Ben-Neriah, 2000; Lawrence et al., 2005). To maintain 
NF-κB homeostasis from over activation, negative feedback mechanisms are available. IκB is a 
negative regulator of NF-κB in the cytoplasm. By ubiquitination and degradation of IκB, NF-κB 
is released and activated for NF-κB-regulated gene expression. In the nucleus, PIAS1 [protein 
inhibitor of activated STAT (signal transducer and activator of transcription)] functions as a 
negative regulator of NF-κB. By specifically binding to p65 in the nucleus, PIAS1 prevents the 
NF-κB dimer from docking to κB sites on DNA (Liu et al., 2005) such that NF-κB-mediated gene 
expression is tightly controlled. 
PIAS1 is one of four members of the PIAS family including PIASx (also known as PIAS2), 
PIAS3, and PIASy (also known as PIAS4) (Shuai, 2000; Shuai and Liu, 2003). Except PIAS1, 
which is the sole form, three other PIAS isoforms are expressed via mRNA splicing. The PIAS 
genes are expressed ubiquitously in mammals, and their homologs are also found in Drosophila 
as dPIAS/Zimp (Betz et al., 2001; Mohr and Boswell, 1999) and in yeast as SIZ1 and SIZ2 
(Johnson and Gupta, 2001), suggesting the broad existence of PIAS proteins in the eukaryotic 
kingdom. The PIAS family proteins share a high sequence identity of more than 40% attributed to 
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several conserved functional domains (Shuai and Liu, 2005). Among the four member proteins, 
PIAS1 is the largest. PIAS1 contains Scaffold-attachment factor (SAF)-A and SAF-B, Apoptotic 
chromatin-condensation inducer in the nucleus (ACINUS), and PIAS domain (SAP) in its N-
terminal region, a Pro-Ile-Asn-Ile-Thr (PINIT) motif and a CCCHCCCC-motif-type RING-finger-
like zinc-binding domain (RLD) in the middle region, and a highly acidic domain (AD) and a 
serine and threonine rich (S/T) in the C-terminal region (Shuai, 2006). These motifs are highly 
conserved and shared in the PIAS family. The PIAS proteins were initially identified as negative 
regulators of STAT signaling (Chung et al., 1997; Liu et al., 1998). Subsequently, PIAS1 has been 
shown to contain a SUMO-E3 ligase activity and regulates p53 tumor suppressor through this 
activity (Kahyo et al., 2001). PIAS1 has also been shown to negatively regulate the interferon-
stimulated genes (ISGs) of innate immunity (Liu et al., 2004) and the NF-κB signaling (Liu et al., 
2005). 
PRRSV has been investigated for NF-κB activation to a certain extent but the molecular 
basis of action is unknown (Luo et al., 2011; Wongyanin et al., 2012a; Yu et al., 2016). The 
nucleocapsid (N) protein of PRRSV is a small protein of 128 and 123 amino acids for genotypes I 
and II, respectively, and is the most abundant viral protein expressed during infection (Snijder et 
al., 2013). N is localized in the cytoplasm of infected cells but is also specifically distributed in the 
nucleus and nucleolus (Rowland et al., 1999; Snijder et al., 2013). N contains a nuclear localization 
signal (NLS), and its nuclear localization is NLS-dependent through binding of N to importin-α 
and importin-β (Rowland et al., 2003b). Even though the exact function of N in the nucleus is still 
unclear, its clinical role has been studied in pigs using NLS-null mutant PRRSV. The NLS-null 
virus-infected pigs show clinical attenuation and short duration of viremia as well as high titers of 
neutralizing antibodies (Lee et al., 2006; Pei et al., 2008). Such studies demonstrate that N protein 
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nuclear localization plays an important role for pathogenesis during infection. Yeast two-hybrid 
assays using the cDNA libraries from MARC-145 cells and PAMs have identified multiple cellular 
proteins interacting with N, which includes fibrillarin (Yoo et al., 2003), I-mfa domain containing 
protein (HIC) (Song et al., 2009b), nucleolin, B23, poly-A binding protein (Wang et al., 2012b; 
Yoo et al., 2010), importin-α, importin-β, and exportin (Rowland et al., 2003b; Rowland and Yoo, 
2003). PIAS1 has also been identified as a molecular partner of N in our laboratory (unpublished 
data) and by two others (personal comunication with H.C. Liu, North Carolina State University, 
Raleigh, NC). 
The identification of the N-PIAS1 interaction by three independent laboratories has led us 
to study the biological consequence of the binding of N to PIAS1. Since PIAS1 can function as a 
repressor for NF-κB (Liu et al., 2005), we hypothesize that PRRSV N may neutralize this function 
by binding to PIAS1. In the present study, we show that PRRSV N binds to the N-terminal half of 
PIAS1 which overlaps the p65 binding domain. N does not bind to p65, and thus the binding of 
PIAS1 to N and p65 is competitive, which results in the release of p65 from PIAS1 by N binding, 
leading to activation of NF-κB. The binding domain of N to PIAS1 overlaps NLS, which reveals 
a novel function of N in the nucleus for NF-κB activation and induction of proinflammatory 
cytokines during infection. 
 
4.3 MATERIALS AND METHODS 
4.3.1 Cells and viruses 
ZMAC macrophages were described elsewhere (Chen et al., 2018), and kindly provided 
by Dr. F. Zuckermann (University of Illinois, Urbana-Champaign, IL). HeLa (NIH AIDS Research 
and Reference Reagent Program, Germantown, MD) and MARC-145 cells were cultivated in 
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Dulbecco’s modified Eagle’s medium (DMEM; Mediatech Inc., Manassas, VA), supplemented 
with 10% heat-inactivated fetal bovine serum (FBS; Gibco, Grand Island, NY), in a humidified 
incubator with 5% CO2 at 37 ºC. Primary PAM cells were cultivated in RPMI-1640 medium 
(Mediatech Inc., Manassas, VA) supplemented with 10 mM glutamine and 10% heat-inactivated 
FBS. North American genotype PRRSV strain PA8 was propagated in MARC-145 cells and used 
for this study. For infection, cells were infected at a multiplicity of infection (moi) of 1 to 5 
depending on experiments.  
 
4.3.2 Antibodies and chemicals 
The antibodies and chemicals used in the present study are listed as follow. Anti (α)-
PRRSV-N MAb (MR40) (mouse) was obtained from E. Nelson (South Dakota State University, 
Brookings, SD). α-p65 PAb (rabbit) (H-286, sc-7151), α-p65 MAb (mouse) (F-6, sc-8008), α-
PIAS1 MAb (mouse) (F-1, sc-365127), α-PARP PAb (rabbit) (H-250, sc-7150), α-HSP90 MAb 
(mouse) (4F10, sc-69703), α-SUMO1 MAb (mouse) (D-11, sc-5308), α-SUMO2/3 PAb (rabbit) 
(FL-103, sc-32873), and α-β-actin MAb (mouse) (C4, sc-47778) were purchased from Santa Cruz 
Biotechnologies Inc. (Santa Cruz, CA). α-FLAG MAb (rat) (M2) was purchased from Agilent 
Technologies Inc. (Cedar Creek, TX). α-FLAG PAb (rabbit) was purchased from Rockland Inc. 
(Gilbertsville, PA). α-GFP MAb (rabbit), α-HA MAb (mouse), α-PIAS1 PAb (rabbit), and Alexa-
Flour 488-conjugated and Alexa-Flour 568-conjugated secondary antibodies were purchased from 
ThermoFisher (Rockford, IL). α-HA MAb (rabbit) (C29F4), α-phospho-NF-κB p65 (Ser 536) 
MAb (rabbit) (93H1), and human Tumor Necrosis Factor-α (TNF-α) (8902) were purchased from 
Cell Signaling (Danvers, MA). The peroxidase-conjugated Affinipure goat anti-mouse IgG and 
peroxidase-conjugated Affinipure goat anti-rabbit IgG were purchased from Jackson Immuno 
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Research (West Grove, PA). Lipopolysaccharides (LPS) and DAPI (4’, 6’-diamidino-2-
phenylindol) were purchased from Sigma (St. Louis, MO).  
 
4.3.3 Genes and plasmids 
The HA-PIAS1 and p65 genes were cloned into the pXJ41 expression vector. The 
nonstructural and structural genes were individually cloned in our laboratory from the FL12 
infectious clone of PRRSV as the template (Truong et al., 2004). The coding sequences were PCR-
amplified to contain ATG translation initiation and TAG termination codons. A FLAG-tag was 
added at the N-terminus of each gene. For membrane protein genes such as nsp2, ORF2, ORF2a, 
ORF5, ORF5a, and ORF6, the FLAG-tag was added to the C-terminus. The C-terminal and N-
terminal deletion mutants of PIAS1 gene (pHA-PIAS1-NTD and pHA-PIAS1-CTD, respectively) 
were cloned into pXJ41 using the Eco RI- and Xho I-recognition sequences. The series of N gene 
deletion mutant are described elsewhere48 and were subcloned to pXJ41. The pNF-κB-luciferase 
reporter plasmid was purchased from Stratagene Inc (La Jolla, CA). The pRL-TK Renilla 
luciferase reporter plasmid was purchased from Promega (Madison, WI). The pHA-SUMO1, 
pHA-SUMO2, and pHA-SUMO3 plasmids were obtained from Dr. L. Flamand (Laval University, 
Quebec, Canada).  
 
4.3.4 Immunofluorescence analysis (IFA) 
HeLa or MARC-145 cells grown on microscope coverslips were fixed with 4% 
paraformaldehyde in PBS for 1 h at room temperature (RT), followed by three washes with PBS. 
Cells were permeabilized with 0.1% Triton X-100 for 15 min at RT, followed by three washes 
with PBS. After blocking with 1% BSA in PBS for 1 h at RT, cells were incubated with a primary 
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antibody in blocking buffer for 2 h, followed by three washes with PBS and incubation with a 
secondary antibody for 1 h at RT. Cells were stained with DAPI in 1:5000 dilution for 5 min, and 
after a final wash with PBS, the coverslips were mounted on microscope slides using the 
Fluoromount-G mounting medium (Southern Biotech, Birmingham, AL). Cells were examined 
under the laser scanning confocal microscope (Nikon A1R).  
 
4.3.5 Reverse transcription-quantitative PCR (RT-qPCR) 
RNA was extracted using the RNeasy mini kit according to the manufacturer’s instruction 
(QIAGEN, Hilden, Germany). RT-qPCR was performed in the ABI sequence detector system 
(ABI Prism 7000, Applied Biosystems, Life Technologies) using the final volume of 25 µl 
containing 3 µl of cDNA from reverse-transcription reaction, 12.5 µl of SYBR Green Master mix 
(Applied Biosystems), 2.5 µl of primer pairs (1.25 µl each of sense and antisense primers [10 µM]), 
and 7 µl of water. The primer sequences were designed as follow; for mIL-1β, forward 5’-
CCCAACTGGTACATCAGCAC-3’, reverse 5’- GGAAGACACAAATTGCATGG-3’; for mIL-
6, forward 5’-GCTGCAGGCACAGAACCA-3’, reverse 5’-AAAGCTGCGCAGGATGAGA-3’; 
for mIL-8, forward 5’- CTGGCGGTGGCTCTCTTG, 5’- CCTTGGCAAAACTGCACCTT-3’; 
for mTNF-α, forward, 5’-TCCTCAGCCTCTTCTCCTTCCT-3’, reverse 5’-
ACTCCAAAGTGCAGCAGACAGA-3’; for mβ-actin, forward 5’-
GCGCGGCTACAGCTTCACCAC-3’, reverse 5’-GGGCGCCAGGGCAGTAATCTC-3’; for 
pIL-1β, forward 5’- AACGTGCAGTCTATGGAGT-3’, reverse 5’-
GAACACCACTTCTCTCTTCA-3’; for pIL-6, forward CTGGCAGAAAACAACCTGAACC-
3’, reverse 5’- TGATTCTCATCAAGCAGGTCTCC-3’; for pIL-8, forward 5’-
CCGTGTCAACATGACTTCCAA-3’, reverse 5’- GCCTCACAGAGAGCTGCAGAA-3’; 
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pTNFα, forward 5’-AACCTCAGATAAGCCCGTCG-3’, reverse 5’- 
ACCACCAGCTGGTTGTCTTT-3’; for pβ-Actin, forward 5’- CTGGCATTGTCATGGACTCT 
-3’; reverse 5’-GCGATGATCTTGATCTTCAT-3’. The mRNA levels were calculated using the 
2-ΔΔCT method (Livak and Schmittgen, 2001) and normalized with respect to that of β-actin mRNA. 
Assays were repeated three times, and each assay was conducted in triplicate. 
 
4.3.6 DNA transfection and Dual luciferase reporter assay 
DNA transfection was performed using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) 
according to the manufacturer’s instructions. Cells were grown in 12-well plates, and in each well 
of the plate, 0.5 µg of pNF-κB-luciferase, 0.05 µg of pRL-TK, and 0.5 µg of the gene of interest 
were cotransfected. After 24 h (HeLa) or 42 h (MARC-145) post-transfection, cells were 
stimulated with TNF-α (20 ng/ml) for 6 h, and lysates were prepared using the passive lysis buffer 
(Promega). Supernatants were collected, and luciferase activities were determined using the Dual 
luciferase reporter assay system (Promega). Signals were obtained with the luminometer (Wallac 
1420 VICTOR multi-label counter, Perkin Elmer, Waltham, MA). Values for firefly luciferase 
reporter activities were normalized using the Renilla internal control, and results were expressed 
as relative luciferase activities. The assay was repeated three times, each assay in triplicate.  
 
4.3.7 Co-immunoprecipitation and western blotting 
Approximately one million cells of HeLa were transfected with plasmid DNA for 30 h. For 
virus infection, MARC-145 cells were infected with PRRSV at 5 moi for 48 h, and cell lysates 
were prepared in lysis buffer (50 mM Tris-HCl, 0.1% Triton-X-100, 150 mM NaCl, pH 7.8) 
containing 1X protease inhibitors (Thermo, Rockford, IL) by rotating at 4 ºC for 30 min. Cell 
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lysates were aliquoted to 100 µl as the whole cell lysates (WCL) and stored at -80 C until use. For 
the nuclear complex co-IP, the Nuclear Complex Co-IP kit (Active Motif, Carlsbad, CA) was used 
according to the manufacturer’s protocols. Cell lysates or nuclear extracts were incubated with 
antibody overnight at 4 ºC. In the following morning, 30 µl of protein G agarose beads (EMD 
Millipore, Temecula, CA) were added and the mix was further incubated for at least 2 hr. Beads 
were washed three times with lysis buffer, and precipitates were eluted in 30 µl of M-PER 
mammalian protein extraction reagent (Thermo, Rockford, IL) and loading buffer by boiling at 95 
ºC for 5 min. The beads were spun down in a microcentrifuge and the supernatants were subjected 
to 10% SDS-PAGE and Western blot.  
Small size proteins including PRRSV-N deletion mutants were resolved by gradient gel 
electrophoresis using Mini protein TGX 4-20% gel (Bio-Rad, Hercules, CA). Proteins were 
transferred to Immobilon-P PVDF membrane (Millipore), and the membranes were incubated in 
the TBST blocking buffer (10 mM Tris-HCl, 150 mM NaCl, 0.05% Tween-20 containing with 5% 
skim milk powder for 1 h at RT, followed by further incubation with primary antibody at 4 ºC for 
overnight. The membranes were washed five times with TBST, and incubated with peroxidase-
conjugated secondary antibody in TBST for another 1 h at RT. The membranes were washed five 
times, and the proteins were visualized using the ECL detection system (Thermo, Rockford, IL). 
 
4.3.8 Cell fractionations 
HeLa cells were grown in 6-well-plates, and at 80% confluency, were transfected with 2 
µg/well of plasmid DNA for 30 h. Cells were stimulated with TNF-α (20 ng/ml) for 20 min and 
fractionated using the Nuclear/Cytosol Fractionation kit (BioVision, Milpitas, CA) according to 
the manufacturer’s instructions with minor modifications. Briefly, cell monolayers were washed 
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with PBS and collected in ice-cold PBS. Cells were centrifuged at 4 ºC for 5 min at 1000 rpm in a 
microcentrifuge and resuspended in 200 µl of CEB-A (cytosolic extraction buffer-A) for 
incubation on ice for 10 min. Then, 11 µl of CEB-B were added to the lysates followed by vortex 
and incubation for 1 min on ice. The lysates were spun at 4 ºC for 5 min in a microcentrifuge, and 
the supernatants were collected as the cytoplasmic fraction. The cell pellets were resuspended in 
the NEB buffer and incubated on ice for 10 min. This process of vortex-incubation was repeated 
4 times. The nuclear pellet was centrifuged at 4 ºC for 10 min in a microcentrifuge, and the 
supernatants were collected as the nuclear fraction. Both cytoplasmic and nuclear fractions were 
stored at -80 ºC until use. 
 
4.3.9 Statistical analysis 
Statistical significance was determined by two-tailed Student’s t-test with a value of 
P<0.05 considered statistically significant. 
 
4.4 RESULTS 
4.4.1 NF-κB activation in PRRSV-infected cells 
To examine the regulation of NF-kB during infection, we infected ZMAC cells with 
PRRSV at 5 multiplicity of infection (moi) for 10 h. ZMAC is an established cell line of porcine 
alveolar macrophages, which are natural target cells for PRRSV, derived from lungs of porcine 
fetus (Chen et al., 2018). The cells were stained with p65-specific polyclonal antibody (PAb) and 
PRRSV N-specific monoclonal antibody (MAb) MR40. As anticipated, p65 was distributed in the 
cytoplasm of ZAMC cells when not stimulated (Fig. 4.1A). When stimulated by adding 
lipopolysaccharide (LPS; 100 ng/ml) however, p65 predominantly accumulated in the nucleus 
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(Fig. 4.1A), indicating the activation of NF-κB in the macrophages. In PRRSV-infected cells, 
almost all of PRRSV-N positive ZMAC cells exhibited p65 accumulation in the nucleus even 
without LPS treatment (Fig. 4.1A), demonstrating the activation of NF-κB by PRRSV.  
Activation of NF-κB triggers expression of proinflammatory cytokines (Dinarello, 2000). 
Thus, we examined the expression of IL-1β, IL-6, IL-8, and TNF-α in primary porcine alveolar 
macrophages (PAMs) during infection. Cells were infected with PRRSV at 1 moi for up to 48 h, 
and quantitative RT-PCR was conducted to measure respective transcripts. The kinetics of PRRSV 
replication was determined using the levels of N gene expression in virus-infected cells (Fig. 4.1B). 
The N gene expression reached the peak at 12 h pi followed by gradual decrease until 48 h pi. The 
mRNA for IL-1β significantly (P=0.00043) increased as early as 6 h postinfection (pi). Thereafter, 
IL-1β expression remained consistent until 24 h pi and reached its peak at 48 h pi. The elevated 
expression of IL-1β confirmed the activation of NF-κB in PAMs by PRRSV. The kinetics of IL-
1β expression suggests the NF-κB activation was gradual and accumulating. Similar patterns of 
induction were observed for IL-6, IL-8, and TNF-α (Fig. 4.1C). Together, these data demonstrate 
the activation of NF-κB by PRRSV.  
 
4.4.2 Identification of NF-κB activating proteins of PRRSV 
The roles that PRRSV plays for modulation of NF-κB signaling are complicate. PRRSV 
activates NF-κB and stimulates proinflammatory cytokine production in virus-infected 
macrophages and pigs (Bi et al., 2014; Fu et al., 2012b; Lee and Kleiboeker, 2005; Lee and Lee, 
2012; Liu et al., 2015; Liu et al., 2010; Luo et al., 2011; Miguel et al., 2010; Pineyro et al., 2016; 
Song et al., 2013a; Van Reeth et al., 1999; Van Reeth and Nauwynck, 2000; Xiao et al., 2015; Yu 
et al., 2016; Zhang et al., 2013) (Fig. 4.1). In other studies however, nonstructural protein (nsp) 
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1α, nsp1β, nsp4, and nsp11 suppress NF-κB signaling (Chen et al., 2010b; Huang et al., 2014a; 
Jing et al., 2017; Song et al., 2010; Subramaniam et al., 2010a; Sun et al., 2016), whereas nsp2 
activates (Fang et al., 2012a) or inhibits (Sun et al., 2010) NF-κB depending on the strains of 
PRRSV. To identify viral proteins regulating NF-κB signaling, all 22 coding sequences of PRRSV 
except nsp2TF and nsp2N were individually cloned with a FLAG tag and expressed in HeLa cells 
as a fusion protein. Then, 14 nsps and 8 structural proteins were individually examined for their 
ability to modulate NF-κB in HeLa cells by the promoter-based reporter assay (Fig. 4.2). The 
relative luciferase activities were obtained by normalizing the firefly luciferase to Renilla 
luciferase activities. The value of the relative activity in the empty vector (pXJ41) control group 
was set as 1 without TNF-α treatment. To compensate the variations of reporter activities, we took 
2-fold induction as the cutoff for significance activation. The NF-κB activity increased slightly by 
1.5-fold without TNF-α stimulation in nsp2-expressing cells, and this was the only protein 
activating NF-κB among all 14 nsps. However, this value was below the 2-fold cutoff and thus 
was considered insignificant, and we concluded that no nsp activated NF-κB signaling. For 
structural proteins, the E protein and the nucleocapsid (N) protein induced NF-κB signaling by 
more than 2-fold (2.01 and 2.83-fold, respectively), indicating the E and N proteins were NF-κB 
activators, with N being more potent than E. The other structural proteins GP5, ORF5a, and M 
showed a tendency towards inducing NF-κB signaling, but their induction levels were lower than 
2-fold, and we concluded their abilities to induce NF-κB signaling were negligible. 
 
4.4.3 PRRSV nucleocapsid (N) protein-mediated NF-κB activation 
Since N was demonstrated as the NF-κB activator in HeLa cells (Fig. 4.2), this activity was 
further studied in other cell types. MARC-145 cells are permissive for PRRSV (Kim et al., 1993) 
129 
 
and they were transfected with the NF-κB luciferase reporter and pRL-TK Renilla control plasmids 
along with an empty vector (pXJ41), nsp1α gene, or N gene for 42 h. Cells were then treated with 
TNF-α for 6 h, and the reporter expression was examined (Fig. 4.3A). Compared to mock-treated 
pXJ41 group, TNF-α treatment stimulated the luciferase activity by 4-fold in MARC-145 cells, 
indicating the normal activation of NF-κB signaling in the assay system. PRRSV nsp1α was known 
to suppress NF-κB signaling (Song et al., 2010; Subramaniam et al., 2010a) and thus, no activation 
of NF-κB was observed by nsp1α as expected (Fig. 4.3A). In contrast, N activated NF-κB signaling 
significantly (P=0.0000821) although it was not as much as TNF-α stimulation (Fig. 4.3A), 
indicating the N-mediated NF-κB activation was not due to different cell types. The N-mediated 
NF-κB activation was determined using different amounts of N, and the signaling activation was 
positively correlated with the increasing amounts of N (Fig. 4.3B), indicating the dose-dependent 
activation of NF-κB by N. 
We next examined the expression of proinflammatory cytokines mediated by N. MARC-
145 cells were transfected with N gene for 42 h and treated with TNF-α for 6 h. Specific transcripts 
were then determined by RT-qPCR for IL-1β, IL-6, IL-8, and TNF-α (Fig. 4.3C). The cytokine 
expressions were upregulated by N even without TNF-α stimulation, while pXJ41 or nsp1α as a 
negative control did not upregulate these cytokines. When stimulated with TNF-α, nsp1α 
suppressed these genes whereas pXJ41 and N elevated the expression of these cytokines. Together, 
these data showed that the N protein activates NF-κB signaling to promote the production of 
proinflammatory cytokines. NF-κB activation is mediated through the phosphorylation of p65 at 
position Ser536 followed by the translocation of phosphorylated p65 to the nucleus (Chen and 
Greene, 2004). Thus, it was of interest to examine the subcellular distribution of p65 in cells 
expressing N using anti-p65 PAb and anti-FLAG MAb. Without stimulation, p65 was distributed 
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in the cytoplasm of cells, but upon stimulated with TNF-α, it was translocated to the nucleus (Fig. 
4.3D, panels in second row). In nsp1α-expressing cells, p65 was distributed in the cytoplasm 
despite the stimulation (Fig. 4.3D, panels in third row), indicating the suppression of p65 activation 
by nsp1α (Song et al., 2010; Subramaniam et al., 2010a). In N-expressing cells however, p65 
accumulated predominately in the nucleus (Fig. 4.3D, panels in fourth row), indicating the p65 
activation by N. The phosphorylation of p65 is an additional feature of activated NF-κB, and thus 
was also examined in N protein-expressing cells using a phosphorylated p65 (p-p65S536)-specific 
antibody (Fig. 4.3E). The basal level of phosphorylated p65 (p-p65S536) in HeLa cells increased 
rapidly when treated with TNF-α. In cells expressing N protein however, p-p65S536 increased by 
two-fold even without TNF-α stimulation comparing to that of the basal level. The treatment of 
TNF-α for 5 min or 20 min enhanced p-p65S536 in N-expressing cells, showing that the synergistic 
phosphorylation of p65 by TNF-α and N. The total amount of p65 was not changed in pXJ41- or 
N-expressing cells regardless of TNF-α stimulation (Fig. 4.3E, lower panel). Since N induced p65 
phosphorylation, its nuclear translocation was examined by Western blot using p-p65S536 antibody 
of the nuclear and cytoplasmic fractions from the cells expressing N (Fig. 4.3F). The p-p65S536 
band was meager in the nuclear fraction of the control cells (lane 1) but became increased when 
stimulated with TNF-α (lane 2). In N-expressing cells, p-p65S536 accumulated in the nuclear 
fraction even without TNF-α treatment (lane 3) compared to control, demonstrating the 
phosphorylation of p65 by N and the nuclear translocation of phosphorylated p65. 
 
4.4.4 Binding of PRRSV nucleocapsid (N) protein to PIAS1 
The basis for NF-κB activation by N remains unknown, and we attempted to identify 
cellular proteins interacting with N by yeast two-hybrid screening using N as the bait. The 
131 
 
screening results showed that poly-A binding protein (PABP), human inhibitor of MyoD family a 
(I-mfa) domain containing protein (HIC), and protein inhibitor of activated STAT1 (PIAS1) were 
among the molecular partners of N. Of these proteins, N interactions with PABP and HIC have 
been reported (Song et al., 2009b; Wang et al., 2012b), and PIAS1 was of our particular interest. 
PIAS1 has been reported as a negative regulator of NF-κB (Liu et al., 2005), and so we 
hypothesized that N protein neutralized the PIAS1 activity by binding to it. To test this hypothesis, 
we first examined the colocalization of N and PIAS1 by IFA. HeLa cells were co-transfected with 
the FLAG-N and HA-PIAS1 plasmids, and IFA was conducted using anti-FLAG MAb and anti-
HA MAb. The N protein was distributed in the cytoplasm and nucleus as anticipated (Fig. 4.4A). 
PIAS1 is reported to distribute in the cytoskeleton, cytoplasm, and majorly nucleus (Liu et al., 
2005, Weiskirchen et al., 2001), and in the N and PIAS1 co-expressing cells, both proteins were 
found to colocalize in the cytoskeleton, cytoplasm, and nucleus (Fig. 4.4A), suggesting the binding 
of N to PIAS1. We confirmed their binding by performing a co-immunoprecipitation (co-IP) assay. 
Cells were co-transfected with the HA- PIAS1 and FLAG-N plasmids, and cell lysates were 
incubated with either anti-HA MAb or anti-PIAS1 MAb, followed by immunoblot using anti-
FLAG Ab. Regardless of whether the PIAS1 expression was exogenous (Fig. 4.4B) or endogenous 
(Fig. 4.4C), N was pulled down by PIAS1 (second panel from top, lane 4), whereas FLAG-tagged 
nsp1α (F-nsp1α) or FLAG-tagged nsp1β (F-nsp1β) was not precipitated by PIAS1. To rule out a 
possibility of non-specific binding due to the overexpression of N or non-specific reactivity of the 
Abs, we performed additional co-IP for which cells were co-transfected with an equal amount of 
the HA-PIAS1 and FLAG-N plasmids, followed by pull-down assays using GFP MAb or HA MAb 
and immunoblotting with FLAG PAb (Fig. 4.4D). FLAG-N was again coprecipitated by HA MAb 
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(lane 2) while it was not coprecipitated by GFP MAb (lane 1), confirming the specific interaction 
of FLAG-N and PIAS1. 
 
4.4.5 Competition binding of N to PIAS1 and release of p65 
Since PIAS1 is known to bind to p65 of NF-κB and inhibits p65 binding to DNA (Liu et 
al., 2005), we anticipated that the N-PIAS1 binding would disrupt the PIAS1-p65 interaction, 
which would result in the release of PIAS1 from p65 and the activation of NF-κB. To test this 
hypothesis, we conducted a competition co-IP assay. Cells were transfected with the HA-PIAS1 
and p65 plasmids along with increasing amounts of N gene (Fig. 4.5A). Lysates were incubated 
with anti-HA Mab, and the precipitates were subjected to Western blot using p65 MAb or FLAG 
PAb. p65 was pulled down by PIAS1 when N was absent (top panel, lane 2), confirming the 
PIAS1-p65 binding. When N was expressed however, the amount of p65 decreased (top panel), 
and the decrease of p65 was proportional to the increasing amounts of N (second panel). This 
finding indicates the competition between N and p65 for binding to PIAS1, and thus N-binding to 
PIAS1 may result in the release of p65 from PIAS1.  
Since the N-terminal 344 amino acids of PIAS1 contains the p65 binding region (Liu et al., 
2005), and because N competes with p65 for PIAS1 binding, we wanted to determine if the p65 
binding region in PIAS1 was also responsible for the N-binding. Two truncations were made to 
represent 1-344 aa and 345-650 aa of PIAS1 and they were designated HA-PIAS1-NTD (N-
terminal domain) and HA-PIAS1-CTD (C-terminal domain), respectively (Fig. 4.5B). We then 
performed co-IP experiments using cells over-expressing PIAS1 truncations and N. The N protein 
was precipitated by HA-PIAS1 (lane 3) and by HA-PIAS1-NTD (lane 4), whereas it was not 
precipitated by HA-PIAS1-CTD (lane 5). This result demonstrated the N-terminal 344 amino acids 
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of PIAS1 was the N protein-binding region. This is the same region as the p65-binding region of 
PIAS1 and further supports that N and p65 compete from each other to bind to PIAS1.  
If N bound to p65, it would also result in the disruption of p65-PIAS1 interaction, and thus, 
we examined if N was also able to bind to p65. We conducted co-IP using cells over-expressing 
p65 and N (Fig. 4.5C). Cell lysates co-expressing HA-PIAS1-NTD and N were incubated with 
p65 MAb, and the precipitates were subjected to Western blot with HA MAb or FLAG PAb. For 
this experiment, HA-PIAS1-NTD was preferred to full-length HA-PIAS1 since the expression 
level of HA-PIAS1-NTD was higher than that of HA-PIAS1 (Fig. 4.5B, third panel), and so it 
would be harder for N to block the HA-PIAS1-NTD binding to p65. HA-PIAS1-NTD was pulled 
down by p65 (Fig. 4.5C, top panel, lane 3), and the amount of HA-PIAS1-NTD was significantly 
reduced when N protein was present (lane 5). This further confirms that PIAS1-NTD binding to 
p65 is inhibited by N. Notably, N did not bind to p65 (Fig. 4.5C, second panel, lanes 4 and 5). 
These results demonstrated that the disruption of PIAS1-p65 interaction was not due to the binding 
of N to p65 but due to the binding of N to PIAS1-NTD.  
The competition between PIAS1 and N for p65 binding was also examined in virus-
infected cells. MARC-145 cells were infected with PRRSV at 5 moi for 48 h, and endogenous 
PIAS1 was precipitated using MAb from the cell lysates, and the precipitates were resolved and 
probed with p65 MAb and N PAb. It was evident that p65 was pulled down by PIAS1 MAb in 
mock-infected cells (Fig. 4.5D, top panel, lane 1). In virus-infected cells however, p65 was not 
pulled down, and instead, N was pulled down by PIAS1 (Fig. 4.5D, second panel, lane 2), 
confirming the competition between N and PIAS1 for p65 binding in PRRSV-infected cells.  
To determine the functional consequence of N-PIAS1 interaction, the NF-κB luciferase 
assay was performed in cells expressing PIAS1 or N (Fig. 4.5E). Cells transfected with an empty 
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vector elicited 10-fold induction of NF-κB activity when stimulated with TNF-α. In contrast, the 
NF-κB activity decreased dramatically when PIAS1 was over-expressed, indicating the 
suppression of NF-κB by PIAS1. When the N expression increased however, the NF-κB activity 
was reversed. Together, these data confirm that N binding to PIAS1 prevents PIAS1 binding to 
p65, thereby frees up p65 for activation. 
 
4.4.6 Identification of PIAS1 binding region in N 
PRRSV N contains multiple motifs; nuclear localization signal (NLS) (Rowland et al., 
1999; Rowland et al., 2003b), a noncovalent N-N interaction domain (Wootton and Yoo, 2003), a 
nucleolar localization signal (NoLS) (Rowland et al., 1999; Rowland et al., 2003b), 
phosphorylation sites, and a β-sheet domain (Doan and Dokland, 2003) (Fig. 4.6A). To determine 
the domain in N for NF-κB activation and to examine the correlation with PIAS1 binding, six 
deletion mutants of N, each fused with a FLAG tag, were constructed; C11 (representing 1-112 
aa), C51 (1-72 aa), C86 (1-37 aa), N18 (18-123 aa), N41 (41-123 aa), and N73 (73-123 aa). Then, 
NF-κB-luciferase assays were performed for each construct by co-transfecting with the NF-κB-
luciferase reporter (Fig. 4.6B). The C11, C51, and N18 constructs showed the similar activity of 
NF-κB to that of full-length wild-type N (N-WT). N41 also activated NF-κB signaling but at a 
reduced rate than the above constructs. In contrast, C86 and N73 did not activate NF-κB, indicating 
the region between 37 and 72 aa of N was the essential domain for activation. Contained in this 
region are NLS and NoLS, suggesting that such localization signals might be crucial for NF-κB 
activation. To investigate the cellular distribution of N and its mutants, IFA was performed using 
anti-FLAG MAb. All mutants of N translocated to the nucleus including C86 and N73, although 
the NLS was absent in these mutants (Fig. 4.6C). We reasoned that C86 (37 aa) and N73 (50 aa) 
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were small in their size and thus passively diffused to the nucleus as previously reported (Timney 
et al., 2016). Nevertheless, the nucleolar localization of N appeared to be NoLS-dependent since 
C11, C51, N18, and N41 localized in the nucleolus (Fig. 4.6C), while C86 and N73 did not. This 
observation indicates the nuclear localization per se was not correlated with NF-κB activation in 
our transfection conditions. To determine the PIAS1-binding domain in N, we performed co-IP 
assays using individual deletion mutants. Cell lysates were precipitated using anti-HA MAb and 
probed with anti-FLAG PAb. N-WT, C11, N18, and N41 were pulled down by PIAS1 (Fig. 4.6D, 
second panel, lanes 2, 3, 6, 7), demonstrating that these constructs retained the PIAS1 binding 
ability. Since these constructs activated NF-κB (Fig. 4.6B), our results also indicate the positive 
correlation between PIAS1 binding of N and NF-κB activation. C51 was not initially detectable 
(Fig. 4.6D, second panel, lane 4), but with the increased amount of C51 plasmid for transfection 
and a longer exposure of the membrane, it was apparent that C51 was also pulled down by PIAS1 
(Fig. 4.6D, third panel, lane 4), showing the binding of C51 to PIAS1. Taken altogether, these data 
indicate that the region between aa position 37 and 72 of N is the region for PIAS1 binding and 
also for NF-κB activation.  
 
4.4.7 NLS of N mediates NF-κB activation 
The PIAS1 binding region (37 aa to 72 aa) of N includes NLS (41 aa to 47 aa) (Fig. 4.6D), 
and the previous studies have shown that NLS is a determinant for the PRRSV pathogenesis in 
pigs. Thus, it was of an interest to examine the role of NLS in the N-mediated NF-κB activation. 
NLS functions by interacting with importin-α and importin-β via the conserved sequence of 41-
PGKKNKK-47 in N51. We made an NLS knock-out N gene mutant to substitute two lysine (K) 
residues at 43 and 44 with two glycine (G) residues and designated this mutant as N-GG (Fig. 
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4.7A). By IFA, N-WT was distributed in the cytoplasm, nucleus, and nucleolar in both HeLa and 
MARC-145 cells whereas N-GG did not enter the nucleus nor the nucleolus of cells (Fig. 4.7B). 
When we examined the NF-κB activity using the luciferase assay, N-WT activated NF-κB in these 
cells; however, N-GG lost the activation drastically (Fig. 4.7C). In HeLa cells, the NF-κB activity 
induced by N-GG was only slightly higher than that of pXJ41 empty vector, but was largely 
reduced compared to N-WT. In MARC-145 cells, N-GG did not induce the NF-κB activity and 
there was no difference between N-GG and pXJ41. These results indicate that NLS of N 
contributes to the NF-κB activity. We further examined the cellular distribution of p65 in N-GG 
expressing cells (Fig. 4.7D). While N-WT caused the p65 translocation and accumulation in the 
nucleus, N-GG did not cause the p65 nuclear translocation and it was rather distributed in the 
cytoplasm, as with in the cells expressing nsp1α or empty vector, indicating no activation of NF-
κB by N-GG. We also examined the proinflammatory cytokine expressions mediated by N-GG by 
RT-qPCR (Fig. 4.7E). TNF-α or N-WT promoted the expression of IL-1β, IL-6, IL-8, and TNF-α, 
but N-GG did not induce the production of IL-1β, IL-6, and IL-8. Interestingly, TNF-α expression 
was slightly increased by 2-fold compared to pXJ41, but it was only about one-third of the level 
by N-WT. Together, these results show that NLS of N was important for N-mediated 
proinflammatory cytokine productions which is likely via NF-κB activation. 
 
4.4.8 N-GG did not bind to PIAS1 
Since N-WT activated NF-κB while N-GG lost this activity, the interaction of N-GG and 
PIAS1 was examined. We co-transfected the HA-PIAS1 and N-GG plasmids in the equal molar 
ratio and conducted a pull-down assay using anti-HA MAb to determine whether N-GG was able 
to bind PIAS1. Surprisingly, a considerably reduced amount of N-GG was pulled down by HA-
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PIAS1 (Fig. 4.7F, top panel, lane 3). N-GG binding to PIAS1 was not completely abolished when 
N-GG was over-expressed. Since PIAS1 resides in the nucleus and suppresses NF-κB, we assumed 
that the lack of binding between N-GG and PIAS1 was likely due to their different cellular 
distributions. N-GG did not localize in the nucleus as expected and this was likely because NLS 
was destroyed (Fig. 4.7B). We also performed the nuclear complex co-IP. The nuclear lysates were 
prepared and subjected to co-IP using anti-PIAS1 MAb and to immunoblot using anti-FLAG PAb. 
Only N-WT was identified in the nuclear extract (Fig. 4.7G, third panel, lane 2), and N-GG was 
not detectable (third panel, lane 3). By co-IP, N-GG was not pulled down by PIAS1 (top panel, 
lane 3), indicating the absence of binding between N-GG and PIAS1 in the nucleus. The results 
showed that, although N-GG still retained a weak binding to PIAS1 when over-expressed, N-GG 
blocked the endogenous PIAS1-binding. Altogether, our data confirm the N-PIAS1 interaction 
leading to NF-κB activation. 
 
4.4.9 SUMOylation of N 
PIAS1 is a SUMO E3-ligase (Kahyo et al., 2001). Since N was shown to bind to PIAS1, it 
was of interest to examine if N would be a SUMO substrate of PIAS1. During the co-IP experiment 
using PRRSV-infected cells, we observed a 25 K protein in addition to N of 15 K (Fig. 4.5D, 
bottom panel, lane 2). The 25 K protein was routinely identified even under the denaturing 
conditions of SDS-PAGE, and its size was smaller than the dimer of N. The molecular weight of 
a SUMO molecule is 11 KDa, and thus we predicted that the 25K protein was possibly a 
SUMOylated form of N (Everett et al., 2013; Wimmer et al., 2012). To examine this possibility, 
cells were infected with PRRSV at 5 moi for 48 h and a co-IP assay was conducted using PRRSV-
N MAb and SUMO-1 or SUMO-2/3 antibody. The 25 K protein was identified in the virus-infected 
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cells (Fig. 4.8A, lane 2). This band was detectable by only SUMO-2/3 antibody in Western blot 
and co-IP (lane 6) but not by SUMO-1 antibody (lane 4). This finding indicates that N was 
conjugated by SUMO-2/3 modifier rather than by SUMO-1 modifier. To confirm this finding, IFA 
was performed using anti-HA Ab and anti-FLAG Ab in cells over-expressing HA-SUMO-1, HA-
SUMO-2, or HA-SUMO-3 along with FLAG-N. It was evident that FLAG-N colocalized with 
HA-SUMO-2 or HA-SUMO-3 but did not colocalize with HA-SUMO-1 (Fig. 4.8B). SUMO-2/3 
conjugated N protein was also detectable in FLAG-N expressing cells (Fig. 4.8C, upper panel, 
lanes 2 and 4). These data demonstrate that PRRSV N was SUMOylated by SUMO-2/3 modifier. 
 
4.5 DISCUSSION 
Proinflammatory cytokines play a wide range of cellular functions, and one major role is 
the contribution to host defense against infections. Production of proinflammatory cytokines is 
precisely balanced, and over-expression may cause tissue damages and immune-mediated 
diseases. PRRSV infects pulmonary alveolar macrophages (PAMs) in the lungs of pigs and causes 
inflammation and respiratory disease (Albina, 1997; Loving et al., 2007). Expressions of IL-1β 
and TNF-α are driven by NF-κB, and in turn, they are potent NF-κB activators (Chen and Greene, 
2004). This positive feedback maintains the homeostasis of a host so that the host can quickly build 
an antiviral status during infection. IL-6 is induced by IL-1β and TNF-α (Zoja et al., 1991) and 
causes fever (Fossum et al., 1998). IL-8 is a neutrophil chemotactic factor and is also driven by 
NF-κB (Lin et al., 1994). The production of such proinflammatory cytokines during PRRSV 
infection contributes to clinical and pathological outcome featured by fever, neutrophil infiltration 
to lungs, and tissue damages (Liu et al., 2015; Van Reeth et al., 1999). The roles of PRRSV in NF-
κB regulation seem complicates since the suppression and the activation have both been reported. 
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The suppression is largely executed by nonstructural proteins, including nsp1α, nsp1β, nsp4, nsp5, 
and nsp11 (Chen et al., 2010b; Huang et al., 2014a; Jing et al., 2017; Song et al., 2010; 
Subramaniam et al., 2010a; Sun et al., 2016), whereas the activation is attributed to structural 
proteins of E and N (Fig. 4.2). The dual roles of PRRSV regulating NF-κB contribute to the overall 
pathogenesis of virus, but in cells and pigs, the virus as a whole activates NF-κB.  
N is a potent viral activator for NF-κB (Fig. 4.2). Previous studies have shown that PRRSV 
activates NF-κB, and the N protein is the viral component inducing NF-κB activation (Fu et al., 
2012b; Lee and Kleiboeker, 2005; Luo et al., 2011; Song et al., 2013a; Wongyanin et al., 2012a; 
Yu et al., 2016; Zhang et al., 2013). However, the mechanism of action remains unknown, and in 
the present study, we have determined the molecular basis for N-mediated NF-κB activation. 
Proinflammatory cytokines including IL-1β, IL-6, IL-8, and TNF-α are upregulated and peak at 
48 hpi in primary PAMs during infection (Fig. 4.1C). Our results show that N activates NF-κB 
luciferase signaling and induces the phosphorylation and nuclear translocation of p65 and confirms 
that N activates NF-κB (Figs. 4.2 and 4.3). By yeast two-hybrid and co-IP assays, we have 
determined PIAS1 as an N-binding protein. PIAS1 is a known NF-κB repressor (Liu et al., 2005), 
and we show that N-PIAS1 binding releases p65 and activates NF-κB. 
Based on the results, we propose a working model for PRRSV-mediated NF-κB activation. 
In resting cells, PIAS1 functions to repress p65 in the nucleus to keep it in check, and therefore 
only minimal levels of cytokines are produced for homeostasis. At an early phase of infection, a 
limited amount of N is produced, and the majority of N is used for progeny virus production in the 
cytoplasm. PRRSV N is a nuclear-cytoplasmic protein (Rowland et al., 1999; Rowland et al., 
2003b), and thus some of N translocates to the nucleus, where it binds PIAS1 and releases p65. At 
this phase, most PIAS1 still remains as a complex with p65 and suppresses NF-κB, and the levels 
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of proinflammatory cytokines are still low. As the infection proceeds, N concentration in the 
nucleus increases and the N binding to PIAS1 releases more p65. Released p65 then binds to the 
κB sites on DNA to initiate transcription of proinflammatory cytokine genes. The cytokine 
expressions gradually increase and they are secreted from cells and bind to their receptors to 
activate the NF-κB signaling. As N concentration becomes predominant in the nucleus, NF-κB 
activation is enhanced, leading to inflammation.  
Previously, we have constructed a series of N-NLS null-mutant PRRSVs and examined 
their pathogenesis in pigs (Lee et al., 2006; Pei et al., 2008). These studies have demonstrated a 
correlation between the N nuclear localization and clinical attenuation of PRRSV. Since PIAS1 is 
predominantly nuclear (Liu et al., 2005) and because N from NLS-null PRRSV remains in the 
cytoplasm, these studies support our model. Indeed, N-GG does not enter the nucleus and does not 
activate NF-κB (Fig. 4.7). Further studies show that losing NF-κB activity of N-GG is due to the 
lack of or reduced PIAS1 binding (Fig. 4.7). Since N neutralizes the repressive function of PIAS1, 
NF-κB singling is sensitized, and NF-κB activation becomes faster and synergistic especially when 
coinfection with other pathogens occurs (Fig. 4.9). 
Porcine respiratory disease complex (PRDC) is a multifactorial disease of pigs, and 
PRRSV is frequently reported as the major pathogen in the diseased animals. In pigs coinfected 
with PRRSV and Mycoplasma hyopneumoniae or other bacterial pathogens, the production of 
proinflammatory cytokines is elevated, and the clinical disease become severe (Qiao et al., 2011; 
Thanawongnuwech et al., 2004; Thanawongnuwech et al., 2001). Elevated production of 
proinflammatory cytokines by PRRSV will benefit the virus. Although inflammation is mounted 
during the late stage of infection, recruitments of monocytes and macrophages to infection site 
provide fresh target cells for virus (Van Reeth et al., 1999). Viruses take advantage by modulating 
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the NF-κB signaling to facilitate their own good or to cause disease (Hiscott et al., 2001; Rahman 
and McFadden, 2011; Santoro et al., 2003). The modulatory actions may vary for different viruses 
(Hiscott et al., 2001; Rahman and McFadden, 2011; Santoro et al., 2003). PIAS1 is an important 
NF-κB repressor that controls inflammation, and the PIAS family proteins are involved in 
regulating immune-related gene expressions (Shuai, 2006; Shuai and Liu, 2005). Despite some 
viral proteins have been reported to interact with the PIAS family proteins and are SUMOylated 
(Everett et al., 2013; Wimmer et al., 2012), viral regulation of NF-κB through the PIAS family 
proteins is relatively new. VP35 of Ebola Zaire virus induces NF-κB activation in cells (Gantke et 
al., 2013) and interacts with PIAS1 (Chang et al., 2009). NP of influenza A virus also activates 
NF-κB (Flory et al., 2000) and interacts with PIAS for SUMOylation (Han et al., 2014). Our study 
presents a novel mechanism for PRRSV pathogenesis mediated by N and provides a new insight 









Fig. 4.1 (cont.). Activation of NF-κB by PRRSV in ZMAC cells and primary porcine alveolar 
macrophages (PAMs). (A), ZMAC cells were infected with the PA8 strain of PRRSV at 5 moi 
for 10 h. Cells were stained with α-PRRSV-N MAb (MR40) (mouse) (green) and α-p65 PAb 
(rabbit) (red). The nuclei were stained with DAPI (blue). Images were taken by confocal 
microscopy (Nikon A1R). White arrows indicate the nucleus (Nu), and the orange arrow indicates 
the nucleolus (No). Scales in micrometers (µm). (B) and (C), Primary PAMs were infected with 
PRRSV at 1 moi for indicated times, and total RNAs were isolated. RT-qPCR was performed to 
detect the levels of PRRSV-N genes (B) and transcripts for IL-1β, IL-6, IL-8, and TNF-α (C). The 
relative levels were calculated using the 2-ΔΔCT method by normalizing the values to that of β-actin. 
The fold changes were compared to the levels at time zero. Error bars, mean ± standard deviation 





Fig. 4.2. Identification of NF-κB activating proteins of PRRSV. NF-κB luciferase activities of 
nonstructural proteins and structural proteins. HeLa cells grown in 12-well plates were transfected 
with pNF-κB-Luciferase (0.5 µg), pRL-TK (0.05 µg), and each (0.5 µg) of for 24 h. Cells were 
treated or mock-treated with TNF-α (20 ng/ml) for 6 h, and cell lysates were prepared in passive 
lysis buffer for luciferase assays as described in Materials and Methods. Relative luciferase 
activities were obtained by normalizing the firefly luciferase to Renilla luciferase activities. Values 
of the relative luciferase activity in the pXJ41 control group were set as 1 and the values for 
individual viral proteins were normalized using that of the pXJ41 control. Error bars, mean ± 







Fig. 4.3. NF-κB activation by N. (A) and (B), Cells were co-transfected with pNF-κB-Luciferase 
(0.5 µg) and pRL-TK (0.05 µg), along with 0.5 µg indicated genes. After 24 h (HeLa cells) or 42 
h (MARC-145 cells), cells were treated or mock-treated with TNF-α (20 ng/ml) for 6 h. Luciferase 
reporter activities were calculated by normalizing to the Renilla activity. Error bars, mean ± s.d. 
(n=3). Significance was calculated by comparing to pXJ41. ***, P<0.001. (C), Cells were 
transfected with 2 µg of indicated genes for 42 h and treated with or mock-treated with TNF-α (20 
ng/ml) for 6 h. The expression levels were calculated with 2-ΔΔCT method by normalizing to that 
of β-actin. The fold changes were calculated with respect to the level of pXJ41. Error bars, mean 
± s.d. (n=3). *: P<0.05, **: P<0.01, ***: P<0.001. (D), HeLa cells were transfected with 2 µg of 
indicated genes for 24 h and treated or mock-treated with TNF-α (20 ng/ml) for 20 min. The cells 
were stained with indicated antibodies. Nuclei (blue) were stained with DAPI. White arrows 
indicate nsp1α or N-expressing cells. (E) and (F), HeLa cells were transfected with 2 µg of 
indicated genes for 30 h and stimulated with TNF-α (20 ng/ml) for indicated times (E) or 20 min 
(F). Cells lysates (E) or cytoplasmic and nuclear fractions (F) were prepared and subjected to 
Western blot. Intensities of phosphor-p65(S536) staining were quantified with the FluroChem R 
system, normalized to that of β-actin, and compared to the pXJ41 control (TNF-α mock-treated) 






Fig. 4.4. Identification of PIAS1 as a molecular partner of N. (A), Colocalization of N and 
PIAS1. HeLa cells were transfected with FLAG-N for 24 h and stained with α-FLAG MAb (green) 
and α-PIAS1 PAb (red). Nuclei (blue) were stained with DAPI. (B) and (C), Specific binding of 
N with exogenously expressing PIAS1 (B) and endogenous PIAS1 (C) determined by co-IP. HeLa 
cells were co-transfected with 1 µg of pXJ41, F-nsp1α, F-nsp1β, or N plasmids, along with HA-
PIAS1 (2 µg) for 30 h, and were subjected to co-IP. Cells lysates were pulled down by α-HA MAb 
and were probed with α-FLAG PAb (middle panel) or α-HA MAb (top panel). Whole cell lysates 
(WCL) were resolved and probed with α-HA MAb (third panel) or α-FLAG PAb (bottom panel). 
(D), HeLa cells were co-transfected with the HA-PIAS1 (2 µg) and FLAG-N (1 µg) plasmids for 
30 h and subjected to co-IP. Cell lysates were pulled down with α-GFP MAb or α-HA MAb 
followed by probing with α-FLAG MAb (top panel) or α-HA MAb (second panel). WCL were 

















Fig. 4.5 (cont.). Competition binding of N and p65 to PIAS1. (A), HeLa cells were transfected 
with the HA-PIAS1 and p65 plasmids along with increasing amounts of N gene for 30 h, and cell 
lysates were subjected to co-IP using α-HA MAb for precipitation and indicated antibodies for 
immunoblot. (B), Schematic presentation of FLAG-tagged N or HA-tagged full length PIAS1 and 
construction of HA-PIAS1-NTD (N-terminal domain) and HA-PIAS1-CTD (C-terminal domain). 
Lower panels, co-IP experiments in which HeLa cells were transfected with N plasmid along with 
HA-PIAS1, HA-PIAS1-NTD, or HA-PIAS1-CTD plasmids as indicated for 30 h, and cell lysates 
were subjected to co-IP using α-HA MAb for precipitation and using indicated antibodies for 
immunoblot. (C), HeLa cells were transfected with p65 along with HA-PIAS1-NTD or FLAG-N 
or both for 30 h, and cell lysates were subjected to co-IP using α-p65 MAb for precipitation and 
indicated antibodies for immunoblot. (D), Approximately 2 million cells of MARC-145 were 
infected with PRRSV at 5 moi for 48 h. Cell lysates were prepared and subjected to co-IP using α-
PIAS1 MAb and immunoblot using α-p65 MAb or α-PRRSV-N PAb (bottom panel). β-actin 
served as a loading control. (E), N expression rescued NF-kB activity from PIAS1-mediated 
suppression. HeLa were transfected with NF-kB-luciferase reporter (0.5 µg) and pRL-TK plasmid 
(0.05 µg) along with PIAS1 plasmid (0.5 µg) alone or with PIAS1 (0.5 µg) and variable amounts 
of N plasmids together. 24 h post-transfection, cells were stimulated with TNF-α (20 ng/ml) for 6 
h. Error bars, mean ± s.d. (n=3). Statistical significance was calculated by comparing the values to 











Fig. 4.6 (cont.). NF-κB binding domain of PIAS1 functions for N binding. (A), Schematic 
presentation of N and construction of N mutants. NLS, nuclear localization signal; N-N, non-
covalent-interaction domain for dimerization of N; NoLS, nucleolar localization signal; β, β-sheet 
responsible for overall conformation of N. Numbers indicate amino acids positions. N-FL, full 
length N. Nuclear and nucleolar localizations, PIAS1 binding, and NF-κB activation of N and its 
mutants are summarized as positive (+) and negative (-). (B), NF-κB activities of N mutants. HeLa 
cells were transfected with plasmids containing the plasmids for NF-κB-Luciferase (0.5 µg), pRL-
TK (0.05 µg), and individual mutants of N (0.5 µg) for 24 h. Cells were treated or mock-treated 
with TNF-α (20 ng/ml) for 6 h. Cell lysates were prepared and subjected to luciferase assays as 
described in Materials and Methods. Relative luciferase activities were obtained by normalizing 
the firefly luciferase to Renilla luciferase activities. Error bars, mean ± s.d. (n=3). Significance 
was calculated by comparing to pXJ41 using two-tailed Student’s t-test. *: P<0.05, **: P<0.01, 
***: P<0.001. (C), Cellular localization of N mutants. HeLa cells were transfected with plasmids 
containing the N gene or each of its mutants (2 µg) of which a FLAG tag was fused at the N-
terminus of each construct. At 24 h post-transfection, cells were stained with α-FLAG MAb 
(green) to indicate N distribution. Nuclei were stained with DAPI (blue). (D), Co-IP for HA-PIAS1 

















Fig. 4.7 (cont.). N-GG lost NF-κB activation and PIAS1 binding in the nucleus. (A), 
Construction of NLS knock-out N-GG mutant. (B), Cells were transfected with 2 µg of plasmids 
and stained with α-FLAG MAb (green). Nuclei were stained with DAPI (blue). nucleus (Nu), 
nucleolus (No). (C), Cells were transfected with pNF-κB-Luciferase (0.5 µg) and pRL-TK (0.05 
µg), along with 0.5 µg of indicated genes. After 24 h (HeLa) or 42 h (MARC-145), cells were 
incubated with 20 ng/ml of TNF-α for 6 h. Cell lysates were subjected to luciferase assays. 
Reporter activities were calculated by normalizing to respective Renilla activities. Error bars, mean 
± s.d. (n=3). *: P<0.05, **: P<0.01, ***: P<0.001. (D), Cells were transfected for 24 h and treated 
with TNF-α (20 ng/ml) for 20 min. Cells were stained with antibodies as indicated. Nuclei (blue) 
were stained with DAPI. White arrows indicate N-expressing cells, and yellow arrow indicates 
p65 in the nucleus. (E), Cells were transfected with 2 µg of indicated genes for 42 h and treated 
with 20 ng/ml of TNF-α for 6 h. Total cellular RNA was isolated and RT-qPCR was performed to 
measure the transcripts levels. Expression levels were calculated with 2-ΔΔCT method by 
normalizing to that of β-actin. Error bars, mean ± s.d. (n=3). *: P<0.05, **: P<0.01, ***: P<0.001. 
(F), HeLa cells were transfected with the 2 µg of indicated genes for 30 h and subjected to co-IP. 
Cell lysates were immunoprecipitated with α-HA MAb followed by probing with α-FLAG PAb or 
α-HA MAb (top panel). (G), HeLa cells were transfected with either F-N-WT (2 µg) or F-N-GG 











Fig. 4.8 (cont.). Modification of N by SUMO2/3 conjugation. (A), MARC-145 cells were 
infected with PRRSV at 5 moi for 48 h, and cell lysates were subjected to co-IP using α-PRRSV-
N MAb (MR40) for immunoprecipitation and α-PRRSV-N PAb, α-SUMO1 MAb, or α-SUMO2/3 
PAb for immunoblot (upper panels). Whole cell lysates (WCL) were subjected to Western blot as 
an input control (bottom panels). (B), HeLa cells were transfected with FLAG-N plasmid (2 µg) 
along with the HA-SUMO1 (2 µg), HA-SUMO2 (2 µg), or HA-SUMO3 (2 µg) plasmids. After 24 
h, cells were stained with α-FLAG PAb (red) and α-HA MAb (green) to detect N and SUMO, 
respectively. Nuclei were stained with DAPI (blue). (C), HeLa cells were transfected with FLAG-
N plasmid (2 µg) for 30 h, and cell lysates were subjected to co-IP using α-FLAG MAb for 
immunoprecipitation and α-SUMO2/3 PAb or α-FLAG PAb for immunoblot. Whole cell lysates 
(WCL) were subjected to Western blot as an input control (bottom panels), and β-actin served as 







Fig. 4.9. Proposed mechanism of PRRSV Nucleocapsid-mediated NF-κB activation. Up-left, 
in uninfected cell, the NF-κB signaling pathway is regulated by PIAS1 in the nucleus which binds 
to NF-κB p65 to prevent it from activating the transcription of proinflammatory cytokine genes. 
The proinflammatory cytokines remain at the basal level. Up-right, in PRRSV infected cell, the 
virus expresses N protein which travels into the nucleus. As the N protein accumulating in the 
nucleus, the PIAS1 is competitively bound by N protein, thus the NF-κB p65 is freed up which 
then activates the transcription of proinflammatory cytokine genes, leading to enhanced 
proinflammatory cytokines production. And these proinflammatory cytokines further enhance the 
NF-κB activation through autocrine or paracrine manners. Down-middle, due to N-PIAS1 




CHAPTER 5: GENERAL CONCLUSION 
 
PRRS is an emerging and re-emerging disease causing significant economic impact in the 
swine industry worldwide. Commercial vaccines are available, but their efficacy and safety are 
unsatisfactory. There are also no effective therapeutic treatments on PRRSV infected pigs or 
regimens to eliminate persisting viruses. PRRSV has developed the ability to suppress type I IFNs 
production and signaling during infection. Type I IFNs are the most potent antiviral cytokines 
against invading viruses and building antiviral status of the host. Considering the role of type I 
IFNs for innate antiviral immunity and priming the adaptive immunity, the loss of type I IFN 
production in hosts infected with PRRSV will hardly lead to developing proper antiviral 
mechanisms against virus infection and to clearing the virus from persistently-infected lymphoid 
tissues. At present, at least six viral proteins (nsp1α, nsp1β, nsp2, nsp4, nsp11 and N) have been 
identified as IFN antagonists.  
PRRSV nsp1 is the first viral protein generated during infection and it will further process 
into two subunits, nsp1α, nsp1β. Both nsp1α and nsp1β potently suppress the type I IFN induction. 
For nsp1β in particular, it also inhibits the IFN mediated JAK-STAT pathway, leading to inhibition 
of ISGs expression. The dual roles for IFN production and signaling suppression make nsp1β of 
special interest. Recent findings show that nsp1β suppresses the host mRNA export from the 
nucleus to the cytoplasm. The blocking of host mRNA nuclear export results in the suppression of 
host protein synthesis. The host mRNA nuclear retention is correlated with the IFN suppression of 
nsp1β as well. A SAP (SAF-A/B, Acinus, and PIAS) motif is found in nsp1β with the consensus 
sequence of 126-LQxxLxxxGL-135 residing in the PLP1β domain. This motif is responsible for the 
host mRNA nuclear retention as well as IFN suppression. Single-amino acid mutations have been 
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introduced in the SAP motif and a series of nsp1β mutants have been constructed to change its 
normal phenotype. These mutants then have been examined for their cellular distribution, their 
ability to inhibit host mRNA nuclear export, and host protein synthesis. It appears that the mutants 
L126A, R128A, R129A, L130A, and L135A have lost the ability to block host mRNA nuclear 
export. The SAP mutant viruses were generated using reverse genetics. Among the viable mutants, 
vL126A and vL135A lost the ability to suppress IFN production and the ability to retain host 
mRNA in the nucleus in cells. In addition, the mutant viruses become attenuated in growth in cells, 
suggesting the IFN-suppression is important for viral growth. To further characterize the IFN-
suppression functions, an in vivo study in pigs was conducted. Pigs infected with vL126A or 
vL135A exhibited less severe clinical signs with lower viral titers and shorter duration of viremia 
when compared to those of WT-infected pigs. The levels of PRRSV-specific antibody remained 
comparable in all infected groups but the neutralizing antibody titers were high in vL126A-infected 
or vL135A-infected pigs. The IFN-α concentration was also high in pigs infected with the SAP 
mutants. Reversion to WT sequence was observed in the SAP motif in some animals, and the 
revertants regained the function to suppress IFN production and host mRNA nuclear export, 
indicating strong selection pressure in the SAP motif of nsp1β. Both the in vitro and in vivo data 
demonstrate that the IFN antagonism and host mRNA nuclear retention mediated by nsp1β 
contributes to viral virulence, and loss of these functions confers PRRSV attenuation. 
The mechanism for nsp1β-mediated host mRNA nuclear export inhibition was 
investigated. Nup62 was identified to specifically interact with nsp1β and the region representing 
the C-terminal 328-522 residues of Nup62 was determined as the binding domain to nsp1β. Nsp1β 
SAP mutant L126A did not bind to Nup62, and in L126A expressing cells, the host mRNA nuclear 
export occurred normally. In nsp1β-, instead of L126A-expressing cells, the viral protein 
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synthesizing got enhanced and the antiviral gene mRNAs were reduced in the cytoplasm. As a 
consequence, viral growth was improved.  
In addition to IFN suppression, activation of NF-κB is another arm of PRRSV 
pathogenesis, and the PRRV-mediated NF-κB activation is closely related to the diseases. As 
mentioned above, PRRSV is reported to activate NF-κB signaling, and the NF-κB-mediated 
inflammation is correlated with the disease. Efficient replication of PRRSV in the macrophages 
generates a large amount of N protein. The N protein activates NF-κB signaling, resulting in an 
enhanced production of proinflammatory cytokines. The proinflammatory cytokines will in turn 
attract more monocytes and macrophages to the site of infection for virus to infect, as well as 
neutrophils infiltration for tissue damage. We examined the ability of all 22 PRRSV proteins for 
NF-κB regulation and determined the N protein as the NF-κB activator. PIAS1 was identified as a 
cellular protein binding to N. PIAS1 is known to bind to p65 (RelA) in the nucleus and blocks its 
DNA binding, thus functions as a repressor of NF-κB. Binding of N to PIAS1 released p65 for 
NF-κB activation. The N-terminal half of PIAS1 was mapped as the N binding domain, and this 
region overlapped its p65-binding domain. For N, the region between 37 and 72 aa was identified 
as the binding domain to PIAS1, and this domain alone was able to activate NF-κB, and this region 
overlaps the NLS. A NLS knock-out mutant N did not activate NF-κB, and this is likely due to the 
lack of its interaction with PIAS1 in the nucleus, demonstrating the positive correlation between 
the binding of N to PIAS1 and the NF-κB activation.  
In summary, this study unveiled the molecular basis of interactions between hosts and 
PRRSV viral proteins to delineate viral strategies for immune evasion and pathogenesis with a 
specific emphasis on type I IFN modulation and NF-κB activation (Fig. 5.1). In this study, the SAP 
motif of nsp1β and the NLS of N protein were identified critical for the type I IFN-suppression 
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and NF-κB activation respectively. Based on these findings, to make a IFN-suppression and NF-
κB activation dual-negative mutant virus is theoretically and technically feasible and such mutant 
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